<?xml version="1.0" encoding="UTF-8"?><xmi:XMI xmlns:cas="http:///uima/cas.ecore" xmlns:xmi="http://www.omg.org/XMI" xmlns:types="http:///edu/cmu/lti/oaqa/framework/types.ecore" xmlns:tcas="http:///uima/tcas.ecore" xmlns:types2="http:///edu/cmu/lti/qalab/types.ecore" xmi:version="2.0"><cas:NULL xmi:id="0"/><cas:Sofa xmi:id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="PLoS ONE: Genetics of Clusterin Isoform Expression and Alzheimer's Disease RiskOpen AccessResearch ArticleGenetics of Clusterin Isoform Expression and Alzheimer's Disease RiskI-Fang Ling1, Jiraganya Bhongsatiern1, James F. Simpson1, David W. Fardo2, Steven Estus1*1 Department of Physiology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America, 2 Department of Biostatistics, University of Kentucky, Lexington, Kentucky, United States of AmericaAbstract Top The minor allele of rs11136000 within CLU is strongly associated with reduced Alzheimer's disease (AD) risk. The mechanism underlying this association is unclear. Here, we report that CLU1 and CLU2 are the two primary CLU isoforms in human brain; CLU1 and CLU2 share exons 2–9 but differ in exon 1 and proximal promoters. The expression of both CLU1 and CLU2 was increased in individuals with significant AD neuropathology. However, only CLU1 was associated with the rs11136000 genotype, with the minor “protective” rs11136000T allele being associated with increased CLU1 expression. Since CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively, we compared their expression; for both CLU1 and CLU2 transfected cells, clusterin is present in the secretory pathway, accumulates in the extracellular media, and is similar in size to clusterin in human brain. Overall, we interpret these results as indicating that the AD-protective minor rs11136000T allele is associated with increased CLU1 expression. Since CLU1 and CLU2 appear to produce similar proteins and are increased in AD, the AD-protection afforded by the rs11136000T allele may reflect increased soluble clusterin throughout life.Citation: Ling I-F, Bhongsatiern J, Simpson JF, Fardo DW, Estus S (2012) Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk. PLoS ONE 7(4): e33923. doi:10.1371/journal.pone.0033923Editor: Tsuneya Ikezu, Boston University School of Medicine, United States of AmericaReceived: July 20, 2011; Accepted: February 21, 2012; Published: April 10, 2012Copyright: © 2012 Ling et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Funding: This work was funded by the NIH (P01AG030128 and P30AG028383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing interests: The authors have declared that no competing interests exist.* E-mail: steve.estus@uky.eduIntroduction Top Clusterin (CLU, APOJ) has been implicated in diseases ranging from cancer to Alzheimer's disease (AD) (reviewed in [1], [2], [3], [4]). Although the primary role of clusterin in AD is unclear, CLU is implicated in AD by several lines of evidence, including (I) CLU mRNA and clusterin protein is increased in AD [5], [6], (ii) clusterin is a component of plaques [4], [5], [7], (iii) clusterin modulates AD-related pathways such as inflammation and apoptosis [1], [8], [9] and (iv) clusterin acts as an amyloid-beta (Aß) chaperone to alter Aß aggregation and/or clearance ([10], [11], reviewed in [4], [12], [13], [14]). The physiologic relevance of CLU to AD was confirmed recently when CLU single nucleotide polymorphisms (SNP)s were associated with AD risk [15], [16], [17], [18], [19]. Overall, CLU genetic variation is essentially unequivocally associated with AD given the robust statistical power of the initial genome-wide association studies and subsequent replication studies [15], [16], [17], [18], [19]. How CLU SNPs modulate clusterin to alter AD risk is unknown.Two CLU isoforms, CLU1 and CLU2, have been reported that consist of nine exons and differ only in their first exons and associated proximal promoters; CLU1 is predicted to encode a nuclear protein and CLU2a secreted protein (reviewed in [20]). Additional reported isoforms include a CLU isoform that lacks exon 5 and a CLU isoform that lacks exon two, which encodes the leader sequence, resulting in another nuclear clusterin [21], [22]. Here, we investigated the hypothesis that CLU isoforms are differentially modulated by AD status and AD-associated SNPs. We identified CLU1 and CLU2 as the major CLU isoforms in human brain. Quantitative expression studies show that both CLU1 and CLU2 are increased in AD but only CLU1 is associated with rs11136000. Lastly, although CLU1 and CLU2 are predicted to produce intracellular and secreted proteins, respectively, immunofluorescence and Western blot studies indicate that CLU1 and CLU2 both produce secreted proteins that are similar to those detected in the human brain. Overall, we interpret our results as suggesting that SNP-mediated increases in secreted, soluble clusterin expression may act to reduce AD risk.Methods Top Ethics StatementThe work described here was performed with approval from the University of Kentucky Institutional Review Board.Cell CultureSH-SY5Y (human neuroblastoma) and HepG2 (human hepatocellular carcinoma) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 50 U/ml penicillin and 50 µg/ml streptomycin at 37°C in a humidified 5% CO2 - 95% air atmosphere.CLU Expression PlasmidExpression plasmids encoding CLU1 and CLU2 were generated from SH-SY5Y cellular mRNA that was reverse transcribed by using the primer 5′-TAGGTGCAAAAGCAACAT-3′ which corresponds to sequence just after the CLU stop codon. CLU1 and CLU2 cDNAs were then amplified by PCR with forward primers 5′-TGAGTCATGCAGGTTTGCAG-3′ (CLU1) and 5′-ATGATGAAGACTCTGCTGCTG-3′ (CLU2) used in combination with the common reverse primer 5′-CTCCTCCCGGTGCTTTTTG-3′. PCR fragments were ligated into pcDNA3.1/V5-His-TOPO T/A cloning vector (Invitrogen, Carlsbad, CA). Clones encoding CLU1 and CLU2 were detected by PCR screening and clone integrity confirmed by sequencing.Human Autopsy TissueDe-identified human brain specimens were provided by the University of Kentucky AD Center Neuropathology Core [23], [24]. AD and non-AD designations followed NIARI neuropathology guidelines, which include indices of neuritic senile plaques and neurofibrillary tangles, and provide a likelihood staging of AD neuropathological diagnosis [25], [26]. Individuals with “low” AD neuropathology were cognitively intact prior to death and had no or low likelihood of AD by NIARI criteria; their average age at death was 81.8±10.2 (mean ±SD, n = 17). Individuals with “high” AD neuropathology represented a combination of demented individuals with high likelihood of AD by NIARI criteria (n = 27) and cognitively intact individuals that were found to have moderate or high AD neuropathology at death (n = 7); their average age at death was 81.9±6.2 (mean ±SD, n = 34). The average post-mortem interval (PMI) for low AD neuropathology individuals was 3.0±0.8 hours (mean ± SD, n = 17) while the PMI for high AD neuropathology individuals was similar (3.2±0.8 hours (n = 34)). Choroid plexus samples were from six individuals with an average age at death of 80.0± 3.3 years and PMI of 2.9±1.1 hours. Fetal tissue RNA samples were obtained commercially (Stratagene, Santa Clara, CA) and have been described previously [27].PCR AmplificationTotal RNA was extracted from human brain specimens and converted to cDNA in 1 µg aliquots with random hexamers and reverse transcriptase (SuperScript III, Invitrogen), essentially as we described previously [24], [28], [29], [30]. PCR primers were designed such that the splicing of each internal CLU exon as well as CLU1 and CLU2 were evaluated (Table 1). In initial screening, cDNA pooled from five high AD neuropathology and five low AD neuropathology samples were subjected to PCR-amplification (Platinum Taq, Invitrogen) by using each primer pair and a PCR profile consisting of initial denaturation for 5 minutes at 95°C, followed by 27–32 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min, and final extension at 72°C for 7 min (Perkin Elmer 9600). PCR products were separated by polyacrylamide gel electrophoresis, stained with SYBR Gold and visualized by using a fluorescence imager (Fuji FLA-2000). The identity of the PCR products was confirmed by direct sequencing (Davis Sequencing, Davis, CA).thumbnailTable 1. PCR Primers for evaluating splice variation.doi:10.1371/journal.pone.0033923.t001 Real-time PCRThe expression level of CLU1 and CLU2 was quantified by real-time PCR. Each isoform was specifically amplified by using a sense primer corresponding to sequence within their respective exon 1, i.e., 5′-GCGAGCAGAGCGCTATAAAT-3′ for CLU1 and 5′-AGATGGATTCGGTGTGAAGG-3′ for CLU2′, and an antisense primer corresponding to sequence at the exon 2–3 boundary, i.e., 5′-GACATTTCCTGGAGCTCATTG-3′. Note that the CLU1 sense primer contains the TATA sequence suggested by Schepeler et al to be present only in a longer “CLU34” isoform [31]. The 20 µl real-time PCR mixture containing approximately 20 ng of brain cDNA, 1 µM of each primer and 1× PerfecTaq PCRSupermix (Quanta Biosciences, Gaithersburg, MD) was subjected to real-time PCR (Bio-Rad, Hercules, CA). PCR profiles consisted of pre-incubation at 95°C for 2 min, followed by 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 20 s. Specificity of the reactions was evaluated by showing a single PCR product by gel electrophoresis and by performing a melting curve analysis after PCR amplification. The PCR product copy number in each sample was determined relative to standard curves that were amplified in parallel and were based upon previously purified and quantified PCR products. The copy numbers were then normalized to the geometric mean of the copy numbers of hypoxanthine-guanine phosphoribosyltransferase 1 and ribosomal protein L13A as described (Vandesompele et al., 2002; Zhang et al., 2005). All real-time PCR assays were repeated twice.GenotypingDNA samples were genotyped for rs11136000 by using unlabeled PCR primers and TaqMan FAM and VIC dye-labeled MGB probes (Pre-designed SNP Genotyping Assay, Applied Biosystems, Foster City, CA) on a real-time PCR machine (Bio-Rad, Hercules, CA).Statistical AnalysisVariation in CLU isoform expression were analyzed as a function of rs11136000 genotype, AD neuropathology, sex and age by using a general linear model (SPSS v.18 (IBM, Somers, NY)). A dominant mode of inheritance was assumed to maximize statistical power.ImmunofluorescenceCLU expression plasmids were transfected into SH-SY5Y cells by using FuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences, Indianapolis, IN). Briefly, 3.75×104 cells/well were maintained in a poly-L-lysine treated 8-well chamber coverglass (Lab-Tek, Nunc, Rochester, NY) and transfected the next day with CLU1 or CLU2 expression plasmid. Twenty-four hours after transfection, cells were washed with phosphate buffered saline (PBS) and fixed with ice-cold methanol for 5 minutes. Non-specific antibody binding sites were blocked by incubating the cells with 5% goat serum in PBS with 0.1% Tween-20 (PBST) for 1 hour and the cells were then incubated with mouse anti-V5 antibody (1:1000 dilution, ab27671, Abcam, Cambridge, MA) and either rabbit anti-calnexin antibody (1:200 dilution, SPA-860, Stressgen, Victoria, BC, Canada) or rabbit anti-TGN46 antibody (1:1000 dilution, ab16052, Abcam) in 5% goat serum at 4°C overnight. The next day, cells were washed with PBST three times and incubated with a mixture containing Alexa-488 goat anti-mouse IgG antibody (1:200 dilution, Molecular Probes, Carlsbad, CA) and Alexa-568 goat anti-rabbit IgG antibody (1:200 dilution, Molecular Probes) in 5% goat serum at room temperature for an hour. After washing with PBST, cells were stained with 10 µg/ml of Hoechst 33258 (Molecular Probes) for 30 minutes, washed with PBS, and subjected to fluorescence microscopy.Western BlotSH-SY5Y cells or HepG2 cells were grown in a 100 mm dish (2.6×106 cells/dish) for 24 hours and then transfected with CLU1 or CLU2 expression plasmid by usingFuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences). Twenty-four hours after transfection, cell medium was replaced with Opti-MEM (Invitrogen) and cells maintained for another 24 hours. The conditioned medium was collected and the cells washed with 5 ml of room-temperature PBS. Cells were then lysed in 0.5 ml of RIPA butter (50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS) containing 1× protease inhibitor cocktail (Roche Applied Sciences) for 30 minutes on ice with occasional rocking. Cell lysates were centrifuged at 10,000×g for 10 minutes at 4°C and the supernatant collected. Conditioned medium was centrifuged at 250×g for 10 minutes and 0.5 ml of the supernatant was collected and supplemented with 1× protease inhibitor cocktail (Roche Applied Science). Human brain anterior cingulate tissue samples were prepared by homogenizing ~0.5 mg tissue in RIPA buffer supplemented with 1× protease inhibitor cocktail, centrifuging at 14,000×g for 10 minutes at 4°C, and then collecting the supernatant. After the protein concentration of each sample was determined (Micro BCA Protein Assay Reagent Kit, Pierce, Rockford, IL), 15 or 20 µg protein were mixed with SDS sample loading buffer containing β-mercaptoethanol, boiled for 5 minutes and subjected to polyacrylamide gel electrophoresis on a 7.5% polyacrylamide gel. Proteins were transferred to nitrocellulose membranes (Bio-Rad). The blots were then incubated with 5% nonfat dry milk for 1 hour at room temperature and probed overnight with mouse anti-V5 antibody (1:5000 dilution, Abcam) or mouse anti-clusterin antibody (1:200, B-5 Santa-Cruz) at 4°C. After washing with PBST four times for 5 minutes each, the blots were incubated with peroxidase-conjugated sheep anti-mouse antibody (1:1,000 dilution, Jackson ImmunoResearch) for 1 hour at room temperature. Bound peroxidase was visualized by using a SuperSignal West Pico kit (Pierce) and a molecular imager (ChemiDoc XRS System, Bio-Rad). For studies involving PNGase F digestion, each protein sample was treated with PNGase F as directed by the manufacturer (New England Biolabs, Ipswich, MA). Briefly, 15 µg protein of each sample was denatured at 100°C for 10 minutes and incubated with 1,500 units of PNGase F at 37°C for 2 hours. Samples were then analyzed by Western blot as described above.Results Top To begin to evaluate CLU expression, we screened human brain cDNA to identify CLU isoforms present in brain. Previously reported isoforms include CLU1 and CLU2, which are identical in exons 2–9 but differ in exon 1, as well as isoforms lacking exons 2 or 5 ([21], [22], reviewed in [20]). RT-PCR analyses of pooled human brain cDNA samples detected only CLU1 and CLU2 (Figure 1A–1B). CLU2 translation is predicted to result in a secreted protein, beginning at the initial ATG in exon 2 that is common to both CLU2 and CLU1 (Figure 1C). In contrast, CLU1 translation is predicted to initiate at an ATG within its exon 1, which is in-frame with the ATG site in the common exon 2. Hence, CLU1 is predicted to encode a protein identical to that encoded by CLU2 except that the CLU1 protein would contain 52 additional amino acids at its amino terminus (Figure 1C). This change is predicted by PSORTII to result in an intracellular and likely nuclear, form of clusterin (reviewed in [20]). In summary, CLU1 and CLU2 are the primary CLU isoforms in brain and are predicted to encode intracellular and secreted proteins, respectively.thumbnailFigure 1. CLU1 and CLU2 are the primary CLU isoforms expressed in human brain.The exon layout for the CLU1 and CLU2 isoforms is shown (A). Coding and non-coding exonic regions are represented by black and white boxes, respectively, while introns are shown as thin black lines. The first ATG site in each isoform is shown as well. Evaluation of CLU splicing by RT-PCR identified only CLU1 and CLU2 in human brain cDNA (B), i.e., single PCR products are observed upon amplification from exon 1a – exon 5 (lane 1), exon 1b – exon 5 (lane 2), exon 4 – exon 6 (lane 3) and exon5 – exon 9 (lane 4). Molecular weight markers are shown at the left. The predicted protein sequences encoded by CLU1 and CLU2, beginning with the initial ATG sites shown in A, are shown in panel C. The sequence in gray font is unique to CLU1 while sequence in black font is common to CLU1 and CLU2. The boxed amino acid sequence represents signal sequence that is removed from clusterin-2 upon its translocation to the ER. Two nuclear localization sequences, as predicted by PSORT II (http://psort.ims.u-tokyo.ac.jp/form2.htm l), are underlined. The asterisk shows the clusterin cleavage site that separates the α- and β- subunits.doi:10.1371/journal.pone.0033923.g001 To evaluate whether rs11136000, the primary AD-related CLU SNP [15], [16], [17], [18], [19], is associated with CLU expression, we quantified CLU1 and CLU2 expression in a series of brain samples. The CLU isoforms were quantified in separate real-time PCR assays that used forward primers corresponding to their unique exon 1 and a common reverse primer that targeted the exon 2–3 boundary. Copy numbers were determined relative to a standard curve for each isoform and normalized to the geometric mean of housekeeping genes [23], [32]. The expression of CLU1 and CLU2 were modestly coordinately regulated (Figure 2A), with CLU2 being consistently greater than CLU1; the overall CLU2: CLU1 ratio was 3.35±1.84 (mean ± SD, n = 51). To gain further insights into CLU isoform expression, we quantified CLU1 and CLU2 in a series of single human fetal tissue samples as well as a set of six adult choroid plexus samples (Figure 2B). Among the fetal tissues, the CLU2: CLU1 ratio varied widely from 0.3 (skin) to 6.2 (kidney) (Figure 2B). The CLU2:CLU1 ratio in choroid plexus, which produces cerebrospinal fluid, was 5.72±0.65 (mean ± SD, n = 6).thumbnailFigure 2. Expression of CLU isoforms in human tissues.CLU1 and CLU2 isoforms were quantified by isoform-specific RT-PCR in a series of adult human cingulate and choroid plexus samples (A–B) as well as a human fetal tissues (B). Within A, each marker reflects the expression of CLU1 and CLU2, normalized to housekeeping genes, in a single brain sample. Within B, the value in parentheses following the tissue name is the CLU1:CLU2 ratio. CLU1 expression shows a positive association with AD neuropathology and rs11136000T allele (C). CLU2 expression was increased in individuals with AD pathology and decreased with age (D–E).doi:10.1371/journal.pone.0033923.g002 We next evaluated CLU isoform expression as a function of AD neuropathology, rs11136000 status, sex and age. We found that CLU1 expression was significantly increased with high AD neuropathology and the minor rs11136000T allele (Figure 2C, Table 2). In contrast, CLU2 expression was significantly increased with AD neuropathology but not rs11136000 genotype, and decreased with age (Figure 2D–E, Table 3). Overall, both CLU1 and CLU2 expression was increased with AD, confirming prior reports. However, only CLU1 expression was associated with rs11136000. Since the minor rs11136000T allele was associated with both increased CLU1 expression and reduced AD risk [15], [16], [17], [18], [19], we interpret these results as suggesting that increased CLU1 expression is associated with reduced AD risk.thumbnailTable 2. Analysis of CLU1 Expression.doi:10.1371/journal.pone.0033923.t002 thumbnailTable 3. Analysis of CLU2 Expression.doi:10.1371/journal.pone.0033923.t003 CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively (Figure 1). Therefore, we evaluated the proteins produced by CLU1 and CLU2 transfected cells to discern whether these corresponded to the intracellular and secreted forms of clusterin that have been reported [4], [8], [33]. When each isoform was transiently transfected into neural SH-SY5Y cells, immunofluorescence analyses showed a similar subcellular localization pattern (Figure 3). The proteins produced by CLU1 and CLU2 tended to concentrate within the Golgi apparatus, as established by double-labeling with an antibody against trans-Golgi network protein 46 (TGN46) (Figure 3A). Relatively modest amounts of clusterin were also detected within the endoplasmic reticulum (ER), as established by double labeling with calnexin (Figure 3B). Nuclear, cytosolic, or mitochondrial-associated clusterin was not observed. Hence, the clusterin produced by CLU1 and CLU2 manifests an intracellular localization that includes the ER and Golgi, consistent with a possible secretory pathway for both proteins.thumbnailFigure 3. CLU1 and CLU2 encoded proteins are localized to the ER and Golgi.SH-SY5Y cells were transfected with vectors encoding CLU1 and CLU2; the resultant clusterin expression was localized by a vector-derived V5 epitope tag. The subcellular localization for both proteins overlapped with the Golgi, as shown by co-labeling with antibody against TGN46 (A) and with the ER, as shown by co-labeling with an antibody against calnexin (B).doi:10.1371/journal.pone.0033923.g003 CLU1 is predicted to encode a 501 amino acid protein with a molecular weight of 57.8 kDa while CLU2 is predicted to encode 449 amino acids, totaling 52.5 kDa. During maturation of secreted clusterin, the protein is N-glycosylated and proteolyzed to generate a heterodimer that is maintained by disulfide bonds [20]. To compare the size of the proteins produced by CLU1 and CLU2, we performed Western blot analyses of transfected SH-SY5Y cells; ectopic clusterin was detected via a V5 epitope tag (Figure 4 A–B). Cell lysates contained both intact and cleaved clusterin while conditioned medium contained only cleaved clusterin; the clusterin protein produced by CLU1 and CLU2 appeared equal in size (Figure 4A). To discern whether glycosylation differences may obscure differences in the clusterin molecular weight derived from their primary sequence, the protein mixtures were digested with PNGase F to remove N-linked sugars prior to electrophoresis; the size of the proteins produced by CLU1 and CLU2 transfected cells were both decreased similarly by PNGase treatment (Figure 4B). We considered the possibility that CLU translation may show cell-type specificity, and therefore repeated this study in an unrelated cell line by transfecting CLU1 and CLU2 into HepG2 cells. As with the SH-SY5Y cells, CLU1 and CLU2 transfected cells produced clusterin of similar size, even after PNGase F digestion (Figure 4C). Hence, we found no evidence to suggest that the proteins produced by CLU1 and CLU2 differ in cellular localization, size, glycosylation, or proteolytic cleavage. Rather, when these Western blot studies are considered in combination with the immunofluorescence studies, CLU1 and CLU2 appear to produce equivalent proteins that are similarly translated, glycosylated, and cleaved as they pass through the ER and Golgi in the secretory pathway to the extracellular space.thumbnailFigure 4. CLU1 and CLU2 produce clusterin proteins that are similar to each other and to clusterin in human brain.Transfection of CLU1 and CLU2 resulted in proteins of similar size, appearing as both intact and cleaved clusterin in cell lysates and conditioned media; the proteins resulting from CLU transfection were detected via their V5 epitope tag (A–B). PNGase F treatment prior to electrophoresis reduced the size of the proteins produced by CLU1 and CLU2 similarly (B). The apparent doublet in the protein encoded by CLU1 at 37 kDa was variable between experiments and likely reflects incomplete glycosylation as the doublet collapsed to a single band after PNGase F digestion. Results similar to those depicted in B were obtained when CLU1 and CLU2 were transfected into HepG2 cells (C). When transfected and endogenous clusterin proteins were detected with an antibody raised against a carboxyl-terminal clusterin epitope (D–E), intact clusterin from transfection (T-labeled arrow) was slightly larger than endogenous clusterin (E-labeled arrow), reflecting the ~5.1 kDa V5 epitope and His tags in the ectopic clusterin (D). The bands labeled “Fragments” are clusterin alpha subunits derived from variably glycosylated endogenous and transfected clusterin. Overall, the cellular clusterin proteins are similar in size to the human brain clusterin, as discerned for the intact and cleaved clusterin under reducing conditions (D) or as the heterodimeric clusterin under non-reducing conditions (E).doi:10.1371/journal.pone.0033923.g004 To evaluate whether the clusterin proteins produced by CLU1 and CLU2 in vitro are similar to those produced in vivo, we compared ectopic clusterin with endogenous clusterin in SH-SY5Y cells and in human brain by Western blotting with a clusterin antibody. Endogenous clusterin in SH-SY5Y cells migrates at a slightly lower molecular weight than that resulting from CLU transfection, reflecting the 5.1 kDa V5/His tag encoded by the pcDNA3.1 vector expressing transfected CLU (Figure 4D). Importantly, this 5.1 kDa size difference between endogenous and transfected clusterin is similar to the size difference between the CLU1 and CLU2-predicted proteins, indicating that if the proteins encoded by CLU1 and CLU2 differed by 5 kDa, the proteins would be resolved easily under these experimental conditions. The endogenous SH-SY5Y clusterin migrates similarly to the intact protein detected in brain homogenates suggesting these cellular forms are similar to those present in vivo (Figure 4D). To extend this analysis to the heterodimeric form of clusterin, we also performed electrophoresis under non-reducing conditions. We found that heterodimeric protein from CLU1 and CLU2 transfected cells appeared similar in size to each other and to the forms found in brain (Figure 4E). Hence, CLU1 and CLU2 produce proteins in vitro that are similar in size to endogenous clusterin in vitro and human brain.Discussion Top The main findings of this report are several. First, CLU1 and CLU2 are the primary CLU isoforms in human brain and differ in their first exon and proximal promoter. Second, the expression of only CLU1 was associated with rs11136000 while both CLU1 and CLU2 were increased with robust AD neuropathology. Third, CLU1 and CLU2 produce secreted clusterin proteins that are similar to each other and to clusterin in human brain. Since CLU is increased in AD and CLU1 is increased with the minor rs11136000T allele, which is also associated with reduced AD risk, we interpret our results as suggesting that increased CLU expression throughout life may reduce AD risk. Overall, these results identify a possible means underlying the association of rs11136000 with AD risk.The association between CLU expression and rs11136000 was discerned because the CLU isoforms were analyzed separately. For example, when we analyzed total CLU expression in the same fashion as reported here, total CLU was not associated with rs11136000 (p = 0.51) although a robust association with AD pathology was observed (p = 0.005, Ling et al., unpublished observations). The lack of a significant association between rs11136000 and total CLU is somewhat disconcerting since CLU1 and CLU2 appear to produce a similar protein. We speculate that (i) the threshold for clusterin biological significance may be less than the threshold for overall CLU statistical significance and/or (ii) CLU1 may be enriched in a cell type different than CLU2, which may affect its functionality. We note that the lack of an association between total CLU and rs11136000 was similar to prior reports that total CLU mRNA or clusterin protein were not associated with rs11136000 [17], [34]. As the clusterin produced by CLU1 and CLU2 appears similar, discerning an association between rs11136000 and clusterin would be especially challenging in tissues with a large proportion of CLU2. In this regard, CLU2 was the major isoform in choroid plexus, suggesting that an association between cerebrospinal fluid clusterin and rs11136000 would be difficult to detect. The differential regulation of CLU1 and CLU2 was not unexpected because CLU1 and CLU2 have separate proximal promoter regions. Consistent with this observation, Cochrane et al found that androgen-treatment in a prostate cancer cell line decreased CLU1 expression while enhancing CLU2 expression [35]. Although the identification of the functional SNPs and transcription factors that modulate CLU expression is beyond the scope of this report, we note that rs11136000 resides within intron 3 and is common to both CLU1 and CLU2. Hence, rs11136000 is likely not functional but rather is in linkage with a functional SNP more proximal to the CLU1 promoter. In summary, the association between rs11136000 and CLU1 was dependent upon analyzing the two CLU isoforms separately.Since earlier predictions were that CLU2 encodes a secreted protein while the additional 52 amino-terminal residues encoded by CLU1 would result in its intracellular localization [20], we expected clusterin in CLU1 and CLU2 transfected cells to differ in cellular locale and size. In support of this prediction, the ATG translation initiation sites in the CLU1-specific exon 1a as well as the common exon 2 both satisfy Kozak consensus sequence requirements (http://bioinfo.iitk.ac.in/AUGPred/). However, clusterin in CLU1 and CLU2 transfected cells was localized to the secretory pathway and was equivalent in size under conditions that would easily discern their predicted five kDa size difference, especially after PNGase F treatment to remove sugar residues. Hence, CLU1 and CLU2 produce similar secreted proteins in vitro. Comparable results were obtained in two cell types, suggesting that CLU1 and CLU2 generally produce soluble clusterin protein. The most parsimonious interpretation of these data is that CLU1 translation is generally initiated at the common exon 2 ATG. The possibility exists that a portion of CLU1 translation is initiated at the exon 1a ATG at levels too low to be readily detected or that produce an unstable protein which is rapidly degraded. Distinguishing among these possibilities is a future direction for this work. Overall, we summarize our current results by noting that the proteins produced from CLU1 and CLU2 in vitro are similar to each other, and similar in size to those present in human brain, leading us to interpret our data as supporting the possibility that CLU1 and CLU2 generally produce secreted clusterin protein in vitro and in vivo.A logical extension of the finding that AD risk is reduced with a genetic variant that correlates with increased CLU expression is that other factors that increase CLU expression may also reduce AD risk. Furthermore, since CLU expression is increased in AD without reversing the disease, we speculate that enhanced CLU expression reduces AD risk only if CLU expression is increased well before AD onset, mimicking the likely SNP effects. One possible modulator of interest is age-dependent changes in sex hormones since CLU isoforms are differentially regulated by androgens [35]. Stress has also been shown to upregulate CLU in many instances [36] and may cause the AD-associated increase in CLU observed here. In terms of possible therapeutic agents, multiple histone deacetylase inhibitors increase CLU expression robustly in vitro [37]. Interestingly, one member of this class, valproate, increases CLU expression in human astrocytes [37] and reduces amyloid accumulation as well as behavioral deficits in mouse amyloid models [38], [39]. While valproate may also act via other mechanisms [38], the actions of valproate on CLU expression may be relevant to its neuroprotection and merit further exploration to reduce AD risk.Limitations of this study include that rs11136000 and AD neuropathological status capture only ~20% of the variance in CLU expression. Identifying the unknown factors that account for the additional variance, which could include epigenetic factors, will facilitate understanding of CLU expression. Moreover, variability in these factors could facilitate or obscure the SNP association with CLU1 expression described here, suggesting that replication of these data in additional samples is necessary for their acceptance by the research community. Additionally, since the nuclear form of clusterin arising from an isoform lacking exon 2 has been associated with apoptosis [21], [22], this isoform may be transientlyexpressed and hence below our limits of detection, especially in comparison with CLU1 and CLU2.In conclusion, the AD-protective allele of rs11136000 was associated with increased expression of CLU1 but not CLU2 in our dataset. Both CLU1 and CLU2 produce a soluble, secreted clusterin protein that is similar to that observed in human brain. Discerning the association between rs11136000 and CLU1 depended upon analyzing these two CLU isoforms separately.Acknowledgments Top The authors gratefully acknowledge tissue supplied by the University of Kentucky AD Center and Ishita Parikh for technical assistance.Author Contributions Top Conceived and designed the experiments: IL SE. Performed the experiments: IF JB JS. Analyzed the data: IL JB JF DF SE. Wrote the paper: IF SE.References Top Sala A, Bettuzzi S, Pucci S, Chayka O, Dews M, et al. (2009) Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Adv Cancer Res 105: 115–132. Find this article online Redondo M, Tellez T, Roldan MJ (2009) The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas. Adv Cancer Res 105: 21–43. Find this article online Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009) Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 61: 89–104. Find this article online Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, et al. (2000) Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech 50: 305–315. Find this article online May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, et al. (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 5: 831–839. Find this article online Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM (2011) Plasma clusterin and the risk of Alzheimer disease. JAMA: the Journal of the American Medical Association 305: 1322–1326. Find this article online Choi-Miura NH, Ihara Y, Fukuchi K, Takeda M, Nakano Y, et al. (1992) SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol 83: 260–264. Find this article online Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, et al. (2005) Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7: 909–915. Find this article online Falgarone G, Chiocchia G (2009) Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity. Adv Cancer Res 104: 139–170. Find this article online Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, et al. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 21: 2312–2322. Find this article online Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, et al. (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27: 909–918. Find this article online Holtzman DM (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J Mol Neurosci 23: 247–254. Find this article online Bertram L, Tanzi REAlzheimer disease: New light on an old CLU. Nat Rev Neurol 6: 11–13. Find this article online van Es MA, van den Berg LH (2009) Alzheimer's disease beyond APOE. Nat Genet 41: 1047–1048. Find this article online Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094–1099. Find this article online Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088–1093. Find this article online Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, et al. (2010) Genetic variability in CLU and its association with Alzheimer's disease. PLoS One 5: e9510. Find this article online Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Archives of Neurology 67: 961–964. Find this article online Jun G, Naj AC, Beecham GW, Wang LS, Buros J, et al. (2010) Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67: 1473–1484. Find this article online Rizzi F, Bettuzzi S (2010) The clusterin paradigm in prostate and breast carcinogenesis. Endocr Relat Cancer 17: R1–17. Find this article online Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278: 11590–11600. Find this article online Kimura K, Yamamoto M (1996) Modification of the alternative splicing process of testosterone-repressed prostate message-2 (TRPM-2) gene by protein synthesis inhibitors and heat shock treatment. Biochim Biophys Acta 1307: 83–88. Find this article online Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, et al. (2009) Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Mol Neurodegener 4: 46. Find this article online Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, et al. (2008) Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet 17: 929–935. Find this article online (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiology of aging 18: S1–2. Find this article online Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68: 1–14. Find this article online Burchett M, Ling I-F, Estus S (2011) FBN1 isoform expression varies in a tissue and development-specific fashion. Biochem Biophys Res Commun 411: 323–328. Find this article online Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 162: 156–159. Find this article online Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, et al. (1999) The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease. Neurochem Res 24: 767–774. Find this article online Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, et al. (2007) A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. Hum Mol Genet 16: 1765–1772. Find this article online Schepeler T, Mansilla F, Christensen LL, Orntoft TF, Andersen CL (2007) Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling. Journal of Molecular Signaling 2: 6. Find this article online Ling IF, Estus S (2010) Role of SFRS13A in low-density lipoprotein receptor splicing. Hum Mutat 31: 702–709. Find this article online Reddy KB, Jin G, Karode MC, Harmony JA, Howe PH (1996) Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35: 6157–6163. Find this article online Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, et al. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Archives of General Psychiatry 67: 739–748. Find this article online Cochrane DR, Wang Z, Muramaki M, Gleave ME, Nelson CC (2007) Differential regulation of clusterin and its isoforms by androgens in prostate cells. J Biol Chem 282: 2278–2287. Find this article online Michel D, Chatelain G, North S, Brun G (1997) Stress-induced transcription of the clusterin/apoJ gene. Biochem J 328(Pt 1): 45–50. Find this article online Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2010) Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease. Neuroscience Letters 475: 64–68. Find this article online Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, et al. (2008) Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med 205: 2781–2789. Find this article online Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, et al. (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35: 870–880. Find this article online"/><tcas:DocumentAnnotation xmi:id="8" sofa="1" begin="0" end="41544" language="x-unspecified"/><types2:Sentence xmi:id="13" sofa="1" begin="0" end="391" id="0" text="Genetics of Clusterin Isoform Expression and Alzheimer's Disease RiskI-Fang Ling1, Jiraganya Bhongsatiern1, James F. Simpson1, David W. Fardo2, Steven Estus1*1 Department of Physiology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America, 2 Department of Biostatistics, University of Kentucky, Lexington, Kentucky, United States of America" qualityScore="0.9420289855072463" bFilter="false" phraseList="" nerList="29 41 53 65"/><types2:Sentence xmi:id="79" sofa="1" begin="0" end="230" id="0" text="Total RNA was extracted from human brain specimens and converted to cDNA in 1 µg aliquots with random hexamers and reverse transcriptase (SuperScript III, Invitrogen), essentially as we described previously [24], [28], [29], [30]." qualityScore="0.8081632653061225" bFilter="false" phraseList="" nerList="95 107"/><types2:Sentence xmi:id="129" sofa="1" begin="0" end="219" id="0" text="Expression plasmids encoding CLU1 and CLU2 were generated from SH-SY5Y cellular mRNA that was reverse transcribed by using the primer 5′-TAGGTGCAAAAGCAACAT-3′ which corresponds to sequence just after the CLU stop codon." qualityScore="0.8611111111111112" bFilter="false" phraseList="" nerList="145 157 169"/><types2:Sentence xmi:id="182" sofa="1" begin="0" end="181" id="0" text="Variation in CLU isoform expression were analyzed as a function of rs11136000 genotype, AD neuropathology, sex and age by using a general linear model (SPSS v.18 (IBM, Somers, NY))." qualityScore="0.8333333333333334" bFilter="false" phraseList="" nerList="198 210"/><types2:Sentence xmi:id="222" sofa="1" begin="0" end="152" id="0" text="Introduction Top Clusterin (CLU, APOJ) has been implicated in diseases ranging from cancer to Alzheimer's disease (AD) (reviewed in [1], [2], [3], [4])." qualityScore="0.825" bFilter="false" phraseList="" nerList="238"/><types2:Sentence xmi:id="854" sofa="1" begin="0" end="121" id="0" text="Abstract Top The minor allele of rs11136000 within CLU is strongly associated with reduced Alzheimer's disease (AD) risk." qualityScore="0.8571428571428572" bFilter="false" phraseList="" nerList="870 882"/><types2:Sentence xmi:id="894" sofa="1" begin="0" end="121" id="0" text="De-identified human brain specimens were provided by the University of Kentucky AD Center Neuropathology Core [23], [24]." qualityScore="0.8090909090909091" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="908" sofa="1" begin="0" end="111" id="0" text="The work described here was performed with approval from the University of Kentucky Institutional Review Board." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="922" sofa="1" begin="0" end="110" id="0" text="Taq PCRSupermix (Quanta Biosciences, Gaithersburg, MD) was subjected to real-time PCR (Bio-Rad, Hercules, CA)." qualityScore="0.8695652173913043" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="2037" sofa="1" begin="0" end="88" id="0" text="FuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences)." qualityScore="0.8307692307692307" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="2051" sofa="1" begin="0" end="85" id="0" text="Editor: Tsuneya Ikezu, Boston University School of Medicine, United States of America" qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="2065" sofa="1" begin="0" end="84" id="0" text="Signal West Pico kit (Pierce) and a molecular imager (ChemiDoc XRS System, Bio-Rad)." qualityScore="0.8777777777777778" bFilter="false" phraseList="" nerList="2081"/><types2:Sentence xmi:id="2092" sofa="1" begin="0" end="79" id="0" text="PLoS ONE: Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk" qualityScore="0.0" bFilter="false"/><types2:Sentence xmi:id="2104" sofa="1" begin="0" end="79" id="0" text="Received: July 20, 2011; Accepted: February 21, 2012; Published: April 10, 2012" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="4656" sofa="1" begin="0" end="29" id="0" text="Copyright: © 2012 Ling et al." qualityScore="0.875" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="5136" sofa="1" begin="0" end="16" id="0" text="Research Article" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="5391" sofa="1" begin="0" end="11" id="0" text="Open Access" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="5803" sofa="1" begin="0" end="9" id="0" text="Figure 1." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="5815" sofa="1" begin="0" end="9" id="0" text="Figure 3." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="5827" sofa="1" begin="0" end="9" id="0" text="Figure 4." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="5839" sofa="1" begin="0" end="9" id="0" text="Figure 2." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="6007" sofa="1" begin="0" end="8" id="0" text="Table 1." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="6019" sofa="1" begin="0" end="8" id="0" text="Table 3." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="6031" sofa="1" begin="0" end="8" id="0" text="Table 2." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="7266" sofa="1" begin="122" end="175" id="1" text="The mechanism underlying this association is unclear." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7281" sofa="1" begin="176" end="334" id="2" text="Here, we report that CLU1 and CLU2 are the two primary CLU isoforms in human brain; CLU1 and CLU2 share exons 2–9 but differ in exon 1 and proximal promoters." qualityScore="0.8787878787878788" bFilter="false" phraseList="" nerList="14603 14615 14627 14639 14651"/><types2:Sentence xmi:id="7296" sofa="1" begin="335" end="436" id="3" text="The expression of both CLU1 and CLU2 was increased in individuals with significant AD neuropathology." qualityScore="0.9333333333333333" bFilter="false" phraseList="" nerList="14575 14587"/><types2:Sentence xmi:id="7311" sofa="1" begin="437" end="596" id="4" text="However, only CLU1 was associated with the rs11136000 genotype, with the minor “protective” rs11136000T allele being associated with increased CLU1 expression." qualityScore="1.0" bFilter="false" phraseList="" nerList="14521 14533 14545 14557"/><types2:Sentence xmi:id="7326" sofa="1" begin="597" end="902" id="5" text="Since CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively, we compared their expression; for both CLU1 and CLU2 transfected cells, clusterin is present in the secretory pathway, accumulates in the extracellular media, and is similar in size to clusterin in human brain." qualityScore="1.0" bFilter="false" phraseList="" nerList="14454 14466 14478 14490 14502"/><types2:Sentence xmi:id="7341" sofa="1" begin="903" end="1046" id="6" text="Overall, we interpret these results as indicating that the AD-protective minor rs11136000T allele is associated with increased CLU1 expression." qualityScore="0.9523809523809523" bFilter="false" phraseList="" nerList="14426 14438"/><types2:Sentence xmi:id="7356" sofa="1" begin="1047" end="1236" id="7" text="Since CLU1 and CLU2 appear to produce similar proteins and are increased in AD, the AD-protection afforded by the rs11136000T allele may reflect increased soluble clusterin throughout life." qualityScore="0.9333333333333333" bFilter="false" phraseList="" nerList="14385 14397 14409"/><types2:Sentence xmi:id="7377" sofa="1" begin="30" end="265" id="1" text="This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7392" sofa="1" begin="265" end="336" id="2" text="Funding: This work was funded by the NIH (P01AG030128 and P30AG028383)." qualityScore="0.9230769230769231" bFilter="false" phraseList="" nerList="14355 14367"/><types2:Sentence xmi:id="7407" sofa="1" begin="337" end="543" id="3" text="The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing interests: The authors have declared that no competing interests exist." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7422" sofa="1" begin="543" end="572" id="4" text="* E-mail: steve.estus@uky.edu" qualityScore="0.8888888888888888" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7440" sofa="1" begin="153" end="636" id="1" text="Although the primary role of clusterin in AD is unclear, CLU is implicated in AD by several lines of evidence, including (I) CLU mRNA and clusterin protein is increased in AD [5], [6], (ii) clusterin is a component of plaques [4], [5], [7], (iii) clusterin modulates AD-related pathways such as inflammation and apoptosis [1], [8], [9] and (iv) clusterin acts as an amyloid-beta (Aß) chaperone to alter Aß aggregation and/or clearance ([10], [11], reviewed in [4], [12], [13], [14])." qualityScore="0.8308823529411764" bFilter="false" phraseList="" nerList="14310 14322 14334"/><types2:Sentence xmi:id="7455" sofa="1" begin="637" end="805" id="2" text="The physiologic relevance of CLU to AD was confirmed recently when CLU single nucleotide polymorphisms (SNP)s were associated with AD risk [15], [16], [17], [18], [19]." qualityScore="0.7560975609756098" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7470" sofa="1" begin="806" end="1031" id="3" text="Overall, CLU genetic variation is essentially unequivocally associated with AD given the robust statistical power of the initial genome-wide association studies and subsequent replication studies [15], [16], [17], [18], [19]." qualityScore="0.8444444444444444" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7485" sofa="1" begin="1092" end="1335" id="5" text="Two CLU isoforms, CLU1 and CLU2, have been reported that consist of nine exons and differ only in their first exons and associated proximal promoters; CLU1 is predicted to encode a nuclear protein and CLU2a secreted protein (reviewed in [20])." qualityScore="0.9288888888888889" bFilter="false" phraseList="" nerList="14239 14251 14263 14275 14287"/><types2:Sentence xmi:id="7500" sofa="1" begin="1336" end="1529" id="6" text="Additional reported isoforms include a CLU isoform that lacks exon 5 and a CLU isoform that lacks exon two, which encodes the leader sequence, resulting in another nuclear clusterin [21], [22]." qualityScore="0.8648648648648649" bFilter="false" phraseList="" nerList="14211 14223"/><types2:Sentence xmi:id="7515" sofa="1" begin="1530" end="1650" id="7" text="Here, we investigated the hypothesis that CLU isoforms are differentially modulated by AD status and AD-associated SNPs." qualityScore="0.8421052631578947" bFilter="false" phraseList="" nerList="14196"/><types2:Sentence xmi:id="7530" sofa="1" begin="1651" end="1720" id="8" text="We identified CLU1 and CLU2 as the major CLU isoforms in human brain." qualityScore="0.9230769230769231" bFilter="false" phraseList="" nerList="14155 14167 14179"/><types2:Sentence xmi:id="7545" sofa="1" begin="1721" end="1846" id="9" text="Quantitative expression studies show that both CLU1 and CLU2 are increased in AD but only CLU1 is associated with rs11136000." qualityScore="0.95" bFilter="false" phraseList="" nerList="14101 14113 14125 14137"/><types2:Sentence xmi:id="7560" sofa="1" begin="1847" end="2111" id="10" text="Lastly, although CLU1 and CLU2 are predicted to produce intracellular and secreted proteins, respectively, immunofluorescence and Western blot studies indicate that CLU1 and CLU2 both produce secreted proteins that are similar to those detected in the human brain." qualityScore="1.0" bFilter="false" phraseList="" nerList="14047 14059 14071 14083"/><types2:Sentence xmi:id="7575" sofa="1" begin="2112" end="2256" id="11" text="Overall, we interpret our results as suggesting that SNP-mediated increases in secreted, soluble clusterin expression may act to reduce AD risk." qualityScore="0.9166666666666666" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7593" sofa="1" begin="111" end="402" id="1" text="Cell CultureSH-SY5Y (human neuroblastoma) and HepG2 (human hepatocellular carcinoma) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 50 U/ml penicillin and 50 µg/ml streptomycin at 37°C in a humidified 5% CO2 - 95% air atmosphere." qualityScore="0.85" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7611" sofa="1" begin="220" end="438" id="1" text="CLU1 and CLU2 cDNAs were then amplified by PCR with forward primers 5′-TGAGTCATGCAGGTTTGCAG-3′ (CLU1) and 5′-ATGATGAAGACTCTGCTGCTG-3′ (CLU2) used in combination with the common reverse primer 5′-CTCCTCCCGGTGCTTTTTG-3′." qualityScore="0.7560975609756098" bFilter="false" phraseList="" nerList="13989 14001 14013 14025"/><types2:Sentence xmi:id="7626" sofa="1" begin="539" end="644" id="3" text="Clones encoding CLU1 and CLU2 were detected by PCR screening and clone integrity confirmed by sequencing." qualityScore="0.9375" bFilter="false" phraseList="" nerList="13961 13973"/><types2:Sentence xmi:id="7644" sofa="1" begin="122" end="347" id="1" text="AD and non-AD designations followed NIARI neuropathology guidelines, which include indices of neuritic senile plaques and neurofibrillary tangles, and provide a likelihood staging of AD neuropathological diagnosis [25], [26]." qualityScore="0.8333333333333334" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7659" sofa="1" begin="348" end="542" id="2" text="Individuals with “low” AD neuropathology were cognitively intact prior to death and had no or low likelihood of AD by NIARI criteria; their average age at death was 81.8±10.2 (mean ±SD, n = 17)." qualityScore="0.7954545454545454" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7674" sofa="1" begin="543" end="860" id="3" text="Individuals with “high” AD neuropathology represented a combination of demented individuals with high likelihood of AD by NIARI criteria (n = 27) and cognitively intact individuals that were found to have moderate or high AD neuropathology at death (n = 7); their average age at death was 81.9±6.2 (mean ±SD, n = 34)." qualityScore="0.8260869565217391" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7689" sofa="1" begin="1190" end="1312" id="6" text="Fetal tissue RNA samples were obtained commercially (Stratagene, Santa Clara, CA) and have been described previously [27]." qualityScore="0.8636363636363636" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7707" sofa="1" begin="231" end="356" id="1" text="PCR primers were designed such that the splicing of each internal CLU exon as well as CLU1 and CLU2 were evaluated (Table 1)." qualityScore="0.875" bFilter="false" phraseList="" nerList="13925 13937"/><types2:Sentence xmi:id="7722" sofa="1" begin="765" end="917" id="3" text="PCR products were separated by polyacrylamide gel electrophoresis, stained with SYBR Gold and visualized by using a fluorescence imager (Fuji FLA-2000)." qualityScore="0.8333333333333334" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7737" sofa="1" begin="918" end="1016" id="4" text="The identity of the PCR products was confirmed by direct sequencing (Davis Sequencing, Davis, CA)." qualityScore="0.8888888888888888" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7752" sofa="1" begin="9" end="53" id="1" text="PCR Primers for evaluating splice variation." qualityScore="0.8333333333333334" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7767" sofa="1" begin="86" end="174" id="4" text="t001 Real-time PCRThe expression level of CLU1 and CLU2 was quantified by real-time PCR." qualityScore="0.9375" bFilter="false" phraseList="" nerList="13878 13890 13902"/><types2:Sentence xmi:id="7782" sofa="1" begin="175" end="491" id="5" text="Each isoform was specifically amplified by using a sense primer corresponding to sequence within their respective exon 1, i.e., 5′-GCGAGCAGAGCGCTATAAAT-3′ for CLU1 and 5′-AGATGGATTCGGTGTGAAGG-3′ for CLU2′, and an antisense primer corresponding to sequence at the exon 2–3 boundary, i.e., 5′-GACATTTCCTGGAGCTCATTG-3′." qualityScore="0.8064516129032258" bFilter="false" phraseList="" nerList="13850 13862"/><types2:Sentence xmi:id="7797" sofa="1" begin="492" end="632" id="6" text="Note that the CLU1 sense primer contains the TATA sequence suggested by Schepeler et al to be present only in a longer “CLU34” isoform [31]." qualityScore="0.9285714285714286" bFilter="false" phraseList="" nerList="13835"/><types2:Sentence xmi:id="7812" sofa="1" begin="633" end="744" id="7" text="The 20 µl real-time PCR mixture containing approximately 20 ng of brain cDNA, 1 µM of each primer and 1× Perfec" qualityScore="0.7692307692307692" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7830" sofa="1" begin="411" end="597" id="2" text="The PCR product copy number in each sample was determined relative to standard curves that were amplified in parallel and were based upon previously purified and quantified PCR products." qualityScore="0.8896551724137931" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7845" sofa="1" begin="598" end="818" id="3" text="The copy numbers were then normalized to the geometric mean of the copy numbers of hypoxanthine-guanine phosphoribosyltransferase 1 and ribosomal protein L13A as described (Vandesompele et al., 2002; Zhang et al., 2005)." qualityScore="0.9230769230769231" bFilter="false" phraseList="" nerList="13816"/><types2:Sentence xmi:id="7860" sofa="1" begin="819" end="864" id="4" text="All real-time PCR assays were repeated twice." qualityScore="0.875" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7875" sofa="1" begin="864" end="1117" id="5" text="GenotypingDNA samples were genotyped for rs11136000 by using unlabeled PCR primers and TaqMan FAM and VIC dye-labeled MGB probes (Pre-designed SNP Genotyping Assay, Applied Biosystems, Foster City, CA) on a real-time PCR machine (Bio-Rad, Hercules, CA)." qualityScore="0.8083333333333333" bFilter="false" phraseList="" nerList="13773 13785 13797"/><types2:Sentence xmi:id="7893" sofa="1" begin="182" end="255" id="1" text="A dominant mode of inheritance was assumed to maximize statistical power." qualityScore="0.9090909090909091" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7908" sofa="1" begin="255" end="448" id="2" text="ImmunofluorescenceCLU expression plasmids were transfected into SH-SY5Y cells by using FuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences, Indianapolis, IN)." qualityScore="0.85" bFilter="false" phraseList="" nerList="13756"/><types2:Sentence xmi:id="7923" sofa="1" begin="449" end="644" id="3" text="Briefly, 3.75×104 cells/well were maintained in a poly-L-lysine treated 8-well chamber coverglass (Lab-Tek, Nunc, Rochester, NY) and transfected the next day with CLU1 or CLU2 expression plasmid." qualityScore="0.85" bFilter="false" phraseList="" nerList="13728 13740"/><types2:Sentence xmi:id="7938" sofa="1" begin="645" end="785" id="4" text="Twenty-four hours after transfection, cells were washed with phosphate buffered saline (PBS) and fixed with ice-cold methanol for 5 minutes." qualityScore="0.92" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7953" sofa="1" begin="786" end="1231" id="5" text="Non-specific antibody binding sites were blocked by incubating the cells with 5% goat serum in PBS with 0.1% Tween-20 (PBST) for 1 hour and the cells were then incubated with mouse anti-V5 antibody (1:1000 dilution, ab27671, Abcam, Cambridge, MA) and either rabbit anti-calnexin antibody (1:200 dilution, SPA-860, Stressgen, Victoria, BC, Canada) or rabbit anti-TGN46 antibody (1:1000 dilution, ab16052, Abcam) in 5% goat serum at 4°C overnight." qualityScore="0.797979797979798" bFilter="false" phraseList="" nerList="13659 13671 13683 13695 13707"/><types2:Sentence xmi:id="7968" sofa="1" begin="1232" end="1542" id="6" text="The next day, cells were washed with PBST three times and incubated with a mixture containing Alexa-488 goat anti-mouse IgG antibody (1:200 dilution, Molecular Probes, Carlsbad, CA) and Alexa-568 goat anti-rabbit IgG antibody (1:200 dilution, Molecular Probes) in 5% goat serum at room temperature for an hour." qualityScore="0.8571428571428572" bFilter="false" phraseList="" nerList="13631 13643"/><types2:Sentence xmi:id="7983" sofa="1" begin="1543" end="1711" id="7" text="After washing with PBST, cells were stained with 10 µg/ml of Hoechst 33258 (Molecular Probes) for 30 minutes, washed with PBS, and subjected to fluorescence microscopy." qualityScore="0.8484848484848485" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="7998" sofa="1" begin="1711" end="1880" id="8" text="Western BlotSH-SY5Y cells or HepG2 cells were grown in a 100 mm dish (2.6×106 cells/dish) for 24 hours and then transfected with CLU1 or CLU2 expression plasmid by using" qualityScore="0.8571428571428572" bFilter="false" phraseList="" nerList="13601 13613"/><types2:Sentence xmi:id="8016" sofa="1" begin="89" end="221" id="1" text="Twenty-four hours after transfection, cell medium was replaced with Opti-MEM (Invitrogen) and cells maintained for another 24 hours." qualityScore="0.9130434782608696" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8031" sofa="1" begin="222" end="314" id="2" text="The conditioned medium was collected and the cells washed with 5 ml of room-temperature PBS." qualityScore="0.875" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8046" sofa="1" begin="648" end="828" id="5" text="Conditioned medium was centrifuged at 250×g for 10 minutes and 0.5 ml of the supernatant was collected and supplemented with 1× protease inhibitor cocktail (Roche Applied Science)." qualityScore="0.8387096774193549" bFilter="false" phraseList="" nerList="13572"/><types2:Sentence xmi:id="8061" sofa="1" begin="829" end="1069" id="6" text="Human brain anterior cingulate tissue samples were prepared by homogenizing ~0.5 mg tissue in RIPA buffer supplemented with 1× protease inhibitor cocktail, centrifuging at 14,000×g for 10 minutes at 4°C, and then collecting the supernatant." qualityScore="0.7906976744186046" bFilter="false" phraseList="" nerList="13547"/><types2:Sentence xmi:id="8076" sofa="1" begin="1070" end="1387" id="7" text="After the protein concentration of each sample was determined (Micro BCA Protein Assay Reagent Kit, Pierce, Rockford, IL), 15 or 20 µg protein were mixed with SDS sample loading buffer containing β-mercaptoethanol, boiled for 5 minutes and subjected to polyacrylamide gel electrophoresis on a 7.5% polyacrylamide gel." qualityScore="0.8440677966101695" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8091" sofa="1" begin="1388" end="1452" id="8" text="Proteins were transferred to nitrocellulose membranes (Bio-Rad)." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8106" sofa="1" begin="1453" end="1884" id="9" text="The blots were then incubated with 5% nonfat dry milk for 1 hour at room temperature and probed overnight with mouse anti-V5 antibody (1:5000 dilution, Abcam) or mouse anti-clusterin antibody (1:200, B-5 Santa-Cruz) at 4°C. After washing with PBST four times for 5 minutes each, the blots were incubated with peroxidase-conjugated sheep anti-mouse antibody (1:1,000 dilution, Jackson ImmunoResearch) for 1 hour at room temperature." qualityScore="0.8160919540229885" bFilter="false" phraseList="" nerList="13515 13527"/><types2:Sentence xmi:id="8121" sofa="1" begin="1885" end="1933" id="10" text="Bound peroxidase was visualized by using a Super" qualityScore="1.0" bFilter="false" phraseList="" nerList="13430"/><types2:Sentence xmi:id="8139" sofa="1" begin="85" end="240" id="1" text="For studies involving PNGase F digestion, each protein sample was treated with PNGase F as directed by the manufacturer (New England Biolabs, Ipswich, MA)." qualityScore="0.8071428571428572" bFilter="false" phraseList="" nerList="13402 13414"/><types2:Sentence xmi:id="8154" sofa="1" begin="381" end="443" id="3" text="Samples were then analyzed by Western blot as described above." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8169" sofa="1" begin="443" end="563" id="4" text="Results Top To begin to evaluate CLU expression, we screened human brain cDNA to identify CLU isoforms present in brain." qualityScore="0.9047619047619048" bFilter="false" phraseList="" nerList="13385"/><types2:Sentence xmi:id="8184" sofa="1" begin="564" end="743" id="5" text="Previously reported isoforms include CLU1 and CLU2, which are identical in exons 2–9 but differ in exon 1, as well as isoforms lacking exons 2 or 5 ([21], [22], reviewed in [20])." qualityScore="0.813953488372093" bFilter="false" phraseList="" nerList="13357 13369"/><types2:Sentence xmi:id="8199" sofa="1" begin="744" end="838" id="6" text="RT-PCR analyses of pooled human brain cDNA samples detected only CLU1 and CLU2 (Figure 1A–1B)." qualityScore="0.8888888888888888" bFilter="false" phraseList="" nerList="13329 13341"/><types2:Sentence xmi:id="8214" sofa="1" begin="839" end="990" id="7" text="CLU2 translation is predicted to result in a secreted protein, beginning at the initial ATG in exon 2 that is common to both CLU2 and CLU1 (Figure 1C)." qualityScore="0.9333333333333333" bFilter="false" phraseList="" nerList="13288 13300 13312"/><types2:Sentence xmi:id="8229" sofa="1" begin="991" end="1132" id="8" text="In contrast, CLU1 translation is predicted to initiate at an ATG within its exon 1, which is in-frame with the ATG site in the common exon 2." qualityScore="0.8666666666666667" bFilter="false" phraseList="" nerList="13260 13272"/><types2:Sentence xmi:id="8244" sofa="1" begin="1133" end="1315" id="9" text="Hence, CLU1 is predicted to encode a protein identical to that encoded by CLU2 except that the CLU1 protein would contain 52 additional amino acids at its amino terminus (Figure 1C)." qualityScore="0.9696969696969697" bFilter="false" phraseList="" nerList="13219 13231 13243"/><types2:Sentence xmi:id="8259" sofa="1" begin="1316" end="1439" id="10" text="This change is predicted by PSORTII to result in an intracellular and likely nuclear, form of clusterin (reviewed in [20])." qualityScore="0.9130434782608696" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8274" sofa="1" begin="1440" end="1582" id="11" text="In summary, CLU1 and CLU2 are the primary CLU isoforms in brain and are predicted to encode intracellular and secreted proteins, respectively." qualityScore="0.9583333333333334" bFilter="false" phraseList="" nerList="13176 13188 13200"/><types2:Sentence xmi:id="8289" sofa="1" begin="10" end="78" id="1" text="CLU1 and CLU2 are the primary CLU isoforms expressed in human brain." qualityScore="0.9166666666666666" bFilter="false" phraseList="" nerList="13135 13147 13159"/><types2:Sentence xmi:id="8304" sofa="1" begin="78" end="138" id="2" text="The exon layout for the CLU1 and CLU2 isoforms is shown (A)." qualityScore="0.9230769230769231" bFilter="false" phraseList="" nerList="13107 13119"/><types2:Sentence xmi:id="8319" sofa="1" begin="139" end="276" id="3" text="Coding and non-coding exonic regions are represented by black and white boxes, respectively, while introns are shown as thin black lines." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8334" sofa="1" begin="277" end="329" id="4" text="The first ATG site in each isoform is shown as well." qualityScore="0.9090909090909091" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8349" sofa="1" begin="330" end="592" id="5" text="Evaluation of CLU splicing by RT-PCR identified only CLU1 and CLU2 in human brain cDNA (B), i.e., single PCR products are observed upon amplification from exon 1a – exon 5 (lane 1), exon 1b – exon 5 (lane 2), exon 4 – exon 6 (lane 3) and exon5 – exon 9 (lane 4)." qualityScore="0.8082191780821918" bFilter="false" phraseList="" nerList="13062 13074 13086"/><types2:Sentence xmi:id="8364" sofa="1" begin="593" end="640" id="6" text="Molecular weight markers are shown at the left." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8379" sofa="1" begin="641" end="870" id="7" text="The predicted protein sequences encoded by CLU1 and CLU2, beginning with the initial ATG sites shown in A, are shown in panel C. The sequence in gray font is unique to CLU1 while sequence in black font is common to CLU1 and CLU2." qualityScore="0.9347826086956522" bFilter="false" phraseList="" nerList="12993 13005 13017 13029 13041"/><types2:Sentence xmi:id="8394" sofa="1" begin="871" end="994" id="8" text="The boxed amino acid sequence represents signal sequence that is removed from clusterin-2 upon its translocation to the ER." qualityScore="0.9" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8409" sofa="1" begin="995" end="1117" id="9" text="Two nuclear localization sequences, as predicted by PSORT II (http://psort.ims.u-tokyo.ac.jp/form2.htm l), are underlined." qualityScore="0.9259259259259259" bFilter="false" phraseList="" nerList="12976"/><types2:Sentence xmi:id="8424" sofa="1" begin="1118" end="1203" id="10" text="The asterisk shows the clusterin cleavage site that separates the α- and β- subunits." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8439" sofa="1" begin="1236" end="1437" id="13" text="g001 To evaluate whether rs11136000, the primary AD-related CLU SNP [15], [16], [17], [18], [19], is associated with CLU expression, we quantified CLU1 and CLU2 expression in a series of brain samples." qualityScore="0.8200000000000001" bFilter="false" phraseList="" nerList="12907 12919 12931 12943 12955"/><types2:Sentence xmi:id="8454" sofa="1" begin="1438" end="1631" id="14" text="The CLU isoforms were quantified in separate real-time PCR assays that used forward primers corresponding to their unique exon 1 and a common reverse primer that targeted the exon 2–3 boundary." qualityScore="0.8121212121212121" bFilter="false" phraseList="" nerList="12892"/><types2:Sentence xmi:id="8469" sofa="1" begin="1632" end="1777" id="15" text="Copy numbers were determined relative to a standard curve for each isoform and normalized to the geometric mean of housekeeping genes [23], [32]." qualityScore="0.9259259259259259" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8484" sofa="1" begin="1778" end="1971" id="16" text="The expression of CLU1 and CLU2 were modestly coordinately regulated (Figure 2A), with CLU2 being consistently greater than CLU1; the overall CLU2: CLU1 ratio was 3.35±1.84 (mean ± SD, n = 51)." qualityScore="0.8636363636363636" bFilter="false" phraseList="" nerList="12823 12835 12847 12859 12871"/><types2:Sentence xmi:id="8499" sofa="1" begin="1972" end="2168" id="17" text="To gain further insights into CLU isoform expression, we quantified CLU1 and CLU2 in a series of single human fetal tissue samples as well as a set of six adult choroid plexus samples (Figure 2B)." qualityScore="0.972972972972973" bFilter="false" phraseList="" nerList="12782 12794 12806"/><types2:Sentence xmi:id="8514" sofa="1" begin="2169" end="2273" id="18" text="Among the fetal tissues, the CLU2: CLU1 ratio varied widely from 0.3 (skin) to 6.2 (kidney) (Figure 2B)." qualityScore="0.8518518518518519" bFilter="false" phraseList="" nerList="12767"/><types2:Sentence xmi:id="8529" sofa="1" begin="2274" end="2382" id="19" text="The CLU2:CLU1 ratio in choroid plexus, which produces cerebrospinal fluid, was 5.72±0.65 (mean ± SD, n = 6)." qualityScore="0.7857142857142857" bFilter="false" phraseList="" nerList="12752"/><types2:Sentence xmi:id="8544" sofa="1" begin="10" end="54" id="1" text="Expression of CLU isoforms in human tissues." qualityScore="0.8571428571428572" bFilter="false" phraseList="" nerList="12737"/><types2:Sentence xmi:id="8559" sofa="1" begin="54" end="227" id="2" text="CLU1 and CLU2 isoforms were quantified by isoform-specific RT-PCR in a series of adult human cingulate and choroid plexus samples (A–B) as well as a human fetal tissues (B)." qualityScore="0.8571428571428572" bFilter="false" phraseList="" nerList="12709 12721"/><types2:Sentence xmi:id="8574" sofa="1" begin="228" end="351" id="3" text="Within A, each marker reflects the expression of CLU1 and CLU2, normalized to housekeeping genes, in a single brain sample." qualityScore="0.9043478260869565" bFilter="false" phraseList="" nerList="12681 12693"/><types2:Sentence xmi:id="8589" sofa="1" begin="352" end="436" id="4" text="Within B, the value in parentheses following the tissue name is the CLU1:CLU2 ratio." qualityScore="0.8625" bFilter="false" phraseList="" nerList="12666"/><types2:Sentence xmi:id="8604" sofa="1" begin="437" end="532" id="5" text="CLU1 expression shows a positive association with AD neuropathology and rs11136000T allele (C)." qualityScore="0.8571428571428572" bFilter="false" phraseList="" nerList="12638 12650"/><types2:Sentence xmi:id="8619" sofa="1" begin="533" end="625" id="6" text="CLU2 expression was increased in individuals with AD pathology and decreased with age (D–E)." qualityScore="0.8125" bFilter="false" phraseList="" nerList="12623"/><types2:Sentence xmi:id="8634" sofa="1" begin="658" end="771" id="9" text="g002 We next evaluated CLU isoform expression as a function of AD neuropathology, rs11136000 status, sex and age." qualityScore="0.9" bFilter="false" phraseList="" nerList="12595 12607"/><types2:Sentence xmi:id="8649" sofa="1" begin="772" end="912" id="10" text="We found that CLU1 expression was significantly increased with high AD neuropathology and the minor rs11136000T allele (Figure 2C, Table 2)." qualityScore="0.9130434782608696" bFilter="false" phraseList="" nerList="12567 12579"/><types2:Sentence xmi:id="8664" sofa="1" begin="913" end="1068" id="11" text="In contrast, CLU2 expression was significantly increased with AD neuropathology but not rs11136000 genotype, and decreased with age (Figure 2D–E, Table 3)." qualityScore="0.8888888888888888" bFilter="false" phraseList="" nerList="12539 12551"/><types2:Sentence xmi:id="8679" sofa="1" begin="1069" end="1156" id="12" text="Overall, both CLU1 and CLU2 expression was increased with AD, confirming prior reports." qualityScore="0.9333333333333333" bFilter="false" phraseList="" nerList="12511 12523"/><types2:Sentence xmi:id="8694" sofa="1" begin="1157" end="1218" id="13" text="However, only CLU1 expression was associated with rs11136000." qualityScore="1.0" bFilter="false" phraseList="" nerList="12483 12495"/><types2:Sentence xmi:id="8709" sofa="1" begin="1219" end="1462" id="14" text="Since the minor rs11136000T allele was associated with both increased CLU1 expression and reduced AD risk [15], [16], [17], [18], [19], we interpret these results as suggesting that increased CLU1 expression is associated with reduced AD risk." qualityScore="0.8653846153846154" bFilter="false" phraseList="" nerList="12455 12467"/><types2:Sentence xmi:id="8724" sofa="1" begin="70" end="174" id="4" text="t003 CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively (Figure 1)." qualityScore="0.9411764705882353" bFilter="false" phraseList="" nerList="12427 12439"/><types2:Sentence xmi:id="8739" sofa="1" begin="175" end="386" id="5" text="Therefore, we evaluated the proteins produced by CLU1 and CLU2 transfected cells to discern whether these corresponded to the intracellular and secreted forms of clusterin that have been reported [4], [8], [33]." qualityScore="0.925" bFilter="false" phraseList="" nerList="12399 12411"/><types2:Sentence xmi:id="8754" sofa="1" begin="387" end="549" id="6" text="When each isoform was transiently transfected into neural SH-SY5Y cells, immunofluorescence analyses showed a similar subcellular localization pattern (Figure 3)." qualityScore="0.9130434782608696" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8769" sofa="1" begin="550" end="749" id="7" text="The proteins produced by CLU1 and CLU2 tended to concentrate within the Golgi apparatus, as established by double-labeling with an antibody against trans-Golgi network protein 46 (TGN46) (Figure 3A)." qualityScore="0.9714285714285714" bFilter="false" phraseList="" nerList="12356 12368 12380"/><types2:Sentence xmi:id="8784" sofa="1" begin="750" end="907" id="8" text="Relatively modest amounts of clusterin were also detected within the endoplasmic reticulum (ER), as established by double labeling with calnexin (Figure 3B)." qualityScore="0.9615384615384616" bFilter="false" phraseList="" nerList="12341"/><types2:Sentence xmi:id="8799" sofa="1" begin="908" end="983" id="9" text="Nuclear, cytosolic, or mitochondrial-associated clusterin was not observed." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8814" sofa="1" begin="984" end="1166" id="10" text="Hence, the clusterin produced by CLU1 and CLU2 manifests an intracellular localization that includes the ER and Golgi, consistent with a possible secretory pathway for both proteins." qualityScore="0.9655172413793104" bFilter="false" phraseList="" nerList="12311 12323"/><types2:Sentence xmi:id="8829" sofa="1" begin="10" end="227" id="1" text="CLU1 and CLU2 encoded proteins are localized to the ER and Golgi.SH-SY5Y cells were transfected with vectors encoding CLU1 and CLU2; the resultant clusterin expression was localized by a vector-derived V5 epitope tag." qualityScore="0.9459459459459459" bFilter="false" phraseList="" nerList="12221 12233 12245 12257 12269 12281"/><types2:Sentence xmi:id="8844" sofa="1" begin="228" end="437" id="2" text="The subcellular localization for both proteins overlapped with the Golgi, as shown by co-labeling with antibody against TGN46 (A) and with the ER, as shown by co-labeling with an antibody against calnexin (B)." qualityScore="0.925" bFilter="false" phraseList="" nerList="12183 12195"/><types2:Sentence xmi:id="8859" sofa="1" begin="470" end="633" id="5" text="g003 CLU1 is predicted to encode a 501 amino acid protein with a molecular weight of 57.8 kDa while CLU2 is predicted to encode 449 amino acids, totaling 52.5 kDa." qualityScore="0.8181818181818181" bFilter="false" phraseList="" nerList="12155 12167"/><types2:Sentence xmi:id="8874" sofa="1" begin="634" end="790" id="6" text="During maturation of secreted clusterin, the protein is N-glycosylated and proteolyzed to generate a heterodimer that is maintained by disulfide bonds [20]." qualityScore="0.92" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="8889" sofa="1" begin="791" end="986" id="7" text="To compare the size of the proteins produced by CLU1 and CLU2, we performed Western blot analyses of transfected SH-SY5Y cells; ectopic clusterin was detected via a V5 epitope tag (Figure 4 A–B)." qualityScore="0.8947368421052632" bFilter="false" phraseList="" nerList="12112 12124 12136"/><types2:Sentence xmi:id="8904" sofa="1" begin="987" end="1186" id="8" text="Cell lysates contained both intact and cleaved clusterin while conditioned medium contained only cleaved clusterin; the clusterin protein produced by CLU1 and CLU2 appeared equal in size (Figure 4A)." qualityScore="1.0" bFilter="false" phraseList="" nerList="12071 12083 12095"/><types2:Sentence xmi:id="8919" sofa="1" begin="1187" end="1559" id="9" text="To discern whether glycosylation differences may obscure differences in the clusterin molecular weight derived from their primary sequence, the protein mixtures were digested with PNGase F to remove N-linked sugars prior to electrophoresis; the size of the proteins produced by CLU1 and CLU2 transfected cells were both decreased similarly by PNGase treatment (Figure 4B)." qualityScore="0.9448275862068966" bFilter="false" phraseList="" nerList="12007 12019 12031 12043"/><types2:Sentence xmi:id="8934" sofa="1" begin="1560" end="1750" id="10" text="We considered the possibility that CLU translation may show cell-type specificity, and therefore repeated this study in an unrelated cell line by transfecting CLU1 and CLU2 into HepG2 cells." qualityScore="0.967741935483871" bFilter="false" phraseList="" nerList="11966 11978 11990"/><types2:Sentence xmi:id="8949" sofa="1" begin="1751" end="1888" id="11" text="As with the SH-SY5Y cells, CLU1 and CLU2 transfected cells produced clusterin of similar size, even after PNGase F digestion (Figure 4C)." qualityScore="0.8769230769230769" bFilter="false" phraseList="" nerList="11925 11937 11949"/><types2:Sentence xmi:id="8964" sofa="1" begin="1889" end="2050" id="12" text="Hence, we found no evidence to suggest that the proteins produced by CLU1 and CLU2 differ in cellular localization, size, glycosylation, or proteolytic cleavage." qualityScore="1.0" bFilter="false" phraseList="" nerList="11897 11909"/><types2:Sentence xmi:id="8979" sofa="1" begin="2051" end="2357" id="13" text="Rather, when these Western blot studies are considered in combination with the immunofluorescence studies, CLU1 and CLU2 appear to produce equivalent proteins that are similarly translated, glycosylated, and cleaved as they pass through the ER and Golgi in the secretory pathway to the extracellular space." qualityScore="0.9795918367346939" bFilter="false" phraseList="" nerList="11869 11881"/><types2:Sentence xmi:id="8994" sofa="1" begin="10" end="114" id="1" text="CLU1 and CLU2 produce clusterin proteins that are similar to each other and to clusterin in human brain." qualityScore="1.0" bFilter="false" phraseList="" nerList="11828 11840 11852"/><types2:Sentence xmi:id="9009" sofa="1" begin="114" end="358" id="2" text="Transfection of CLU1 and CLU2 resulted in proteins of similar size, appearing as both intact and cleaved clusterin in cell lysates and conditioned media; the proteins resulting from CLU transfection were detected via their V5 epitope tag (A–B)." qualityScore="0.9285714285714286" bFilter="false" phraseList="" nerList="11800 11812"/><types2:Sentence xmi:id="9024" sofa="1" begin="359" end="476" id="3" text="PNGase F treatment prior to electrophoresis reduced the size of the proteins produced by CLU1 and CLU2 similarly (B)." qualityScore="0.84" bFilter="false" phraseList="" nerList="11749 11761 11773"/><types2:Sentence xmi:id="9039" sofa="1" begin="477" end="684" id="4" text="The apparent doublet in the protein encoded by CLU1 at 37 kDa was variable between experiments and likely reflects incomplete glycosylation as the doublet collapsed to a single band after PNGase F digestion." qualityScore="0.9030303030303031" bFilter="false" phraseList="" nerList="11721 11733"/><types2:Sentence xmi:id="9054" sofa="1" begin="685" end="795" id="5" text="Results similar to those depicted in B were obtained when CLU1 and CLU2 were transfected into HepG2 cells (C)." qualityScore="0.9" bFilter="false" phraseList="" nerList="11693 11705"/><types2:Sentence xmi:id="9069" sofa="1" begin="796" end="1133" id="6" text="When transfected and endogenous clusterin proteins were detected with an antibody raised against a carboxyl-terminal clusterin epitope (D–E), intact clusterin from transfection (T-labeled arrow) was slightly larger than endogenous clusterin (E-labeled arrow), reflecting the ~5.1 kDa V5 epitope and His tags in the ectopic clusterin (D)." qualityScore="0.8852459016393442" bFilter="false" phraseList="" nerList="11639 11651 11663 11675"/><types2:Sentence xmi:id="9084" sofa="1" begin="1134" end="1265" id="7" text="The bands labeled “Fragments” are clusterin alpha subunits derived from variably glycosylated endogenous and transfected clusterin." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9099" sofa="1" begin="1266" end="1505" id="8" text="Overall, the cellular clusterin proteins are similar in size to the human brain clusterin, as discerned for the intact and cleaved clusterin under reducing conditions (D) or as the heterodimeric clusterin under non-reducing conditions (E)." qualityScore="0.9512195121951219" bFilter="false" phraseList="" nerList="11609 11621"/><types2:Sentence xmi:id="9114" sofa="1" begin="1538" end="1798" id="11" text="g004 To evaluate whether the clusterin proteins produced by CLU1 and CLU2 in vitro are similar to those produced in vivo, we compared ectopic clusterin with endogenous clusterin in SH-SY5Y cells and in human brain by Western blotting with a clusterin antibody." qualityScore="0.9772727272727273" bFilter="false" phraseList="" nerList="11555 11567 11579 11591"/><types2:Sentence xmi:id="9129" sofa="1" begin="1799" end="2030" id="12" text="Endogenous clusterin in SH-SY5Y cells migrates at a slightly lower molecular weight than that resulting from CLU transfection, reflecting the 5.1 kDa V5/His tag encoded by the pcDNA3.1 vector expressing transfected CLU (Figure 4D)." qualityScore="0.85" bFilter="false" phraseList="" nerList="11540"/><types2:Sentence xmi:id="9144" sofa="1" begin="2031" end="2348" id="13" text="Importantly, this 5.1 kDa size difference between endogenous and transfected clusterin is similar to the size difference between the CLU1 and CLU2-predicted proteins, indicating that if the proteins encoded by CLU1 and CLU2 differed by 5 kDa, the proteins would be resolved easily under these experimental conditions." qualityScore="0.9423076923076923" bFilter="false" phraseList="" nerList="11486 11498 11510 11522"/><types2:Sentence xmi:id="9159" sofa="1" begin="2349" end="2534" id="14" text="The endogenous SH-SY5Y clusterin migrates similarly to the intact protein detected in brain homogenates suggesting these cellular forms are similar to those present in vivo (Figure 4D)." qualityScore="0.9655172413793104" bFilter="false" phraseList="" nerList="11471"/><types2:Sentence xmi:id="9174" sofa="1" begin="2535" end="2663" id="15" text="To extend this analysis to the heterodimeric form of clusterin, we also performed electrophoresis under non-reducing conditions." qualityScore="1.0" bFilter="false" phraseList="" nerList="11456"/><types2:Sentence xmi:id="9189" sofa="1" begin="2664" end="2820" id="16" text="We found that heterodimeric protein from CLU1 and CLU2 transfected cells appeared similar in size to each other and to the forms found in brain (Figure 4E)." qualityScore="1.0" bFilter="false" phraseList="" nerList="11428 11440"/><types2:Sentence xmi:id="9204" sofa="1" begin="2821" end="2942" id="17" text="Hence, CLU1 and CLU2 produce proteins in vitro that are similar in size to endogenous clusterin in vitro and human brain." qualityScore="1.0" bFilter="false" phraseList="" nerList="11400 11412"/><types2:Sentence xmi:id="9219" sofa="1" begin="2942" end="3002" id="18" text="Discussion Top The main findings of this report are several." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9234" sofa="1" begin="3003" end="3121" id="19" text="First, CLU1 and CLU2 are the primary CLU isoforms in human brain and differ in their first exon and proximal promoter." qualityScore="0.9545454545454546" bFilter="false" phraseList="" nerList="11357 11369 11381"/><types2:Sentence xmi:id="9249" sofa="1" begin="3122" end="3259" id="20" text="Second, the expression of only CLU1 was associated with rs11136000 while both CLU1 and CLU2 were increased with robust AD neuropathology." qualityScore="0.9545454545454546" bFilter="false" phraseList="" nerList="11303 11315 11327 11339"/><types2:Sentence xmi:id="9264" sofa="1" begin="3260" end="3380" id="21" text="Third, CLU1 and CLU2 produce secreted clusterin proteins that are similar to each other and to clusterin in human brain." qualityScore="1.0" bFilter="false" phraseList="" nerList="11262 11274 11286"/><types2:Sentence xmi:id="9279" sofa="1" begin="3381" end="3618" id="22" text="Since CLU is increased in AD and CLU1 is increased with the minor rs11136000T allele, which is also associated with reduced AD risk, we interpret our results as suggesting that increased CLU expression throughout life may reduce AD risk." qualityScore="0.848780487804878" bFilter="false" phraseList="" nerList="11221 11233 11245"/><types2:Sentence xmi:id="9294" sofa="1" begin="3619" end="3722" id="23" text="Overall, these results identify a possible means underlying the association of rs11136000 with AD risk." qualityScore="0.9375" bFilter="false" phraseList="" nerList="11206"/><types2:Sentence xmi:id="9309" sofa="1" begin="3722" end="3840" id="24" text="The association between CLU expression and rs11136000 was discerned because the CLU isoforms were analyzed separately." qualityScore="0.875" bFilter="false" phraseList="" nerList="11165 11177 11189"/><types2:Sentence xmi:id="9324" sofa="1" begin="3841" end="4098" id="25" text="For example, when we analyzed total CLU expression in the same fashion as reported here, total CLU was not associated with rs11136000 (p = 0.51) although a robust association with AD pathology was observed (p = 0.005, Ling et al., unpublished observations)." qualityScore="0.8703703703703703" bFilter="false" phraseList="" nerList="11150"/><types2:Sentence xmi:id="9339" sofa="1" begin="4099" end="4252" id="26" text="The lack of a significant association between rs11136000 and total CLU is somewhat disconcerting since CLU1 and CLU2 appear to produce a similar protein." qualityScore="0.9583333333333334" bFilter="false" phraseList="" nerList="11109 11121 11133"/><types2:Sentence xmi:id="9354" sofa="1" begin="4253" end="4503" id="27" text="We speculate that (i) the threshold for clusterin biological significance may be less than the threshold for overall CLU statistical significance and/or (ii) CLU1 may be enriched in a cell type different than CLU2, which may affect its functionality." qualityScore="0.9777777777777777" bFilter="false" phraseList="" nerList="11081 11093"/><types2:Sentence xmi:id="9369" sofa="1" begin="4504" end="4694" id="28" text="We note that the lack of an association between total CLU and rs11136000 was similar to prior reports that total CLU mRNA or clusterin protein were not associated with rs11136000 [17], [34]." qualityScore="0.8888888888888888" bFilter="false" phraseList="" nerList="11040 11052 11064"/><types2:Sentence xmi:id="9384" sofa="1" begin="4695" end="4889" id="29" text="As the clusterin produced by CLU1 and CLU2 appears similar, discerning an association between rs11136000 and clusterin would be especially challenging in tissues with a large proportion of CLU2." qualityScore="1.0" bFilter="false" phraseList="" nerList="10986 10998 11010 11022"/><types2:Sentence xmi:id="9399" sofa="1" begin="4890" end="5065" id="30" text="In this regard, CLU2 was the major isoform in choroid plexus, suggesting that an association between cerebrospinal fluid clusterin and rs11136000 would be difficult to detect." qualityScore="1.0" bFilter="false" phraseList="" nerList="10971"/><types2:Sentence xmi:id="9414" sofa="1" begin="5066" end="5192" id="31" text="The differential regulation of CLU1 and CLU2 was not unexpected because CLU1 and CLU2 have separate proximal promoter regions." qualityScore="1.0" bFilter="false" phraseList="" nerList="10917 10929 10941 10953"/><types2:Sentence xmi:id="9429" sofa="1" begin="5193" end="5366" id="32" text="Consistent with this observation, Cochrane et al found that androgen-treatment in a prostate cancer cell line decreased CLU1 expression while enhancing CLU2 expression [35]." qualityScore="0.962962962962963" bFilter="false" phraseList="" nerList="10889 10901"/><types2:Sentence xmi:id="9444" sofa="1" begin="5367" end="5593" id="33" text="Although the identification of the functional SNPs and transcription factors that modulate CLU expression is beyond the scope of this report, we note that rs11136000 resides within intron 3 and is common to both CLU1 and CLU2." qualityScore="0.9473684210526316" bFilter="false" phraseList="" nerList="10835 10847 10859 10871"/><types2:Sentence xmi:id="9459" sofa="1" begin="5594" end="5719" id="34" text="Hence, rs11136000 is likely not functional but rather is in linkage with a functional SNP more proximal to the CLU1 promoter." qualityScore="0.9545454545454546" bFilter="false" phraseList="" nerList="10807 10819"/><types2:Sentence xmi:id="9474" sofa="1" begin="5720" end="5837" id="35" text="In summary, the association between rs11136000 and CLU1 was dependent upon analyzing the two CLU isoforms separately." qualityScore="0.9444444444444444" bFilter="false" phraseList="" nerList="10766 10778 10790"/><types2:Sentence xmi:id="9489" sofa="1" begin="5837" end="6117" id="36" text="Since earlier predictions were that CLU2 encodes a secreted protein while the additional 52 amino-terminal residues encoded by CLU1 would result in its intracellular localization [20], we expected clusterin in CLU1 and CLU2 transfected cells to differ in cellular locale and size." qualityScore="0.9565217391304348" bFilter="false" phraseList="" nerList="10725 10737 10749"/><types2:Sentence xmi:id="9504" sofa="1" begin="6118" end="6332" id="37" text="In support of this prediction, the ATG translation initiation sites in the CLU1-specific exon 1a as well as the common exon 2 both satisfy Kozak consensus sequence requirements (http://bioinfo.iitk.ac.in/AUGPred/)." qualityScore="0.9487179487179487" bFilter="false" phraseList="" nerList="10697 10709"/><types2:Sentence xmi:id="9519" sofa="1" begin="6333" end="6599" id="38" text="However, clusterin in CLU1 and CLU2 transfected cells was localized to the secretory pathway and was equivalent in size under conditions that would easily discern their predicted five kDa size difference, especially after PNGase F treatment to remove sugar residues." qualityScore="0.9476190476190476" bFilter="false" phraseList="" nerList="10656 10668 10680"/><types2:Sentence xmi:id="9534" sofa="1" begin="6600" end="6664" id="39" text="Hence, CLU1 and CLU2 produce similar secreted proteins in vitro." qualityScore="1.0" bFilter="false" phraseList="" nerList="10628 10640"/><types2:Sentence xmi:id="9549" sofa="1" begin="6665" end="6791" id="40" text="Comparable results were obtained in two cell types, suggesting that CLU1 and CLU2 generally produce soluble clusterin protein." qualityScore="1.0" bFilter="false" phraseList="" nerList="10587 10599 10611"/><types2:Sentence xmi:id="9564" sofa="1" begin="6792" end="6916" id="41" text="The most parsimonious interpretation of these data is that CLU1 translation is generally initiated at the common exon 2 ATG." qualityScore="0.9" bFilter="false" phraseList="" nerList="10572"/><types2:Sentence xmi:id="9579" sofa="1" begin="6917" end="7110" id="42" text="The possibility exists that a portion of CLU1 translation is initiated at the exon 1a ATG at levels too low to be readily detected or that produce an unstable protein which is rapidly degraded." qualityScore="0.9705882352941176" bFilter="false" phraseList="" nerList="10557"/><types2:Sentence xmi:id="9594" sofa="1" begin="7111" end="7188" id="43" text="Distinguishing among these possibilities is a future direction for this work." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9609" sofa="1" begin="7189" end="7524" id="44" text="Overall, we summarize our current results by noting that the proteins produced from CLU1 and CLU2 in vitro are similar to each other, and similar in size to those present in human brain, leading us to interpret our data as supporting the possibility that CLU1 and CLU2 generally produce secreted clusterin protein in vitro and in vivo." qualityScore="1.0" bFilter="false" phraseList="" nerList="10488 10500 10512 10524 10536"/><types2:Sentence xmi:id="9624" sofa="1" begin="7524" end="7727" id="45" text="A logical extension of the finding that AD risk is reduced with a genetic variant that correlates with increased CLU expression is that other factors that increase CLU expression may also reduce AD risk." qualityScore="0.8529411764705882" bFilter="false" phraseList="" nerList="10460 10472"/><types2:Sentence xmi:id="9639" sofa="1" begin="7728" end="7961" id="46" text="Furthermore, since CLU expression is increased in AD without reversing the disease, we speculate that enhanced CLU expression reduces AD risk only if CLU expression is increased well before AD onset, mimicking the likely SNP effects." qualityScore="0.8205128205128205" bFilter="false" phraseList="" nerList="10432 10444"/><types2:Sentence xmi:id="9654" sofa="1" begin="7962" end="8104" id="47" text="One possible modulator of interest is age-dependent changes in sex hormones since CLU isoforms are differentially regulated by androgens [35]." qualityScore="0.9090909090909091" bFilter="false" phraseList="" nerList="10417"/><types2:Sentence xmi:id="9669" sofa="1" begin="8105" end="8235" id="48" text="Stress has also been shown to upregulate CLU in many instances [36] and may cause the AD-associated increase in CLU observed here." qualityScore="0.84" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9684" sofa="1" begin="8236" end="8364" id="49" text="In terms of possible therapeutic agents, multiple histone deacetylase inhibitors increase CLU expression robustly in vitro [37]." qualityScore="0.8947368421052632" bFilter="false" phraseList="" nerList="10390"/><types2:Sentence xmi:id="9699" sofa="1" begin="8365" end="8566" id="50" text="Interestingly, one member of this class, valproate, increases CLU expression in human astrocytes [37] and reduces amyloid accumulation as well as behavioral deficits in mouse amyloid models [38], [39]." qualityScore="0.8947368421052632" bFilter="false" phraseList="" nerList="10375"/><types2:Sentence xmi:id="9714" sofa="1" begin="8567" end="8753" id="51" text="While valproate may also act via other mechanisms [38], the actions of valproate on CLU expression may be relevant to its neuroprotection and merit further exploration to reduce AD risk." qualityScore="0.9090909090909091" bFilter="false" phraseList="" nerList="10360"/><types2:Sentence xmi:id="9729" sofa="1" begin="8753" end="8887" id="52" text="Limitations of this study include that rs11136000 and AD neuropathological status capture only ~20% of the variance in CLU expression." qualityScore="0.8636363636363636" bFilter="false" phraseList="" nerList="10345"/><types2:Sentence xmi:id="9744" sofa="1" begin="8888" end="9050" id="53" text="Identifying the unknown factors that account for the additional variance, which could include epigenetic factors, will facilitate understanding of CLU expression." qualityScore="0.9565217391304348" bFilter="false" phraseList="" nerList="10330"/><types2:Sentence xmi:id="9759" sofa="1" begin="9051" end="9299" id="54" text="Moreover, variability in these factors could facilitate or obscure the SNP association with CLU1 expression described here, suggesting that replication of these data in additional samples is necessary for their acceptance by the research community." qualityScore="0.972972972972973" bFilter="false" phraseList="" nerList="10315"/><types2:Sentence xmi:id="9774" sofa="1" begin="9300" end="9562" id="55" text="Additionally, since the nuclear form of clusterin arising from an isoform lacking exon 2 has been associated with apoptosis [21], [22], this isoform may be transientlyexpressed and hence below our limits of detection, especially in comparison with CLU1 and CLU2." qualityScore="0.9375" bFilter="false" phraseList="" nerList="10287 10299"/><types2:Sentence xmi:id="9789" sofa="1" begin="9562" end="9693" id="56" text="In conclusion, the AD-protective allele of rs11136000 was associated with increased expression of CLU1 but not CLU2 in our dataset." qualityScore="0.9545454545454546" bFilter="false" phraseList="" nerList="10246 10258 10270"/><types2:Sentence xmi:id="9804" sofa="1" begin="9694" end="9807" id="57" text="Both CLU1 and CLU2 produce a soluble, secreted clusterin protein that is similar to that observed in human brain." qualityScore="1.0" bFilter="false" phraseList="" nerList="10205 10217 10229"/><types2:Sentence xmi:id="9819" sofa="1" begin="9808" end="9921" id="58" text="Discerning the association between rs11136000 and CLU1 depended upon analyzing these two CLU isoforms separately." qualityScore="0.9333333333333333" bFilter="false" phraseList="" nerList="10164 10176 10188"/><types2:Sentence xmi:id="9834" sofa="1" begin="9921" end="10075" id="59" text="Acknowledgments Top The authors gratefully acknowledge tissue supplied by the University of Kentucky AD Center and Ishita Parikh for technical assistance." qualityScore="0.8952380952380953" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9849" sofa="1" begin="10075" end="10146" id="60" text="Author Contributions Top Conceived and designed the experiments: IL SE." qualityScore="0.8181818181818181" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9864" sofa="1" begin="12487" end="12615" id="86" text="Find this article online Holtzman DM (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology." qualityScore="0.8090909090909091" bFilter="false" phraseList="" nerList="10145"/><types2:Sentence xmi:id="9879" sofa="1" begin="12644" end="12731" id="88" text="Find this article online Bertram L, Tanzi REAlzheimer disease: New light on an old CLU." qualityScore="0.8117647058823529" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9894" sofa="1" begin="15000" end="15110" id="112" text="Find this article online (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease." qualityScore="0.8823529411764706" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9909" sofa="1" begin="15111" end="15262" id="113" text="The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease." qualityScore="1.0" bFilter="false" phraseList="" nerList=""/><types2:Sentence xmi:id="9924" sofa="1" begin="15855" end="16176" id="121" text="Find this article online Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, et al. (1999) The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease." qualityScore="0.7627118644067796" bFilter="false" phraseList="" nerList="9941 9953"/><types2:Sentence xmi:id="14797" sofa="1" begin="9" end="37" id="1" text="Analysis of CLU1 Expression." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14809" sofa="1" begin="9" end="37" id="1" text="Analysis of CLU2 Expression." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14821" sofa="1" begin="37" end="57" id="2" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14833" sofa="1" begin="37" end="57" id="2" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14845" sofa="1" begin="53" end="73" id="2" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14857" sofa="1" begin="57" end="70" id="3" text="pone.0033923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14869" sofa="1" begin="57" end="70" id="3" text="pone.0033923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14881" sofa="1" begin="70" end="84" id="4" text="t002 thumbnail" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14893" sofa="1" begin="73" end="86" id="3" text="pone.0033923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14905" sofa="1" begin="111" end="410" id="1" text="PCR profiles consisted of pre-incubation at 95°C for 2 min, followed by 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 20 s. Specificity of the reactions was evaluated by showing a single PCR product by gel electrophoresis and by performing a melting curve analysis after PCR amplification." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14917" sofa="1" begin="241" end="380" id="2" text="Briefly, 15 µg protein of each sample was denatured at 100°C for 10 minutes and incubated with 1,500 units of PNGase F at 37°C for 2 hours." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14929" sofa="1" begin="315" end="552" id="3" text="Cells were then lysed in 0.5 ml of RIPA butter (50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS) containing 1× protease inhibitor cocktail (Roche Applied Sciences) for 30 minutes on ice with occasional rocking." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14941" sofa="1" begin="357" end="764" id="2" text="In initial screening, cDNA pooled from five high AD neuropathology and five low AD neuropathology samples were subjected to PCR-amplification (Platinum Taq, Invitrogen) by using each primer pair and a PCR profile consisting of initial denaturation for 5 minutes at 95°C, followed by 27–32 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min, and final extension at 72°C for 7 min (Perkin Elmer 9600)." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14953" sofa="1" begin="402" end="424" id="2" text="CLU Expression Plasmid" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14965" sofa="1" begin="437" end="457" id="3" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14977" sofa="1" begin="439" end="538" id="2" text="PCR fragments were ligated into pcDNA3.1/V5-His-TOPO T/A cloning vector (Invitrogen, Carlsbad, CA)." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="14989" sofa="1" begin="457" end="470" id="4" text="pone.0033923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15001" sofa="1" begin="553" end="647" id="4" text="Cell lysates were centrifuged at 10,000×g for 10 minutes at 4°C and the supernatant collected." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15013" sofa="1" begin="625" end="645" id="7" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15025" sofa="1" begin="644" end="664" id="4" text="Human Autopsy Tissue" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15037" sofa="1" begin="645" end="658" id="8" text="pone.0033923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15049" sofa="1" begin="861" end="1066" id="4" text="The average post-mortem interval (PMI) for low AD neuropathology individuals was 3.0±0.8 hours (mean ± SD, n = 17) while the PMI for high AD neuropathology individuals was similar (3.2±0.8 hours (n = 34))." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15061" sofa="1" begin="1016" end="1025" id="5" text="thumbnail" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15073" sofa="1" begin="1032" end="1092" id="4" text="How CLU SNPs modulate clusterin to alter AD risk is unknown." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15085" sofa="1" begin="1067" end="1189" id="5" text="Choroid plexus samples were from six individuals with an average age at death of 80.0± 3.3 years and PMI of 2.9±1.1 hours." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15097" sofa="1" begin="1117" end="1137" id="6" text="Statistical Analysis" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15109" sofa="1" begin="1166" end="1175" id="11" text="thumbnail" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15121" sofa="1" begin="1203" end="1223" id="11" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15133" sofa="1" begin="1223" end="1236" id="12" text="pone.0033923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15145" sofa="1" begin="1236" end="1379" id="8" text="Citation: Ling I-F, Bhongsatiern J, Simpson JF, Fardo DW, Estus S (2012) Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15157" sofa="1" begin="1312" end="1329" id="7" text="PCR Amplification" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15169" sofa="1" begin="1380" end="1402" id="9" text="PLoS ONE 7(4): e33923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15181" sofa="1" begin="1403" end="1423" id="10" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15193" sofa="1" begin="1423" end="1435" id="11" text="pone.0033923" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15205" sofa="1" begin="1462" end="1471" id="15" text="thumbnail" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15217" sofa="1" begin="1505" end="1525" id="9" text="doi:10.1371/journal." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15229" sofa="1" begin="1525" end="1538" id="10" text="pone.0033923." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15241" sofa="1" begin="1582" end="1591" id="12" text="thumbnail" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15253" sofa="1" begin="2256" end="2284" id="12" text="Methods Top Ethics Statement" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15265" sofa="1" begin="2357" end="2366" id="14" text="thumbnail" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15277" sofa="1" begin="2382" end="2391" id="20" text="thumbnail" qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15289" sofa="1" begin="10147" end="10183" id="61" text="Performed the experiments: IF JB JS." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15301" sofa="1" begin="10184" end="10218" id="62" text="Analyzed the data: IL JB JF DF SE." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15313" sofa="1" begin="10219" end="10242" id="63" text="Wrote the paper: IF SE." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15325" sofa="1" begin="10242" end="10419" id="64" text="References Top Sala A, Bettuzzi S, Pucci S, Chayka O, Dews M, et al. (2009) Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15337" sofa="1" begin="10420" end="10448" id="65" text="Adv Cancer Res 105: 115–132." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15349" sofa="1" begin="10449" end="10609" id="66" text="Find this article online Redondo M, Tellez T, Roldan MJ (2009) The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15361" sofa="1" begin="10610" end="10636" id="67" text="Adv Cancer Res 105: 21–43." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15373" sofa="1" begin="10637" end="10770" id="68" text="Find this article online Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009) Clusterin: a forgotten player in Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15385" sofa="1" begin="10771" end="10796" id="69" text="Brain Res Rev 61: 89–104." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15397" sofa="1" begin="10797" end="10949" id="70" text="Find this article online Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, et al. (2000) Apolipoprotein J (clusterin) and Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15409" sofa="1" begin="10950" end="10979" id="71" text="Microsc Res Tech 50: 305–315." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15421" sofa="1" begin="10980" end="11220" id="72" text="Find this article online May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, et al. (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15433" sofa="1" begin="11221" end="11239" id="73" text="Neuron 5: 831–839." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15445" sofa="1" begin="11240" end="11374" id="74" text="Find this article online Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM (2011) Plasma clusterin and the risk of Alzheimer disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15457" sofa="1" begin="11375" end="11444" id="75" text="JAMA: the Journal of the American Medical Association 305: 1322–1326." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15469" sofa="1" begin="11445" end="11588" id="76" text="Find this article online Choi-Miura NH, Ihara Y, Fukuchi K, Takeda M, Nakano Y, et al. (1992) SP-40,40 is a constituent of Alzheimer's amyloid." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15481" sofa="1" begin="11589" end="11618" id="77" text="Acta Neuropathol 83: 260–264." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15493" sofa="1" begin="11619" end="11768" id="78" text="Find this article online Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, et al. (2005) Clusterin inhibits apoptosis by interacting with activated Bax." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15505" sofa="1" begin="11769" end="11794" id="79" text="Nat Cell Biol 7: 909–915." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15517" sofa="1" begin="11795" end="11945" id="80" text="Find this article online Falgarone G, Chiocchia G (2009) Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15529" sofa="1" begin="11946" end="11974" id="81" text="Adv Cancer Res 104: 139–170." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15541" sofa="1" begin="11975" end="12191" id="82" text="Find this article online Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, et al. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15553" sofa="1" begin="12192" end="12214" id="83" text="FASEB J 21: 2312–2322." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15565" sofa="1" begin="12215" end="12448" id="84" text="Find this article online Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, et al. (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15577" sofa="1" begin="12449" end="12486" id="85" text="J Cereb Blood Flow Metab 27: 909–918." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15589" sofa="1" begin="12616" end="12643" id="87" text="J Mol Neurosci 23: 247–254." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15601" sofa="1" begin="12732" end="12756" id="89" text="Nat Rev Neurol 6: 11–13." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15613" sofa="1" begin="12757" end="12848" id="90" text="Find this article online van Es MA, van den Berg LH (2009) Alzheimer's disease beyond APOE." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15625" sofa="1" begin="12849" end="12873" id="91" text="Nat Genet 41: 1047–1048." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15637" sofa="1" begin="12874" end="13066" id="92" text="Find this article online Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15649" sofa="1" begin="13067" end="13091" id="93" text="Nat Genet 41: 1094–1099." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15661" sofa="1" begin="13092" end="13291" id="94" text="Find this article online Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15673" sofa="1" begin="13292" end="13316" id="95" text="Nat Genet 41: 1088–1093." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15685" sofa="1" begin="13317" end="13482" id="96" text="Find this article online Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, et al. (2010) Genetic variability in CLU and its association with Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15697" sofa="1" begin="13483" end="13501" id="97" text="PLoS One 5: e9510." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15709" sofa="1" begin="13502" end="13671" id="98" text="Find this article online Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM associations with Alzheimer disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15721" sofa="1" begin="13672" end="13706" id="99" text="Archives of Neurology 67: 961–964." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15733" sofa="1" begin="13707" end="13911" id="100" text="Find this article online Jun G, Naj AC, Beecham GW, Wang LS, Buros J, et al. (2010) Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15745" sofa="1" begin="13912" end="13938" id="101" text="Arch Neurol 67: 1473–1484." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15757" sofa="1" begin="13939" end="14052" id="102" text="Find this article online Rizzi F, Bettuzzi S (2010) The clusterin paradigm in prostate and breast carcinogenesis." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15769" sofa="1" begin="14053" end="14083" id="103" text="Endocr Relat Cancer 17: R1–17." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15781" sofa="1" begin="14084" end="14246" id="104" text="Find this article online Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15793" sofa="1" begin="14247" end="14276" id="105" text="J Biol Chem 278: 11590–11600." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15805" sofa="1" begin="14277" end="14495" id="106" text="Find this article online Kimura K, Yamamoto M (1996) Modification of the alternative splicing process of testosterone-repressed prostate message-2 (TRPM-2) gene by protein synthesis inhibitors and heat shock treatment." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15817" sofa="1" begin="14496" end="14529" id="107" text="Biochim Biophys Acta 1307: 83–88." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15829" sofa="1" begin="14530" end="14715" id="108" text="Find this article online Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, et al. (2009) Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15841" sofa="1" begin="14716" end="14739" id="109" text="Mol Neurodegener 4: 46." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15853" sofa="1" begin="14740" end="14972" id="110" text="Find this article online Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, et al. (2008) Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15865" sofa="1" begin="14973" end="14999" id="111" text="Hum Mol Genet 17: 929–935." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15877" sofa="1" begin="15263" end="15294" id="114" text="Neurobiology of aging 18: S1–2." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15889" sofa="1" begin="15295" end="15459" id="115" text="Find this article online Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15901" sofa="1" begin="15460" end="15494" id="116" text="J Neuropathol Exp Neurol 68: 1–14." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15913" sofa="1" begin="15495" end="15633" id="117" text="Find this article online Burchett M, Ling I-F, Estus S (2011) FBN1 isoform expression varies in a tissue and development-specific fashion." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15925" sofa="1" begin="15634" end="15674" id="118" text="Biochem Biophys Res Commun 411: 323–328." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15937" sofa="1" begin="15675" end="15827" id="119" text="Find this article online Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15949" sofa="1" begin="15828" end="15854" id="120" text="Anal Biochem 162: 156–159." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15961" sofa="1" begin="16177" end="16203" id="122" text="Neurochem Res 24: 767–774." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15973" sofa="1" begin="16204" end="16430" id="123" text="Find this article online Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, et al. (2007) A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15985" sofa="1" begin="16431" end="16459" id="124" text="Hum Mol Genet 16: 1765–1772." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="15997" sofa="1" begin="16460" end="16637" id="125" text="Find this article online Schepeler T, Mansilla F, Christensen LL, Orntoft TF, Andersen CL (2007) Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16009" sofa="1" begin="16638" end="16674" id="126" text="Journal of Molecular Signaling 2: 6." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16021" sofa="1" begin="16675" end="16785" id="127" text="Find this article online Ling IF, Estus S (2010) Role of SFRS13A in low-density lipoprotein receptor splicing." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16033" sofa="1" begin="16786" end="16808" id="128" text="Hum Mutat 31: 702–709." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16045" sofa="1" begin="16809" end="17011" id="129" text="Find this article online Reddy KB, Jin G, Karode MC, Harmony JA, Howe PH (1996) Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16057" sofa="1" begin="17012" end="17039" id="130" text="Biochemistry 35: 6157–6163." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16069" sofa="1" begin="17040" end="17247" id="131" text="Find this article online Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, et al. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16081" sofa="1" begin="17248" end="17291" id="132" text="Archives of General Psychiatry 67: 739–748." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16093" sofa="1" begin="17292" end="17463" id="133" text="Find this article online Cochrane DR, Wang Z, Muramaki M, Gleave ME, Nelson CC (2007) Differential regulation of clusterin and its isoforms by androgens in prostate cells." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16105" sofa="1" begin="17464" end="17491" id="134" text="J Biol Chem 282: 2278–2287." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16117" sofa="1" begin="17492" end="17619" id="135" text="Find this article online Michel D, Chatelain G, North S, Brun G (1997) Stress-induced transcription of the clusterin/apoJ gene." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16129" sofa="1" begin="17620" end="17647" id="136" text="Biochem J 328(Pt 1): 45–50." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16141" sofa="1" begin="17648" end="17832" id="137" text="Find this article online Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2010) Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16153" sofa="1" begin="17833" end="17865" id="138" text="Neuroscience Letters 475: 64–68." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16165" sofa="1" begin="17866" end="18077" id="139" text="Find this article online Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, et al. (2008) Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16177" sofa="1" begin="18078" end="18103" id="140" text="J Exp Med 205: 2781–2789." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16189" sofa="1" begin="18104" end="18316" id="141" text="Find this article online Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, et al. (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16201" sofa="1" begin="18317" end="18353" id="142" text="Neuropsychopharmacology 35: 870–880." qualityScore="0.0" bFilter="true"/><types2:Sentence xmi:id="16213" sofa="1" begin="18354" end="18378" id="143" text="Find this article online" qualityScore="0.0" bFilter="true"/><types2:Question xmi:id="249" sofa="1" begin="0" end="125" id="3" text="Which clusterin single nucleotide polymorphism has been linked to a reduction in the risk for developing Alzheimer's disease?" dependencies="520 530 540 550 560 570 580 590 600 610 620 630 640 650" nerList="" nounList="467 477 487 497 507" tokenList="269 279 289 299 309 319 329 339 349 359 369 379 389 399 409 419 429 439 449 459"/><types2:Question xmi:id="936" sofa="1" begin="0" end="96" id="0" text="Which technique was used to determine the cellular locations of the CLU1 and CLU2 gene products?" dependencies="1192 1202 1212 1222 1232 1242 1252 1262 1272 1282 1292 1302 1312 1322" nerList="1168 1180" nounList="1126 1136 1146 1156" tokenList="958 968 978 988 998 1008 1018 1028 1038 1048 1058 1068 1078 1088 1098 1108 1118"/><types2:Question xmi:id="1526" sofa="1" begin="0" end="95" id="8" text="Which particular histone deacetylase inhibitor has been shown to enhance the expression of CLU? " dependencies="1751 1761 1771 1781 1791 1801 1811 1821 1831 1841 1851 1861" nerList="1727 1739" nounList="1696 1706 1716" tokenList="1548 1558 1568 1578 1588 1598 1608 1618 1628 1638 1648 1658 1668 1678 1688"/><types2:Question xmi:id="2116" sofa="1" begin="0" end="78" id="2" text="Which of the two CLU isoforms is the main one expressed in the choroid plexus?" dependencies="2338 2348 2358 2368 2378 2388 2398 2408 2418 2428 2438 2448" nerList="2327" nounList="2296 2306 2316" tokenList="2138 2148 2158 2168 2178 2188 2198 2208 2218 2228 2238 2248 2258 2268 2278 2288"/><types2:Question xmi:id="2624" sofa="1" begin="0" end="64" id="4" text="Which CLU protein isoforms in the brain have been characterized?" dependencies="2785 2795 2805 2815 2825 2835 2845 2855" nerList="2774" nounList="2754 2764" tokenList="2646 2656 2666 2676 2686 2696 2706 2716 2726 2736 2746"/><types2:Question xmi:id="2975" sofa="1" begin="0" end="61" id="1" text="What compartments inside the cell contain clusterin proteins?" dependencies="3127 3137 3147 3157 3167 3177" nerList="3116" nounList="3085 3095 3105" tokenList="2997 3007 3017 3027 3037 3047 3057 3067 3077"/><types2:Question xmi:id="3269" sofa="1" begin="0" end="60" id="5" text="Which CLU isoform has a consistently higher gene expression?" dependencies="3420 3430 3440 3450 3460 3470 3480 3490" nerList="3409" nounList="3389 3399" tokenList="3291 3301 3311 3321 3331 3341 3351 3361 3371 3381"/><types2:Question xmi:id="3610" sofa="1" begin="0" end="57" id="6" text="Which hormone can control the expression of CLU isoforms?" dependencies="3772 3782 3792 3802 3812 3822 3832" nerList="3761" nounList="3730 3740 3750" tokenList="3632 3642 3652 3662 3672 3682 3692 3702 3712 3722"/><types2:Question xmi:id="3938" sofa="1" begin="0" end="54" id="7" text="What effect do androgens have on CLU2 gene expression?" dependencies="4100 4110 4120 4130 4140 4150 4160" nerList="4089" nounList="4058 4068 4078" tokenList="3960 3970 3980 3990 4000 4010 4020 4030 4040 4050"/><types2:Question xmi:id="4266" sofa="1" begin="0" end="54" id="9" text="How many residues does the CLU2 protein sequence have?" dependencies="4417 4427 4437 4447 4457 4467 4477 4487" nerList="4406" nounList="4386 4396" tokenList="4288 4298 4308 4318 4328 4338 4348 4358 4368 4378"/><types2:Answer xmi:id="4607" sofa="1" begin="0" end="30" text="immunofluorescence experiments" id="4" isCorrect="true" isSelected="false" nounPhraseList="4647" nerList="" tokenList="4629 4639"/><types2:Answer xmi:id="4670" sofa="1" begin="0" end="26" text="intracellular and secreted" id="0" isCorrect="false" isSelected="false" nounPhraseList="4720" nerList="" tokenList="4692 4702 4712"/><types2:Answer xmi:id="4729" sofa="1" begin="0" end="26" text="intracellular localization" id="2" isCorrect="false" isSelected="false" nounPhraseList="4769" nerList="" tokenList="4751 4761"/><types2:Answer xmi:id="4778" sofa="1" begin="0" end="26" text="ER and the Golgi apparatus" id="0" isCorrect="true" isSelected="false" nounPhraseList="4848 4858" nerList="" tokenList="4800 4810 4820 4830 4840"/><types2:Answer xmi:id="4868" sofa="1" begin="0" end="22" text="ribosomal protein L13A" id="1" isCorrect="false" isSelected="false" nounPhraseList="4931" nerList="4920" tokenList="4892 4902 4912"/><types2:Answer xmi:id="4940" sofa="1" begin="0" end="19" text="cerebrospinal fluid" id="4" isCorrect="false" isSelected="false" nounPhraseList="4980" nerList="" tokenList="4962 4972"/><types2:Answer xmi:id="4989" sofa="1" begin="0" end="18" text="therapeutic agents" id="2" isCorrect="false" isSelected="false" nounPhraseList="5029" nerList="" tokenList="5011 5021"/><types2:Answer xmi:id="5038" sofa="1" begin="0" end="17" text="secretory pathway" id="3" isCorrect="false" isSelected="false" nounPhraseList="5078" nerList="" tokenList="5060 5070"/><types2:Answer xmi:id="5087" sofa="1" begin="0" end="17" text="secreted proteins" id="3" isCorrect="false" isSelected="false" nounPhraseList="5127" nerList="" tokenList="5109 5119"/><types2:Answer xmi:id="5148" sofa="1" begin="0" end="15" text="Golgi apparatus" id="3" isCorrect="false" isSelected="false" nounPhraseList="5188" nerList="" tokenList="5170 5180"/><types2:Answer xmi:id="5197" sofa="1" begin="0" end="13" text="CLU1 and CLU2" id="0" isCorrect="false" isSelected="false" nounPhraseList="5273 5283" nerList="5249 5261" tokenList="5221 5231 5241"/><types2:Answer xmi:id="5293" sofa="1" begin="0" end="13" text="real-time PCR" id="0" isCorrect="false" isSelected="false" nounPhraseList="5333" nerList="" tokenList="5315 5325"/><types2:Answer xmi:id="5342" sofa="1" begin="0" end="12" text="fetal tissue" id="0" isCorrect="false" isSelected="false" nounPhraseList="5382" nerList="" tokenList="5364 5374"/><types2:Answer xmi:id="5403" sofa="1" begin="0" end="11" text="epitope tag" id="1" isCorrect="false" isSelected="false" nounPhraseList="5443" nerList="" tokenList="5425 5435"/><types2:Answer xmi:id="5452" sofa="1" begin="0" end="11" text="association" id="0" isCorrect="false" isSelected="false" nounPhraseList="5482" nerList="" tokenList="5474"/><types2:Answer xmi:id="5491" sofa="1" begin="0" end="11" text="rs11136000T" id="2" isCorrect="true" isSelected="false" nounPhraseList="5521" nerList="" tokenList="5513"/><types2:Answer xmi:id="5530" sofa="1" begin="0" end="10" text="rs11136000" id="2" isCorrect="true" isSelected="false" nounPhraseList="5560" nerList="" tokenList="5552"/><types2:Answer xmi:id="5569" sofa="1" begin="0" end="10" text="repression" id="1" isCorrect="false" isSelected="false" nounPhraseList="5599" nerList="" tokenList="5591"/><types2:Answer xmi:id="5608" sofa="1" begin="0" end="10" text="astrocytes" id="0" isCorrect="false" isSelected="false" nounPhraseList="5638" nerList="" tokenList="5630"/><types2:Answer xmi:id="5647" sofa="1" begin="0" end="10" text="expression" id="4" isCorrect="false" isSelected="false" nounPhraseList="5677" nerList="" tokenList="5669"/><types2:Answer xmi:id="5686" sofa="1" begin="0" end="10" text="activation" id="3" isCorrect="true" isSelected="false" nounPhraseList="5716" nerList="" tokenList="5708"/><types2:Answer xmi:id="5725" sofa="1" begin="0" end="10" text="inhibition" id="2" isCorrect="false" isSelected="false" nounPhraseList="5755" nerList="" tokenList="5747"/><types2:Answer xmi:id="5764" sofa="1" begin="0" end="10" text="rs11136000" id="3" isCorrect="false" isSelected="false" nounPhraseList="5794" nerList="" tokenList="5786"/><types2:Answer xmi:id="5851" sofa="1" begin="0" end="9" text="clusterin" id="2" isCorrect="false" isSelected="false" nounPhraseList="5881" nerList="" tokenList="5873"/><types2:Answer xmi:id="5890" sofa="1" begin="0" end="9" text="valproate" id="3" isCorrect="true" isSelected="false" nounPhraseList="5920" nerList="" tokenList="5912"/><types2:Answer xmi:id="5929" sofa="1" begin="0" end="9" text="clusterin" id="3" isCorrect="false" isSelected="false" nounPhraseList="5959" nerList="" tokenList="5951"/><types2:Answer xmi:id="5968" sofa="1" begin="0" end="9" text="clusterin" id="1" isCorrect="false" isSelected="false" nounPhraseList="5998" nerList="" tokenList="5990"/><types2:Answer xmi:id="6043" sofa="1" begin="0" end="8" text="secreted" id="4" isCorrect="false" isSelected="false" nounPhraseList="" nerList="" tokenList="6063"/><types2:Answer xmi:id="6071" sofa="1" begin="0" end="8" text="androgen" id="4" isCorrect="true" isSelected="false" nounPhraseList="6101" nerList="" tokenList="6093"/><types2:Answer xmi:id="6110" sofa="1" begin="0" end="7" text="anibody" id="2" isCorrect="false" isSelected="false" nounPhraseList="6140" nerList="" tokenList="6132"/><types2:Answer xmi:id="6149" sofa="1" begin="0" end="7" text="amyloid" id="4" isCorrect="false" isSelected="false" nounPhraseList="6179" nerList="" tokenList="6171"/><types2:Answer xmi:id="6188" sofa="1" begin="0" end="7" text="protein" id="1" isCorrect="false" isSelected="false" nounPhraseList="6218" nerList="" tokenList="6210"/><types2:Answer xmi:id="6227" sofa="1" begin="0" end="6" text="allele" id="3" isCorrect="false" isSelected="false" nounPhraseList="6257" nerList="" tokenList="6249"/><types2:Answer xmi:id="6266" sofa="1" begin="0" end="6" text="PNGase" id="4" isCorrect="false" isSelected="false" nounPhraseList="6296" nerList="" tokenList="6288"/><types2:Answer xmi:id="6305" sofa="1" begin="0" end="4" text="CLU1" id="1" isCorrect="false" isSelected="false" nounPhraseList="6335" nerList="" tokenList="6327"/><types2:Answer xmi:id="6344" sofa="1" begin="0" end="4" text="82.3" id="2" isCorrect="false" isSelected="false" nounPhraseList="6374" nerList="" tokenList="6366"/><types2:Answer xmi:id="6383" sofa="1" begin="0" end="4" text="CLU2" id="0" isCorrect="false" isSelected="false" nounPhraseList="6426" nerList="6415" tokenList="6407"/><types2:Answer xmi:id="6435" sofa="1" begin="0" end="4" text="SNPs" id="1" isCorrect="false" isSelected="false" nounPhraseList="6465" nerList="" tokenList="6457"/><types2:Answer xmi:id="6474" sofa="1" begin="0" end="4" text="52.5" id="3" isCorrect="false" isSelected="false" nounPhraseList="6504" nerList="" tokenList="6496"/><types2:Answer xmi:id="6513" sofa="1" begin="0" end="4" text="CLU2" id="1" isCorrect="false" isSelected="false" nounPhraseList="6556" nerList="6545" tokenList="6537"/><types2:Answer xmi:id="6565" sofa="1" begin="0" end="4" text="cDNA" id="1" isCorrect="false" isSelected="false" nounPhraseList="6595" nerList="" tokenList="6587"/><types2:Answer xmi:id="6604" sofa="1" begin="0" end="4" text="CLU1" id="2" isCorrect="false" isSelected="false" nounPhraseList="6634" nerList="" tokenList="6626"/><types2:Answer xmi:id="6643" sofa="1" begin="0" end="4" text="CLU2" id="0" isCorrect="true" isSelected="false" nounPhraseList="6686" nerList="6675" tokenList="6667"/><types2:Answer xmi:id="6695" sofa="1" begin="0" end="4" text="CLU2" id="3" isCorrect="true" isSelected="false" nounPhraseList="6738" nerList="6727" tokenList="6719"/><types2:Answer xmi:id="6747" sofa="1" begin="0" end="3" text="CLU" id="4" isCorrect="false" isSelected="false" nounPhraseList="6777" nerList="" tokenList="6769"/><types2:Answer xmi:id="6786" sofa="1" begin="0" end="3" text="449" id="0" isCorrect="true" isSelected="false" nounPhraseList="6816" nerList="" tokenList="6808"/><types2:Answer xmi:id="6825" sofa="1" begin="0" end="2" text="ER" id="1" isCorrect="false" isSelected="false" nounPhraseList="6855" nerList="" tokenList="6847"/><types2:Answer xmi:id="6864" sofa="1" begin="0" end="2" text="AD" id="2" isCorrect="false" isSelected="false" nounPhraseList="6894" nerList="" tokenList="6886"/><types2:Answer xmi:id="6903" sofa="1" begin="0" end="2" text="AD" id="4" isCorrect="false" isSelected="false" nounPhraseList="6933" nerList="" tokenList="6925"/><types2:Answer xmi:id="6942" sofa="1" begin="0" end="1" text="6" id="4" isCorrect="false" isSelected="false" nounPhraseList="6972" nerList="" tokenList="6964"/><types2:Token xmi:id="269" sofa="1" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="279" sofa="1" begin="6" end="15" text="clusterin" pos="JJ" ner="O"/><types2:Token xmi:id="289" sofa="1" begin="16" end="22" text="single" pos="JJ" ner="O"/><types2:Token xmi:id="299" sofa="1" begin="23" end="33" text="nucleotide" pos="NN" ner="O"/><types2:Token xmi:id="309" sofa="1" begin="34" end="46" text="polymorphism" pos="NN" ner="O"/><types2:Token xmi:id="319" sofa="1" begin="47" end="50" text="has" pos="VBZ" ner="O"/><types2:Token xmi:id="329" sofa="1" begin="51" end="55" text="been" pos="VBN" ner="O"/><types2:Token xmi:id="339" sofa="1" begin="56" end="62" text="linked" pos="VBN" ner="O"/><types2:Token xmi:id="349" sofa="1" begin="63" end="65" text="to" pos="TO" ner="O"/><types2:Token xmi:id="359" sofa="1" begin="66" end="67" text="a" pos="DT" ner="O"/><types2:Token xmi:id="369" sofa="1" begin="68" end="77" text="reduction" pos="NN" ner="O"/><types2:Token xmi:id="379" sofa="1" begin="78" end="80" text="in" pos="IN" ner="O"/><types2:Token xmi:id="389" sofa="1" begin="81" end="84" text="the" pos="DT" ner="O"/><types2:Token xmi:id="399" sofa="1" begin="85" end="89" text="risk" pos="NN" ner="O"/><types2:Token xmi:id="409" sofa="1" begin="90" end="93" text="for" pos="IN" ner="O"/><types2:Token xmi:id="419" sofa="1" begin="94" end="104" text="developing" pos="VBG" ner="O"/><types2:Token xmi:id="429" sofa="1" begin="105" end="114" text="Alzheimer" pos="NN" ner="O"/><types2:Token xmi:id="439" sofa="1" begin="114" end="116" text="'s" pos="POS" ner="O"/><types2:Token xmi:id="449" sofa="1" begin="117" end="124" text="disease" pos="NN" ner="O"/><types2:Token xmi:id="459" sofa="1" begin="124" end="125" text="?" pos="." ner="O"/><types2:Token xmi:id="658" sofa="1" begin="0" end="0" text="developing" pos="VBG" ner="O"/><types2:Token xmi:id="665" sofa="1" begin="0" end="0" text="disease" pos="NN" ner="O"/><types2:Token xmi:id="672" sofa="1" begin="0" end="0" text="disease" pos="NN" ner="O"/><types2:Token xmi:id="679" sofa="1" begin="0" end="0" text="Alzheimer" pos="NN" ner="O"/><types2:Token xmi:id="686" sofa="1" begin="0" end="0" text="linked" pos="VBN" ner="O"/><types2:Token xmi:id="693" sofa="1" begin="0" end="0" text="developing" pos="VBG" ner="O"/><types2:Token xmi:id="700" sofa="1" begin="0" end="0" text="reduction" pos="NN" ner="O"/><types2:Token xmi:id="707" sofa="1" begin="0" end="0" text="risk" pos="NN" ner="O"/><types2:Token xmi:id="714" sofa="1" begin="0" end="0" text="risk" pos="NN" ner="O"/><types2:Token xmi:id="721" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="728" sofa="1" begin="0" end="0" text="linked" pos="VBN" ner="O"/><types2:Token xmi:id="735" sofa="1" begin="0" end="0" text="reduction" pos="NN" ner="O"/><types2:Token xmi:id="742" sofa="1" begin="0" end="0" text="reduction" pos="NN" ner="O"/><types2:Token xmi:id="749" sofa="1" begin="0" end="0" text="a" pos="DT" ner="O"/><types2:Token xmi:id="756" sofa="1" begin="0" end="0" text="linked" pos="VBN" ner="O"/><types2:Token xmi:id="763" sofa="1" begin="0" end="0" text="been" pos="VBN" ner="O"/><types2:Token xmi:id="770" sofa="1" begin="0" end="0" text="linked" pos="VBN" ner="O"/><types2:Token xmi:id="777" sofa="1" begin="0" end="0" text="has" pos="VBZ" ner="O"/><types2:Token xmi:id="784" sofa="1" begin="0" end="0" text="nucleotide" pos="NN" ner="O"/><types2:Token xmi:id="791" sofa="1" begin="0" end="0" text="polymorphism" pos="NN" ner="O"/><types2:Token xmi:id="798" sofa="1" begin="0" end="0" text="linked" pos="VBN" ner="O"/><types2:Token xmi:id="805" sofa="1" begin="0" end="0" text="nucleotide" pos="NN" ner="O"/><types2:Token xmi:id="812" sofa="1" begin="0" end="0" text="nucleotide" pos="NN" ner="O"/><types2:Token xmi:id="819" sofa="1" begin="0" end="0" text="single" pos="JJ" ner="O"/><types2:Token xmi:id="826" sofa="1" begin="0" end="0" text="nucleotide" pos="NN" ner="O"/><types2:Token xmi:id="833" sofa="1" begin="0" end="0" text="clusterin" pos="JJ" ner="O"/><types2:Token xmi:id="840" sofa="1" begin="0" end="0" text="nucleotide" pos="NN" ner="O"/><types2:Token xmi:id="847" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="958" sofa="1" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="968" sofa="1" begin="6" end="15" text="technique" pos="NN" ner="O"/><types2:Token xmi:id="978" sofa="1" begin="16" end="19" text="was" pos="VBD" ner="O"/><types2:Token xmi:id="988" sofa="1" begin="20" end="24" text="used" pos="VBN" ner="O"/><types2:Token xmi:id="998" sofa="1" begin="25" end="27" text="to" pos="TO" ner="O"/><types2:Token xmi:id="1008" sofa="1" begin="28" end="37" text="determine" pos="VB" ner="O"/><types2:Token xmi:id="1018" sofa="1" begin="38" end="41" text="the" pos="DT" ner="O"/><types2:Token xmi:id="1028" sofa="1" begin="42" end="50" text="cellular" pos="JJ" ner="O"/><types2:Token xmi:id="1038" sofa="1" begin="51" end="60" text="locations" pos="NNS" ner="O"/><types2:Token xmi:id="1048" sofa="1" begin="61" end="63" text="of" pos="IN" ner="O"/><types2:Token xmi:id="1058" sofa="1" begin="64" end="67" text="the" pos="DT" ner="O"/><types2:Token xmi:id="1068" sofa="1" begin="68" end="72" text="CLU1" pos="NN" ner="O"/><types2:Token xmi:id="1078" sofa="1" begin="73" end="76" text="and" pos="CC" ner="O"/><types2:Token xmi:id="1088" sofa="1" begin="77" end="81" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="1098" sofa="1" begin="82" end="86" text="gene" pos="NN" ner="O"/><types2:Token xmi:id="1108" sofa="1" begin="87" end="95" text="products" pos="NNS" ner="O"/><types2:Token xmi:id="1118" sofa="1" begin="95" end="96" text="?" pos="." ner="O"/><types2:Token xmi:id="1330" sofa="1" begin="0" end="0" text="CLU1" pos="NN" ner="O"/><types2:Token xmi:id="1337" sofa="1" begin="0" end="0" text="products" pos="NNS" ner="O"/><types2:Token xmi:id="1344" sofa="1" begin="0" end="0" text="locations" pos="NNS" ner="O"/><types2:Token xmi:id="1351" sofa="1" begin="0" end="0" text="products" pos="NNS" ner="O"/><types2:Token xmi:id="1358" sofa="1" begin="0" end="0" text="products" pos="NNS" ner="O"/><types2:Token xmi:id="1365" sofa="1" begin="0" end="0" text="gene" pos="NN" ner="O"/><types2:Token xmi:id="1372" sofa="1" begin="0" end="0" text="products" pos="NNS" ner="O"/><types2:Token xmi:id="1379" sofa="1" begin="0" end="0" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="1386" sofa="1" begin="0" end="0" text="locations" pos="NNS" ner="O"/><types2:Token xmi:id="1393" sofa="1" begin="0" end="0" text="CLU1" pos="NN" ner="O"/><types2:Token xmi:id="1400" sofa="1" begin="0" end="0" text="CLU1" pos="NN" ner="O"/><types2:Token xmi:id="1407" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="1414" sofa="1" begin="0" end="0" text="determine" pos="VB" ner="O"/><types2:Token xmi:id="1421" sofa="1" begin="0" end="0" text="locations" pos="NNS" ner="O"/><types2:Token xmi:id="1428" sofa="1" begin="0" end="0" text="locations" pos="NNS" ner="O"/><types2:Token xmi:id="1435" sofa="1" begin="0" end="0" text="cellular" pos="JJ" ner="O"/><types2:Token xmi:id="1442" sofa="1" begin="0" end="0" text="locations" pos="NNS" ner="O"/><types2:Token xmi:id="1449" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="1456" sofa="1" begin="0" end="0" text="used" pos="VBN" ner="O"/><types2:Token xmi:id="1463" sofa="1" begin="0" end="0" text="determine" pos="VB" ner="O"/><types2:Token xmi:id="1470" sofa="1" begin="0" end="0" text="determine" pos="VB" ner="O"/><types2:Token xmi:id="1477" sofa="1" begin="0" end="0" text="to" pos="TO" ner="O"/><types2:Token xmi:id="1484" sofa="1" begin="0" end="0" text="used" pos="VBN" ner="O"/><types2:Token xmi:id="1491" sofa="1" begin="0" end="0" text="was" pos="VBD" ner="O"/><types2:Token xmi:id="1498" sofa="1" begin="0" end="0" text="used" pos="VBN" ner="O"/><types2:Token xmi:id="1505" sofa="1" begin="0" end="0" text="technique" pos="NN" ner="O"/><types2:Token xmi:id="1512" sofa="1" begin="0" end="0" text="technique" pos="NN" ner="O"/><types2:Token xmi:id="1519" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="1548" sofa="1" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="1558" sofa="1" begin="6" end="16" text="particular" pos="JJ" ner="O"/><types2:Token xmi:id="1568" sofa="1" begin="17" end="24" text="histone" pos="NN" ner="O"/><types2:Token xmi:id="1578" sofa="1" begin="25" end="36" text="deacetylase" pos="NN" ner="O"/><types2:Token xmi:id="1588" sofa="1" begin="37" end="46" text="inhibitor" pos="NN" ner="O"/><types2:Token xmi:id="1598" sofa="1" begin="47" end="50" text="has" pos="VBZ" ner="O"/><types2:Token xmi:id="1608" sofa="1" begin="51" end="55" text="been" pos="VBN" ner="O"/><types2:Token xmi:id="1618" sofa="1" begin="56" end="61" text="shown" pos="VBN" ner="O"/><types2:Token xmi:id="1628" sofa="1" begin="62" end="64" text="to" pos="TO" ner="O"/><types2:Token xmi:id="1638" sofa="1" begin="65" end="72" text="enhance" pos="VB" ner="O"/><types2:Token xmi:id="1648" sofa="1" begin="73" end="76" text="the" pos="DT" ner="O"/><types2:Token xmi:id="1658" sofa="1" begin="77" end="87" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="1668" sofa="1" begin="88" end="90" text="of" pos="IN" ner="O"/><types2:Token xmi:id="1678" sofa="1" begin="91" end="94" text="CLU" pos="NNP" ner="O"/><types2:Token xmi:id="1688" sofa="1" begin="94" end="95" text="?" pos="." ner="O"/><types2:Token xmi:id="1869" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="1876" sofa="1" begin="0" end="0" text="CLU" pos="NNP" ner="O"/><types2:Token xmi:id="1883" sofa="1" begin="0" end="0" text="enhance" pos="VB" ner="O"/><types2:Token xmi:id="1890" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="1897" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="1904" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="1911" sofa="1" begin="0" end="0" text="shown" pos="VBN" ner="O"/><types2:Token xmi:id="1918" sofa="1" begin="0" end="0" text="enhance" pos="VB" ner="O"/><types2:Token xmi:id="1925" sofa="1" begin="0" end="0" text="enhance" pos="VB" ner="O"/><types2:Token xmi:id="1932" sofa="1" begin="0" end="0" text="to" pos="TO" ner="O"/><types2:Token xmi:id="1939" sofa="1" begin="0" end="0" text="shown" pos="VBN" ner="O"/><types2:Token xmi:id="1946" sofa="1" begin="0" end="0" text="been" pos="VBN" ner="O"/><types2:Token xmi:id="1953" sofa="1" begin="0" end="0" text="shown" pos="VBN" ner="O"/><types2:Token xmi:id="1960" sofa="1" begin="0" end="0" text="has" pos="VBZ" ner="O"/><types2:Token xmi:id="1967" sofa="1" begin="0" end="0" text="histone" pos="NN" ner="O"/><types2:Token xmi:id="1974" sofa="1" begin="0" end="0" text="inhibitor" pos="NN" ner="O"/><types2:Token xmi:id="1981" sofa="1" begin="0" end="0" text="inhibitor" pos="NN" ner="O"/><types2:Token xmi:id="1988" sofa="1" begin="0" end="0" text="deacetylase" pos="NN" ner="O"/><types2:Token xmi:id="1995" sofa="1" begin="0" end="0" text="shown" pos="VBN" ner="O"/><types2:Token xmi:id="2002" sofa="1" begin="0" end="0" text="histone" pos="NN" ner="O"/><types2:Token xmi:id="2009" sofa="1" begin="0" end="0" text="histone" pos="NN" ner="O"/><types2:Token xmi:id="2016" sofa="1" begin="0" end="0" text="particular" pos="JJ" ner="O"/><types2:Token xmi:id="2023" sofa="1" begin="0" end="0" text="histone" pos="NN" ner="O"/><types2:Token xmi:id="2030" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="2138" sofa="1" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="2148" sofa="1" begin="6" end="8" text="of" pos="IN" ner="O"/><types2:Token xmi:id="2158" sofa="1" begin="9" end="12" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2168" sofa="1" begin="13" end="16" text="two" pos="CD" ner="NUMBER"/><types2:Token xmi:id="2178" sofa="1" begin="17" end="20" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="2188" sofa="1" begin="21" end="29" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2198" sofa="1" begin="30" end="32" text="is" pos="VBZ" ner="O"/><types2:Token xmi:id="2208" sofa="1" begin="33" end="36" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2218" sofa="1" begin="37" end="41" text="main" pos="JJ" ner="O"/><types2:Token xmi:id="2228" sofa="1" begin="42" end="45" text="one" pos="CD" ner="NUMBER"/><types2:Token xmi:id="2238" sofa="1" begin="46" end="55" text="expressed" pos="VBN" ner="O"/><types2:Token xmi:id="2248" sofa="1" begin="56" end="58" text="in" pos="IN" ner="O"/><types2:Token xmi:id="2258" sofa="1" begin="59" end="62" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2268" sofa="1" begin="63" end="70" text="choroid" pos="NN" ner="O"/><types2:Token xmi:id="2278" sofa="1" begin="71" end="77" text="plexus" pos="NN" ner="O"/><types2:Token xmi:id="2288" sofa="1" begin="77" end="78" text="?" pos="." ner="O"/><types2:Token xmi:id="2456" sofa="1" begin="0" end="0" text="expressed" pos="VBN" ner="O"/><types2:Token xmi:id="2463" sofa="1" begin="0" end="0" text="plexus" pos="NN" ner="O"/><types2:Token xmi:id="2470" sofa="1" begin="0" end="0" text="plexus" pos="NN" ner="O"/><types2:Token xmi:id="2477" sofa="1" begin="0" end="0" text="choroid" pos="NN" ner="O"/><types2:Token xmi:id="2484" sofa="1" begin="0" end="0" text="plexus" pos="NN" ner="O"/><types2:Token xmi:id="2491" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2498" sofa="1" begin="0" end="0" text="expressed" pos="VBN" ner="O"/><types2:Token xmi:id="2505" sofa="1" begin="0" end="0" text="one" pos="CD" ner="NUMBER"/><types2:Token xmi:id="2512" sofa="1" begin="0" end="0" text="one" pos="CD" ner="NUMBER"/><types2:Token xmi:id="2519" sofa="1" begin="0" end="0" text="main" pos="JJ" ner="O"/><types2:Token xmi:id="2526" sofa="1" begin="0" end="0" text="one" pos="CD" ner="NUMBER"/><types2:Token xmi:id="2533" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2540" sofa="1" begin="0" end="0" text="expressed" pos="VBN" ner="O"/><types2:Token xmi:id="2547" sofa="1" begin="0" end="0" text="is" pos="VBZ" ner="O"/><types2:Token xmi:id="2554" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="2561" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2568" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2575" sofa="1" begin="0" end="0" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="2582" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2589" sofa="1" begin="0" end="0" text="two" pos="CD" ner="NUMBER"/><types2:Token xmi:id="2596" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2603" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2610" sofa="1" begin="0" end="0" text="expressed" pos="VBN" ner="O"/><types2:Token xmi:id="2617" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="2646" sofa="1" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="2656" sofa="1" begin="6" end="9" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="2666" sofa="1" begin="10" end="17" text="protein" pos="NN" ner="O"/><types2:Token xmi:id="2676" sofa="1" begin="18" end="26" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2686" sofa="1" begin="27" end="29" text="in" pos="IN" ner="O"/><types2:Token xmi:id="2696" sofa="1" begin="30" end="33" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2706" sofa="1" begin="34" end="39" text="brain" pos="NN" ner="O"/><types2:Token xmi:id="2716" sofa="1" begin="40" end="44" text="have" pos="VBP" ner="O"/><types2:Token xmi:id="2726" sofa="1" begin="45" end="49" text="been" pos="VBN" ner="O"/><types2:Token xmi:id="2736" sofa="1" begin="50" end="63" text="characterized" pos="VBN" ner="O"/><types2:Token xmi:id="2746" sofa="1" begin="63" end="64" text="?" pos="." ner="O"/><types2:Token xmi:id="2863" sofa="1" begin="0" end="0" text="characterized" pos="VBN" ner="O"/><types2:Token xmi:id="2870" sofa="1" begin="0" end="0" text="been" pos="VBN" ner="O"/><types2:Token xmi:id="2877" sofa="1" begin="0" end="0" text="characterized" pos="VBN" ner="O"/><types2:Token xmi:id="2884" sofa="1" begin="0" end="0" text="have" pos="VBP" ner="O"/><types2:Token xmi:id="2891" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2898" sofa="1" begin="0" end="0" text="brain" pos="NN" ner="O"/><types2:Token xmi:id="2905" sofa="1" begin="0" end="0" text="brain" pos="NN" ner="O"/><types2:Token xmi:id="2912" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="2919" sofa="1" begin="0" end="0" text="characterized" pos="VBN" ner="O"/><types2:Token xmi:id="2926" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2933" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2940" sofa="1" begin="0" end="0" text="protein" pos="NN" ner="O"/><types2:Token xmi:id="2947" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2954" sofa="1" begin="0" end="0" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="2961" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="2968" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="2997" sofa="1" begin="0" end="4" text="What" pos="WDT" ner="O"/><types2:Token xmi:id="3007" sofa="1" begin="5" end="17" text="compartments" pos="NNS" ner="O"/><types2:Token xmi:id="3017" sofa="1" begin="18" end="24" text="inside" pos="IN" ner="O"/><types2:Token xmi:id="3027" sofa="1" begin="25" end="28" text="the" pos="DT" ner="O"/><types2:Token xmi:id="3037" sofa="1" begin="29" end="33" text="cell" pos="NN" ner="O"/><types2:Token xmi:id="3047" sofa="1" begin="34" end="41" text="contain" pos="VBP" ner="O"/><types2:Token xmi:id="3057" sofa="1" begin="42" end="51" text="clusterin" pos="NN" ner="O"/><types2:Token xmi:id="3067" sofa="1" begin="52" end="60" text="proteins" pos="NNS" ner="O"/><types2:Token xmi:id="3077" sofa="1" begin="60" end="61" text="?" pos="." ner="O"/><types2:Token xmi:id="3185" sofa="1" begin="0" end="0" text="contain" pos="VBP" ner="O"/><types2:Token xmi:id="3192" sofa="1" begin="0" end="0" text="proteins" pos="NNS" ner="O"/><types2:Token xmi:id="3199" sofa="1" begin="0" end="0" text="proteins" pos="NNS" ner="O"/><types2:Token xmi:id="3206" sofa="1" begin="0" end="0" text="clusterin" pos="NN" ner="O"/><types2:Token xmi:id="3213" sofa="1" begin="0" end="0" text="compartments" pos="NNS" ner="O"/><types2:Token xmi:id="3220" sofa="1" begin="0" end="0" text="cell" pos="NN" ner="O"/><types2:Token xmi:id="3227" sofa="1" begin="0" end="0" text="cell" pos="NN" ner="O"/><types2:Token xmi:id="3234" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="3241" sofa="1" begin="0" end="0" text="contain" pos="VBP" ner="O"/><types2:Token xmi:id="3248" sofa="1" begin="0" end="0" text="compartments" pos="NNS" ner="O"/><types2:Token xmi:id="3255" sofa="1" begin="0" end="0" text="compartments" pos="NNS" ner="O"/><types2:Token xmi:id="3262" sofa="1" begin="0" end="0" text="What" pos="WDT" ner="O"/><types2:Token xmi:id="3291" sofa="1" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="3301" sofa="1" begin="6" end="9" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="3311" sofa="1" begin="10" end="17" text="isoform" pos="NN" ner="O"/><types2:Token xmi:id="3321" sofa="1" begin="18" end="21" text="has" pos="VBZ" ner="O"/><types2:Token xmi:id="3331" sofa="1" begin="22" end="23" text="a" pos="DT" ner="O"/><types2:Token xmi:id="3341" sofa="1" begin="24" end="36" text="consistently" pos="RB" ner="O"/><types2:Token xmi:id="3351" sofa="1" begin="37" end="43" text="higher" pos="JJR" ner="O"/><types2:Token xmi:id="3361" sofa="1" begin="44" end="48" text="gene" pos="NN" ner="O"/><types2:Token xmi:id="3371" sofa="1" begin="49" end="59" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3381" sofa="1" begin="59" end="60" text="?" pos="." ner="O"/><types2:Token xmi:id="3498" sofa="1" begin="0" end="0" text="has" pos="VBZ" ner="O"/><types2:Token xmi:id="3505" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3512" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3519" sofa="1" begin="0" end="0" text="gene" pos="NN" ner="O"/><types2:Token xmi:id="3526" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3533" sofa="1" begin="0" end="0" text="higher" pos="JJR" ner="O"/><types2:Token xmi:id="3540" sofa="1" begin="0" end="0" text="higher" pos="JJR" ner="O"/><types2:Token xmi:id="3547" sofa="1" begin="0" end="0" text="consistently" pos="RB" ner="O"/><types2:Token xmi:id="3554" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3561" sofa="1" begin="0" end="0" text="a" pos="DT" ner="O"/><types2:Token xmi:id="3568" sofa="1" begin="0" end="0" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="3575" sofa="1" begin="0" end="0" text="isoform" pos="NN" ner="O"/><types2:Token xmi:id="3582" sofa="1" begin="0" end="0" text="has" pos="VBZ" ner="O"/><types2:Token xmi:id="3589" sofa="1" begin="0" end="0" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="3596" sofa="1" begin="0" end="0" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="3603" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="3632" sofa="1" begin="0" end="5" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="3642" sofa="1" begin="6" end="13" text="hormone" pos="NN" ner="O"/><types2:Token xmi:id="3652" sofa="1" begin="14" end="17" text="can" pos="MD" ner="O"/><types2:Token xmi:id="3662" sofa="1" begin="18" end="25" text="control" pos="VB" ner="O"/><types2:Token xmi:id="3672" sofa="1" begin="26" end="29" text="the" pos="DT" ner="O"/><types2:Token xmi:id="3682" sofa="1" begin="30" end="40" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3692" sofa="1" begin="41" end="43" text="of" pos="IN" ner="O"/><types2:Token xmi:id="3702" sofa="1" begin="44" end="47" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="3712" sofa="1" begin="48" end="56" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="3722" sofa="1" begin="56" end="57" text="?" pos="." ner="O"/><types2:Token xmi:id="3840" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3847" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="3854" sofa="1" begin="0" end="0" text="isoforms" pos="NNS" ner="O"/><types2:Token xmi:id="3861" sofa="1" begin="0" end="0" text="CLU" pos="NN" ner="ORGANIZATION"/><types2:Token xmi:id="3868" sofa="1" begin="0" end="0" text="control" pos="VB" ner="O"/><types2:Token xmi:id="3875" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3882" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="3889" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="3896" sofa="1" begin="0" end="0" text="control" pos="VB" ner="O"/><types2:Token xmi:id="3903" sofa="1" begin="0" end="0" text="can" pos="MD" ner="O"/><types2:Token xmi:id="3910" sofa="1" begin="0" end="0" text="control" pos="VB" ner="O"/><types2:Token xmi:id="3917" sofa="1" begin="0" end="0" text="hormone" pos="NN" ner="O"/><types2:Token xmi:id="3924" sofa="1" begin="0" end="0" text="hormone" pos="NN" ner="O"/><types2:Token xmi:id="3931" sofa="1" begin="0" end="0" text="Which" pos="WDT" ner="O"/><types2:Token xmi:id="3960" sofa="1" begin="0" end="4" text="What" pos="WDT" ner="O"/><types2:Token xmi:id="3970" sofa="1" begin="5" end="11" text="effect" pos="NN" ner="O"/><types2:Token xmi:id="3980" sofa="1" begin="12" end="14" text="do" pos="VBP" ner="O"/><types2:Token xmi:id="3990" sofa="1" begin="15" end="24" text="androgens" pos="NNS" ner="O"/><types2:Token xmi:id="4000" sofa="1" begin="25" end="29" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4010" sofa="1" begin="30" end="32" text="on" pos="IN" ner="O"/><types2:Token xmi:id="4020" sofa="1" begin="33" end="37" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="4030" sofa="1" begin="38" end="42" text="gene" pos="NN" ner="O"/><types2:Token xmi:id="4040" sofa="1" begin="43" end="53" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="4050" sofa="1" begin="53" end="54" text="?" pos="." ner="O"/><types2:Token xmi:id="4168" sofa="1" begin="0" end="0" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4175" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="4182" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="4189" sofa="1" begin="0" end="0" text="gene" pos="NN" ner="O"/><types2:Token xmi:id="4196" sofa="1" begin="0" end="0" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="4203" sofa="1" begin="0" end="0" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="4210" sofa="1" begin="0" end="0" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4217" sofa="1" begin="0" end="0" text="androgens" pos="NNS" ner="O"/><types2:Token xmi:id="4224" sofa="1" begin="0" end="0" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4231" sofa="1" begin="0" end="0" text="do" pos="VBP" ner="O"/><types2:Token xmi:id="4238" sofa="1" begin="0" end="0" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4245" sofa="1" begin="0" end="0" text="effect" pos="NN" ner="O"/><types2:Token xmi:id="4252" sofa="1" begin="0" end="0" text="effect" pos="NN" ner="O"/><types2:Token xmi:id="4259" sofa="1" begin="0" end="0" text="What" pos="WDT" ner="O"/><types2:Token xmi:id="4288" sofa="1" begin="0" end="3" text="How" pos="WRB" ner="O"/><types2:Token xmi:id="4298" sofa="1" begin="4" end="8" text="many" pos="JJ" ner="O"/><types2:Token xmi:id="4308" sofa="1" begin="9" end="17" text="residues" pos="NNS" ner="O"/><types2:Token xmi:id="4318" sofa="1" begin="18" end="22" text="does" pos="VBZ" ner="O"/><types2:Token xmi:id="4328" sofa="1" begin="23" end="26" text="the" pos="DT" ner="O"/><types2:Token xmi:id="4338" sofa="1" begin="27" end="31" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="4348" sofa="1" begin="32" end="39" text="protein" pos="NN" ner="O"/><types2:Token xmi:id="4358" sofa="1" begin="40" end="48" text="sequence" pos="NN" ner="O"/><types2:Token xmi:id="4368" sofa="1" begin="49" end="53" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4378" sofa="1" begin="53" end="54" text="?" pos="." ner="O"/><types2:Token xmi:id="4495" sofa="1" begin="0" end="0" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4502" sofa="1" begin="0" end="0" text="sequence" pos="NN" ner="O"/><types2:Token xmi:id="4509" sofa="1" begin="0" end="0" text="sequence" pos="NN" ner="O"/><types2:Token xmi:id="4516" sofa="1" begin="0" end="0" text="protein" pos="NN" ner="O"/><types2:Token xmi:id="4523" sofa="1" begin="0" end="0" text="sequence" pos="NN" ner="O"/><types2:Token xmi:id="4530" sofa="1" begin="0" end="0" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="4537" sofa="1" begin="0" end="0" text="sequence" pos="NN" ner="O"/><types2:Token xmi:id="4544" sofa="1" begin="0" end="0" text="the" pos="DT" ner="O"/><types2:Token xmi:id="4551" sofa="1" begin="0" end="0" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4558" sofa="1" begin="0" end="0" text="does" pos="VBZ" ner="O"/><types2:Token xmi:id="4565" sofa="1" begin="0" end="0" text="have" pos="VB" ner="O"/><types2:Token xmi:id="4572" sofa="1" begin="0" end="0" text="residues" pos="NNS" ner="O"/><types2:Token xmi:id="4579" sofa="1" begin="0" end="0" text="residues" pos="NNS" ner="O"/><types2:Token xmi:id="4586" sofa="1" begin="0" end="0" text="many" pos="JJ" ner="O"/><types2:Token xmi:id="4593" sofa="1" begin="0" end="0" text="many" pos="JJ" ner="O"/><types2:Token xmi:id="4600" sofa="1" begin="0" end="0" text="How" pos="WRB" ner="O"/><types2:Token xmi:id="4629" sofa="1" begin="0" end="18" text="immunofluorescence" pos="NN" ner="O"/><types2:Token xmi:id="4639" sofa="1" begin="19" end="30" text="experiments" pos="NNS" ner="O"/><types2:Token xmi:id="4692" sofa="1" begin="0" end="13" text="intracellular" pos="JJ" ner="O"/><types2:Token xmi:id="4702" sofa="1" begin="14" end="17" text="and" pos="CC" ner="O"/><types2:Token xmi:id="4712" sofa="1" begin="18" end="26" text="secreted" pos="VBN" ner="O"/><types2:Token xmi:id="4751" sofa="1" begin="0" end="13" text="intracellular" pos="JJ" ner="O"/><types2:Token xmi:id="4761" sofa="1" begin="14" end="26" text="localization" pos="NN" ner="O"/><types2:Token xmi:id="4800" sofa="1" begin="0" end="2" text="ER" pos="NN" ner="O"/><types2:Token xmi:id="4810" sofa="1" begin="3" end="6" text="and" pos="CC" ner="O"/><types2:Token xmi:id="4820" sofa="1" begin="7" end="10" text="the" pos="DT" ner="O"/><types2:Token xmi:id="4830" sofa="1" begin="11" end="16" text="Golgi" pos="NN" ner="MISC"/><types2:Token xmi:id="4840" sofa="1" begin="17" end="26" text="apparatus" pos="NN" ner="O"/><types2:Token xmi:id="4892" sofa="1" begin="0" end="9" text="ribosomal" pos="JJ" ner="O"/><types2:Token xmi:id="4902" sofa="1" begin="10" end="17" text="protein" pos="NN" ner="O"/><types2:Token xmi:id="4912" sofa="1" begin="18" end="22" text="L13A" pos="NN" ner="O"/><types2:Token xmi:id="4962" sofa="1" begin="0" end="13" text="cerebrospinal" pos="JJ" ner="O"/><types2:Token xmi:id="4972" sofa="1" begin="14" end="19" text="fluid" pos="NN" ner="O"/><types2:Token xmi:id="5011" sofa="1" begin="0" end="11" text="therapeutic" pos="JJ" ner="O"/><types2:Token xmi:id="5021" sofa="1" begin="12" end="18" text="agents" pos="NNS" ner="O"/><types2:Token xmi:id="5060" sofa="1" begin="0" end="9" text="secretory" pos="JJ" ner="O"/><types2:Token xmi:id="5070" sofa="1" begin="10" end="17" text="pathway" pos="NN" ner="O"/><types2:Token xmi:id="5109" sofa="1" begin="0" end="8" text="secreted" pos="VBN" ner="O"/><types2:Token xmi:id="5119" sofa="1" begin="9" end="17" text="proteins" pos="NNS" ner="O"/><types2:Token xmi:id="5170" sofa="1" begin="0" end="5" text="Golgi" pos="NN" ner="O"/><types2:Token xmi:id="5180" sofa="1" begin="6" end="15" text="apparatus" pos="NN" ner="O"/><types2:Token xmi:id="5221" sofa="1" begin="0" end="4" text="CLU1" pos="NN" ner="O"/><types2:Token xmi:id="5231" sofa="1" begin="5" end="8" text="and" pos="CC" ner="O"/><types2:Token xmi:id="5241" sofa="1" begin="9" end="13" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="5315" sofa="1" begin="0" end="9" text="real-time" pos="JJ" ner="O"/><types2:Token xmi:id="5325" sofa="1" begin="10" end="13" text="PCR" pos="NN" ner="O"/><types2:Token xmi:id="5364" sofa="1" begin="0" end="5" text="fetal" pos="JJ" ner="O"/><types2:Token xmi:id="5374" sofa="1" begin="6" end="12" text="tissue" pos="NN" ner="O"/><types2:Token xmi:id="5425" sofa="1" begin="0" end="7" text="epitope" pos="NN" ner="O"/><types2:Token xmi:id="5435" sofa="1" begin="8" end="11" text="tag" pos="NN" ner="O"/><types2:Token xmi:id="5474" sofa="1" begin="0" end="11" text="association" pos="NN" ner="O"/><types2:Token xmi:id="5513" sofa="1" begin="0" end="11" text="rs11136000T" pos="NN" ner="O"/><types2:Token xmi:id="5552" sofa="1" begin="0" end="10" text="rs11136000" pos="NN" ner="O"/><types2:Token xmi:id="5591" sofa="1" begin="0" end="10" text="repression" pos="NN" ner="O"/><types2:Token xmi:id="5630" sofa="1" begin="0" end="10" text="astrocytes" pos="NNS" ner="O"/><types2:Token xmi:id="5669" sofa="1" begin="0" end="10" text="expression" pos="NN" ner="O"/><types2:Token xmi:id="5708" sofa="1" begin="0" end="10" text="activation" pos="NN" ner="O"/><types2:Token xmi:id="5747" sofa="1" begin="0" end="10" text="inhibition" pos="NN" ner="O"/><types2:Token xmi:id="5786" sofa="1" begin="0" end="10" text="rs11136000" pos="NN" ner="O"/><types2:Token xmi:id="5873" sofa="1" begin="0" end="9" text="clusterin" pos="NN" ner="O"/><types2:Token xmi:id="5912" sofa="1" begin="0" end="9" text="valproate" pos="NN" ner="O"/><types2:Token xmi:id="5951" sofa="1" begin="0" end="9" text="clusterin" pos="NN" ner="O"/><types2:Token xmi:id="5990" sofa="1" begin="0" end="9" text="clusterin" pos="NN" ner="O"/><types2:Token xmi:id="6063" sofa="1" begin="0" end="8" text="secreted" pos="VBN" ner="O"/><types2:Token xmi:id="6093" sofa="1" begin="0" end="8" text="androgen" pos="NN" ner="O"/><types2:Token xmi:id="6132" sofa="1" begin="0" end="7" text="anibody" pos="NN" ner="O"/><types2:Token xmi:id="6171" sofa="1" begin="0" end="7" text="amyloid" pos="NN" ner="O"/><types2:Token xmi:id="6210" sofa="1" begin="0" end="7" text="protein" pos="NN" ner="O"/><types2:Token xmi:id="6249" sofa="1" begin="0" end="6" text="allele" pos="NN" ner="O"/><types2:Token xmi:id="6288" sofa="1" begin="0" end="6" text="PNGase" pos="NN" ner="O"/><types2:Token xmi:id="6327" sofa="1" begin="0" end="4" text="CLU1" pos="NN" ner="O"/><types2:Token xmi:id="6366" sofa="1" begin="0" end="4" text="82.3" pos="CD" ner="NUMBER"/><types2:Token xmi:id="6407" sofa="1" begin="0" end="4" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="6457" sofa="1" begin="0" end="4" text="SNPs" pos="NNS" ner="O"/><types2:Token xmi:id="6496" sofa="1" begin="0" end="4" text="52.5" pos="CD" ner="NUMBER"/><types2:Token xmi:id="6537" sofa="1" begin="0" end="4" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="6587" sofa="1" begin="0" end="4" text="cDNA" pos="NN" ner="O"/><types2:Token xmi:id="6626" sofa="1" begin="0" end="4" text="CLU1" pos="NN" ner="O"/><types2:Token xmi:id="6667" sofa="1" begin="0" end="4" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="6719" sofa="1" begin="0" end="4" text="CLU2" pos="NN" ner="O"/><types2:Token xmi:id="6769" sofa="1" begin="0" end="3" text="CLU" pos="NN" ner="O"/><types2:Token xmi:id="6808" sofa="1" begin="0" end="3" text="449" pos="CD" ner="NUMBER"/><types2:Token xmi:id="6847" sofa="1" begin="0" end="2" text="ER" pos="NN" ner="O"/><types2:Token xmi:id="6886" sofa="1" begin="0" end="2" text="AD" pos="NN" ner="O"/><types2:Token xmi:id="6925" sofa="1" begin="0" end="2" text="AD" pos="NN" ner="O"/><types2:Token xmi:id="6964" sofa="1" begin="0" end="1" text="6" pos="CD" ner="NUMBER"/><types2:Dependency xmi:id="520" sofa="1" begin="0" end="0" governor="840" dependent="847" relation="det"/><types2:Dependency xmi:id="530" sofa="1" begin="0" end="0" governor="826" dependent="833" relation="amod"/><types2:Dependency xmi:id="540" sofa="1" begin="0" end="0" governor="812" dependent="819" relation="amod"/><types2:Dependency xmi:id="550" sofa="1" begin="0" end="0" governor="798" dependent="805" relation="nsubjpass"/><types2:Dependency xmi:id="560" sofa="1" begin="0" end="0" governor="784" dependent="791" relation="dep"/><types2:Dependency xmi:id="570" sofa="1" begin="0" end="0" governor="770" dependent="777" relation="aux"/><types2:Dependency xmi:id="580" sofa="1" begin="0" end="0" governor="756" dependent="763" relation="auxpass"/><types2:Dependency xmi:id="590" sofa="1" begin="0" end="0" governor="742" dependent="749" relation="det"/><types2:Dependency xmi:id="600" sofa="1" begin="0" end="0" governor="728" dependent="735" relation="prep_to"/><types2:Dependency xmi:id="610" sofa="1" begin="0" end="0" governor="714" dependent="721" relation="det"/><types2:Dependency xmi:id="620" sofa="1" begin="0" end="0" governor="700" dependent="707" relation="prep_in"/><types2:Dependency xmi:id="630" sofa="1" begin="0" end="0" governor="686" dependent="693" relation="prepc_for"/><types2:Dependency xmi:id="640" sofa="1" begin="0" end="0" governor="672" dependent="679" relation="poss"/><types2:Dependency xmi:id="650" sofa="1" begin="0" end="0" governor="658" dependent="665" relation="dobj"/><types2:Dependency xmi:id="1192" sofa="1" begin="0" end="0" governor="1512" dependent="1519" relation="det"/><types2:Dependency xmi:id="1202" sofa="1" begin="0" end="0" governor="1498" dependent="1505" relation="nsubjpass"/><types2:Dependency xmi:id="1212" sofa="1" begin="0" end="0" governor="1484" dependent="1491" relation="auxpass"/><types2:Dependency xmi:id="1222" sofa="1" begin="0" end="0" governor="1470" dependent="1477" relation="aux"/><types2:Dependency xmi:id="1232" sofa="1" begin="0" end="0" governor="1456" dependent="1463" relation="xcomp"/><types2:Dependency xmi:id="1242" sofa="1" begin="0" end="0" governor="1442" dependent="1449" relation="det"/><types2:Dependency xmi:id="1252" sofa="1" begin="0" end="0" governor="1428" dependent="1435" relation="amod"/><types2:Dependency xmi:id="1262" sofa="1" begin="0" end="0" governor="1414" dependent="1421" relation="dobj"/><types2:Dependency xmi:id="1272" sofa="1" begin="0" end="0" governor="1400" dependent="1407" relation="det"/><types2:Dependency xmi:id="1282" sofa="1" begin="0" end="0" governor="1386" dependent="1393" relation="prep_of"/><types2:Dependency xmi:id="1292" sofa="1" begin="0" end="0" governor="1372" dependent="1379" relation="nn"/><types2:Dependency xmi:id="1302" sofa="1" begin="0" end="0" governor="1358" dependent="1365" relation="nn"/><types2:Dependency xmi:id="1312" sofa="1" begin="0" end="0" governor="1344" dependent="1351" relation="prep_of"/><types2:Dependency xmi:id="1322" sofa="1" begin="0" end="0" governor="1330" dependent="1337" relation="conj_and"/><types2:Dependency xmi:id="1751" sofa="1" begin="0" end="0" governor="2023" dependent="2030" relation="det"/><types2:Dependency xmi:id="1761" sofa="1" begin="0" end="0" governor="2009" dependent="2016" relation="amod"/><types2:Dependency xmi:id="1771" sofa="1" begin="0" end="0" governor="1995" dependent="2002" relation="nsubjpass"/><types2:Dependency xmi:id="1781" sofa="1" begin="0" end="0" governor="1981" dependent="1988" relation="nn"/><types2:Dependency xmi:id="1791" sofa="1" begin="0" end="0" governor="1967" dependent="1974" relation="dep"/><types2:Dependency xmi:id="1801" sofa="1" begin="0" end="0" governor="1953" dependent="1960" relation="aux"/><types2:Dependency xmi:id="1811" sofa="1" begin="0" end="0" governor="1939" dependent="1946" relation="auxpass"/><types2:Dependency xmi:id="1821" sofa="1" begin="0" end="0" governor="1925" dependent="1932" relation="aux"/><types2:Dependency xmi:id="1831" sofa="1" begin="0" end="0" governor="1911" dependent="1918" relation="xcomp"/><types2:Dependency xmi:id="1841" sofa="1" begin="0" end="0" governor="1897" dependent="1904" relation="det"/><types2:Dependency xmi:id="1851" sofa="1" begin="0" end="0" governor="1883" dependent="1890" relation="dobj"/><types2:Dependency xmi:id="1861" sofa="1" begin="0" end="0" governor="1869" dependent="1876" relation="prep_of"/><types2:Dependency xmi:id="2338" sofa="1" begin="0" end="0" governor="2610" dependent="2617" relation="dobj"/><types2:Dependency xmi:id="2348" sofa="1" begin="0" end="0" governor="2596" dependent="2603" relation="det"/><types2:Dependency xmi:id="2358" sofa="1" begin="0" end="0" governor="2582" dependent="2589" relation="num"/><types2:Dependency xmi:id="2368" sofa="1" begin="0" end="0" governor="2568" dependent="2575" relation="nn"/><types2:Dependency xmi:id="2378" sofa="1" begin="0" end="0" governor="2554" dependent="2561" relation="prep_of"/><types2:Dependency xmi:id="2388" sofa="1" begin="0" end="0" governor="2540" dependent="2547" relation="auxpass"/><types2:Dependency xmi:id="2398" sofa="1" begin="0" end="0" governor="2526" dependent="2533" relation="det"/><types2:Dependency xmi:id="2408" sofa="1" begin="0" end="0" governor="2512" dependent="2519" relation="amod"/><types2:Dependency xmi:id="2418" sofa="1" begin="0" end="0" governor="2498" dependent="2505" relation="nsubjpass"/><types2:Dependency xmi:id="2428" sofa="1" begin="0" end="0" governor="2484" dependent="2491" relation="det"/><types2:Dependency xmi:id="2438" sofa="1" begin="0" end="0" governor="2470" dependent="2477" relation="nn"/><types2:Dependency xmi:id="2448" sofa="1" begin="0" end="0" governor="2456" dependent="2463" relation="prep_in"/><types2:Dependency xmi:id="2785" sofa="1" begin="0" end="0" governor="2961" dependent="2968" relation="det"/><types2:Dependency xmi:id="2795" sofa="1" begin="0" end="0" governor="2947" dependent="2954" relation="nn"/><types2:Dependency xmi:id="2805" sofa="1" begin="0" end="0" governor="2933" dependent="2940" relation="nn"/><types2:Dependency xmi:id="2815" sofa="1" begin="0" end="0" governor="2919" dependent="2926" relation="nsubjpass"/><types2:Dependency xmi:id="2825" sofa="1" begin="0" end="0" governor="2905" dependent="2912" relation="det"/><types2:Dependency xmi:id="2835" sofa="1" begin="0" end="0" governor="2891" dependent="2898" relation="prep_in"/><types2:Dependency xmi:id="2845" sofa="1" begin="0" end="0" governor="2877" dependent="2884" relation="aux"/><types2:Dependency xmi:id="2855" sofa="1" begin="0" end="0" governor="2863" dependent="2870" relation="auxpass"/><types2:Dependency xmi:id="3127" sofa="1" begin="0" end="0" governor="3255" dependent="3262" relation="det"/><types2:Dependency xmi:id="3137" sofa="1" begin="0" end="0" governor="3241" dependent="3248" relation="nsubj"/><types2:Dependency xmi:id="3147" sofa="1" begin="0" end="0" governor="3227" dependent="3234" relation="det"/><types2:Dependency xmi:id="3157" sofa="1" begin="0" end="0" governor="3213" dependent="3220" relation="prep_inside"/><types2:Dependency xmi:id="3167" sofa="1" begin="0" end="0" governor="3199" dependent="3206" relation="nn"/><types2:Dependency xmi:id="3177" sofa="1" begin="0" end="0" governor="3185" dependent="3192" relation="dobj"/><types2:Dependency xmi:id="3420" sofa="1" begin="0" end="0" governor="3596" dependent="3603" relation="det"/><types2:Dependency xmi:id="3430" sofa="1" begin="0" end="0" governor="3582" dependent="3589" relation="nsubj"/><types2:Dependency xmi:id="3440" sofa="1" begin="0" end="0" governor="3568" dependent="3575" relation="dep"/><types2:Dependency xmi:id="3450" sofa="1" begin="0" end="0" governor="3554" dependent="3561" relation="det"/><types2:Dependency xmi:id="3460" sofa="1" begin="0" end="0" governor="3540" dependent="3547" relation="advmod"/><types2:Dependency xmi:id="3470" sofa="1" begin="0" end="0" governor="3526" dependent="3533" relation="amod"/><types2:Dependency xmi:id="3480" sofa="1" begin="0" end="0" governor="3512" dependent="3519" relation="nn"/><types2:Dependency xmi:id="3490" sofa="1" begin="0" end="0" governor="3498" dependent="3505" relation="dobj"/><types2:Dependency xmi:id="3772" sofa="1" begin="0" end="0" governor="3924" dependent="3931" relation="det"/><types2:Dependency xmi:id="3782" sofa="1" begin="0" end="0" governor="3910" dependent="3917" relation="nsubj"/><types2:Dependency xmi:id="3792" sofa="1" begin="0" end="0" governor="3896" dependent="3903" relation="aux"/><types2:Dependency xmi:id="3802" sofa="1" begin="0" end="0" governor="3882" dependent="3889" relation="det"/><types2:Dependency xmi:id="3812" sofa="1" begin="0" end="0" governor="3868" dependent="3875" relation="dobj"/><types2:Dependency xmi:id="3822" sofa="1" begin="0" end="0" governor="3854" dependent="3861" relation="nn"/><types2:Dependency xmi:id="3832" sofa="1" begin="0" end="0" governor="3840" dependent="3847" relation="prep_of"/><types2:Dependency xmi:id="4100" sofa="1" begin="0" end="0" governor="4252" dependent="4259" relation="det"/><types2:Dependency xmi:id="4110" sofa="1" begin="0" end="0" governor="4238" dependent="4245" relation="dobj"/><types2:Dependency xmi:id="4120" sofa="1" begin="0" end="0" governor="4224" dependent="4231" relation="aux"/><types2:Dependency xmi:id="4130" sofa="1" begin="0" end="0" governor="4210" dependent="4217" relation="nsubj"/><types2:Dependency xmi:id="4140" sofa="1" begin="0" end="0" governor="4196" dependent="4203" relation="nn"/><types2:Dependency xmi:id="4150" sofa="1" begin="0" end="0" governor="4182" dependent="4189" relation="nn"/><types2:Dependency xmi:id="4160" sofa="1" begin="0" end="0" governor="4168" dependent="4175" relation="prep_on"/><types2:Dependency xmi:id="4417" sofa="1" begin="0" end="0" governor="4593" dependent="4600" relation="advmod"/><types2:Dependency xmi:id="4427" sofa="1" begin="0" end="0" governor="4579" dependent="4586" relation="amod"/><types2:Dependency xmi:id="4437" sofa="1" begin="0" end="0" governor="4565" dependent="4572" relation="dobj"/><types2:Dependency xmi:id="4447" sofa="1" begin="0" end="0" governor="4551" dependent="4558" relation="aux"/><types2:Dependency xmi:id="4457" sofa="1" begin="0" end="0" governor="4537" dependent="4544" relation="det"/><types2:Dependency xmi:id="4467" sofa="1" begin="0" end="0" governor="4523" dependent="4530" relation="nn"/><types2:Dependency xmi:id="4477" sofa="1" begin="0" end="0" governor="4509" dependent="4516" relation="nn"/><types2:Dependency xmi:id="4487" sofa="1" begin="0" end="0" governor="4495" dependent="4502" relation="nsubj"/><types:ExperimentUUID xmi:id="6981" sofa="1" begin="0" end="0" uuid="13c9d52b-1eb2-4518-99cd-ba2c8d1d7573" stageId="1"/><types2:TestDocument xmi:id="6987" sofa="1" begin="0" end="0" text="PLoS ONE: Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk&#10;Open Access&#10;Research Article&#10;Genetics of Clusterin Isoform Expression and Alzheimer's Disease RiskI-Fang Ling1, Jiraganya Bhongsatiern1, James F. Simpson1, David W. Fardo2, Steven Estus1*1 Department of Physiology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America, 2 Department of Biostatistics, University of Kentucky, Lexington, Kentucky, United States of America&#10;Abstract Top The minor allele of rs11136000 within CLU is strongly associated with reduced Alzheimer's disease (AD) risk. The mechanism underlying this association is unclear. Here, we report that CLU1 and CLU2 are the two primary CLU isoforms in human brain; CLU1 and CLU2 share exons 2–9 but differ in exon 1 and proximal promoters. The expression of both CLU1 and CLU2 was increased in individuals with significant AD neuropathology. However, only CLU1 was associated with the rs11136000 genotype, with the minor “protective” rs11136000T allele being associated with increased CLU1 expression. Since CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively, we compared their expression; for both CLU1 and CLU2 transfected cells, clusterin is present in the secretory pathway, accumulates in the extracellular media, and is similar in size to clusterin in human brain. Overall, we interpret these results as indicating that the AD-protective minor rs11136000T allele is associated with increased CLU1 expression. Since CLU1 and CLU2 appear to produce similar proteins and are increased in AD, the AD-protection afforded by the rs11136000T allele may reflect increased soluble clusterin throughout life.Citation: Ling I-F, Bhongsatiern J, Simpson JF, Fardo DW, Estus S (2012) Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk. PLoS ONE 7(4): e33923. doi:10.1371/journal.pone.0033923&#10;Editor: Tsuneya Ikezu, Boston University School of Medicine, United States of America&#10;Received: July 20, 2011; Accepted: February 21, 2012; Published: April 10, 2012&#10;Copyright: © 2012 Ling et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Funding: This work was funded by the NIH (P01AG030128 and P30AG028383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing interests: The authors have declared that no competing interests exist.* E-mail: steve.estus@uky.edu&#10;Introduction Top Clusterin (CLU, APOJ) has been implicated in diseases ranging from cancer to Alzheimer's disease (AD) (reviewed in [1], [2], [3], [4]). Although the primary role of clusterin in AD is unclear, CLU is implicated in AD by several lines of evidence, including (I) CLU mRNA and clusterin protein is increased in AD [5], [6], (ii) clusterin is a component of plaques [4], [5], [7], (iii) clusterin modulates AD-related pathways such as inflammation and apoptosis [1], [8], [9] and (iv) clusterin acts as an amyloid-beta (Aß) chaperone to alter Aß aggregation and/or clearance ([10], [11], reviewed in [4], [12], [13], [14]). The physiologic relevance of CLU to AD was confirmed recently when CLU single nucleotide polymorphisms (SNP)s were associated with AD risk [15], [16], [17], [18], [19]. Overall, CLU genetic variation is essentially unequivocally associated with AD given the robust statistical power of the initial genome-wide association studies and subsequent replication studies [15], [16], [17], [18], [19]. How CLU SNPs modulate clusterin to alter AD risk is unknown.Two CLU isoforms, CLU1 and CLU2, have been reported that consist of nine exons and differ only in their first exons and associated proximal promoters; CLU1 is predicted to encode a nuclear protein and CLU2a secreted protein (reviewed in [20]). Additional reported isoforms include a CLU isoform that lacks exon 5 and a CLU isoform that lacks exon two, which encodes the leader sequence, resulting in another nuclear clusterin [21], [22]. Here, we investigated the hypothesis that CLU isoforms are differentially modulated by AD status and AD-associated SNPs. We identified CLU1 and CLU2 as the major CLU isoforms in human brain. Quantitative expression studies show that both CLU1 and CLU2 are increased in AD but only CLU1 is associated with rs11136000. Lastly, although CLU1 and CLU2 are predicted to produce intracellular and secreted proteins, respectively, immunofluorescence and Western blot studies indicate that CLU1 and CLU2 both produce secreted proteins that are similar to those detected in the human brain. Overall, we interpret our results as suggesting that SNP-mediated increases in secreted, soluble clusterin expression may act to reduce AD risk.Methods Top Ethics Statement&#10;The work described here was performed with approval from the University of Kentucky Institutional Review Board.Cell CultureSH-SY5Y (human neuroblastoma) and HepG2 (human hepatocellular carcinoma) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 50 U/ml penicillin and 50 µg/ml streptomycin at 37°C in a humidified 5% CO2 - 95% air atmosphere.CLU Expression Plasmid&#10;Expression plasmids encoding CLU1 and CLU2 were generated from SH-SY5Y cellular mRNA that was reverse transcribed by using the primer 5′-TAGGTGCAAAAGCAACAT-3′ which corresponds to sequence just after the CLU stop codon. CLU1 and CLU2 cDNAs were then amplified by PCR with forward primers 5′-TGAGTCATGCAGGTTTGCAG-3′ (CLU1) and 5′-ATGATGAAGACTCTGCTGCTG-3′ (CLU2) used in combination with the common reverse primer 5′-CTCCTCCCGGTGCTTTTTG-3′. PCR fragments were ligated into pcDNA3.1/V5-His-TOPO T/A cloning vector (Invitrogen, Carlsbad, CA). Clones encoding CLU1 and CLU2 were detected by PCR screening and clone integrity confirmed by sequencing.Human Autopsy Tissue&#10;De-identified human brain specimens were provided by the University of Kentucky AD Center Neuropathology Core [23], [24]. AD and non-AD designations followed NIARI neuropathology guidelines, which include indices of neuritic senile plaques and neurofibrillary tangles, and provide a likelihood staging of AD neuropathological diagnosis [25], [26]. Individuals with “low” AD neuropathology were cognitively intact prior to death and had no or low likelihood of AD by NIARI criteria; their average age at death was 81.8±10.2 (mean ±SD, n = 17). Individuals with “high” AD neuropathology represented a combination of demented individuals with high likelihood of AD by NIARI criteria (n = 27) and cognitively intact individuals that were found to have moderate or high AD neuropathology at death (n = 7); their average age at death was 81.9±6.2 (mean ±SD, n = 34). The average post-mortem interval (PMI) for low AD neuropathology individuals was 3.0±0.8 hours (mean ± SD, n = 17) while the PMI for high AD neuropathology individuals was similar (3.2±0.8 hours (n = 34)). Choroid plexus samples were from six individuals with an average age at death of 80.0± 3.3 years and PMI of 2.9±1.1 hours. Fetal tissue RNA samples were obtained commercially (Stratagene, Santa Clara, CA) and have been described previously [27].PCR Amplification&#10;Total RNA was extracted from human brain specimens and converted to cDNA in 1 µg aliquots with random hexamers and reverse transcriptase (SuperScript III, Invitrogen), essentially as we described previously [24], [28], [29], [30]. PCR primers were designed such that the splicing of each internal CLU exon as well as CLU1 and CLU2 were evaluated (Table 1). In initial screening, cDNA pooled from five high AD neuropathology and five low AD neuropathology samples were subjected to PCR-amplification (Platinum Taq, Invitrogen) by using each primer pair and a PCR profile consisting of initial denaturation for 5 minutes at 95°C, followed by 27–32 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min, and final extension at 72°C for 7 min (Perkin Elmer 9600). PCR products were separated by polyacrylamide gel electrophoresis, stained with SYBR Gold and visualized by using a fluorescence imager (Fuji FLA-2000). The identity of the PCR products was confirmed by direct sequencing (Davis Sequencing, Davis, CA).thumbnail&#10;Table 1. PCR Primers for evaluating splice variation.doi:10.1371/journal.pone.0033923.t001 Real-time PCRThe expression level of CLU1 and CLU2 was quantified by real-time PCR. Each isoform was specifically amplified by using a sense primer corresponding to sequence within their respective exon 1, i.e., 5′-GCGAGCAGAGCGCTATAAAT-3′ for CLU1 and 5′-AGATGGATTCGGTGTGAAGG-3′ for CLU2′, and an antisense primer corresponding to sequence at the exon 2–3 boundary, i.e., 5′-GACATTTCCTGGAGCTCATTG-3′. Note that the CLU1 sense primer contains the TATA sequence suggested by Schepeler et al to be present only in a longer “CLU34” isoform [31]. The 20 µl real-time PCR mixture containing approximately 20 ng of brain cDNA, 1 µM of each primer and 1× Perfec&#10;Taq PCRSupermix (Quanta Biosciences, Gaithersburg, MD) was subjected to real-time PCR (Bio-Rad, Hercules, CA). PCR profiles consisted of pre-incubation at 95°C for 2 min, followed by 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 20 s. Specificity of the reactions was evaluated by showing a single PCR product by gel electrophoresis and by performing a melting curve analysis after PCR amplification. The PCR product copy number in each sample was determined relative to standard curves that were amplified in parallel and were based upon previously purified and quantified PCR products. The copy numbers were then normalized to the geometric mean of the copy numbers of hypoxanthine-guanine phosphoribosyltransferase 1 and ribosomal protein L13A as described (Vandesompele et al., 2002; Zhang et al., 2005). All real-time PCR assays were repeated twice.GenotypingDNA samples were genotyped for rs11136000 by using unlabeled PCR primers and TaqMan FAM and VIC dye-labeled MGB probes (Pre-designed SNP Genotyping Assay, Applied Biosystems, Foster City, CA) on a real-time PCR machine (Bio-Rad, Hercules, CA).Statistical Analysis&#10;Variation in CLU isoform expression were analyzed as a function of rs11136000 genotype, AD neuropathology, sex and age by using a general linear model (SPSS v.18 (IBM, Somers, NY)). A dominant mode of inheritance was assumed to maximize statistical power.ImmunofluorescenceCLU expression plasmids were transfected into SH-SY5Y cells by using FuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences, Indianapolis, IN). Briefly, 3.75×104 cells/well were maintained in a poly-L-lysine treated 8-well chamber coverglass (Lab-Tek, Nunc, Rochester, NY) and transfected the next day with CLU1 or CLU2 expression plasmid. Twenty-four hours after transfection, cells were washed with phosphate buffered saline (PBS) and fixed with ice-cold methanol for 5 minutes. Non-specific antibody binding sites were blocked by incubating the cells with 5% goat serum in PBS with 0.1% Tween-20 (PBST) for 1 hour and the cells were then incubated with mouse anti-V5 antibody (1:1000 dilution, ab27671, Abcam, Cambridge, MA) and either rabbit anti-calnexin antibody (1:200 dilution, SPA-860, Stressgen, Victoria, BC, Canada) or rabbit anti-TGN46 antibody (1:1000 dilution, ab16052, Abcam) in 5% goat serum at 4°C overnight. The next day, cells were washed with PBST three times and incubated with a mixture containing Alexa-488 goat anti-mouse IgG antibody (1:200 dilution, Molecular Probes, Carlsbad, CA) and Alexa-568 goat anti-rabbit IgG antibody (1:200 dilution, Molecular Probes) in 5% goat serum at room temperature for an hour. After washing with PBST, cells were stained with 10 µg/ml of Hoechst 33258 (Molecular Probes) for 30 minutes, washed with PBS, and subjected to fluorescence microscopy.Western BlotSH-SY5Y cells or HepG2 cells were grown in a 100 mm dish (2.6×106 cells/dish) for 24 hours and then transfected with CLU1 or CLU2 expression plasmid by using&#10;FuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences). Twenty-four hours after transfection, cell medium was replaced with Opti-MEM (Invitrogen) and cells maintained for another 24 hours. The conditioned medium was collected and the cells washed with 5 ml of room-temperature PBS. Cells were then lysed in 0.5 ml of RIPA butter (50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS) containing 1× protease inhibitor cocktail (Roche Applied Sciences) for 30 minutes on ice with occasional rocking. Cell lysates were centrifuged at 10,000×g for 10 minutes at 4°C and the supernatant collected. Conditioned medium was centrifuged at 250×g for 10 minutes and 0.5 ml of the supernatant was collected and supplemented with 1× protease inhibitor cocktail (Roche Applied Science). Human brain anterior cingulate tissue samples were prepared by homogenizing ~0.5 mg tissue in RIPA buffer supplemented with 1× protease inhibitor cocktail, centrifuging at 14,000×g for 10 minutes at 4°C, and then collecting the supernatant. After the protein concentration of each sample was determined (Micro BCA Protein Assay Reagent Kit, Pierce, Rockford, IL), 15 or 20 µg protein were mixed with SDS sample loading buffer containing β-mercaptoethanol, boiled for 5 minutes and subjected to polyacrylamide gel electrophoresis on a 7.5% polyacrylamide gel. Proteins were transferred to nitrocellulose membranes (Bio-Rad). The blots were then incubated with 5% nonfat dry milk for 1 hour at room temperature and probed overnight with mouse anti-V5 antibody (1:5000 dilution, Abcam) or mouse anti-clusterin antibody (1:200, B-5 Santa-Cruz) at 4°C. After washing with PBST four times for 5 minutes each, the blots were incubated with peroxidase-conjugated sheep anti-mouse antibody (1:1,000 dilution, Jackson ImmunoResearch) for 1 hour at room temperature. Bound peroxidase was visualized by using a Super&#10;Signal West Pico kit (Pierce) and a molecular imager (ChemiDoc XRS System, Bio-Rad). For studies involving PNGase F digestion, each protein sample was treated with PNGase F as directed by the manufacturer (New England Biolabs, Ipswich, MA). Briefly, 15 µg protein of each sample was denatured at 100°C for 10 minutes and incubated with 1,500 units of PNGase F at 37°C for 2 hours. Samples were then analyzed by Western blot as described above.Results Top To begin to evaluate CLU expression, we screened human brain cDNA to identify CLU isoforms present in brain. Previously reported isoforms include CLU1 and CLU2, which are identical in exons 2–9 but differ in exon 1, as well as isoforms lacking exons 2 or 5 ([21], [22], reviewed in [20]). RT-PCR analyses of pooled human brain cDNA samples detected only CLU1 and CLU2 (Figure 1A–1B). CLU2 translation is predicted to result in a secreted protein, beginning at the initial ATG in exon 2 that is common to both CLU2 and CLU1 (Figure 1C). In contrast, CLU1 translation is predicted to initiate at an ATG within its exon 1, which is in-frame with the ATG site in the common exon 2. Hence, CLU1 is predicted to encode a protein identical to that encoded by CLU2 except that the CLU1 protein would contain 52 additional amino acids at its amino terminus (Figure 1C). This change is predicted by PSORTII to result in an intracellular and likely nuclear, form of clusterin (reviewed in [20]). In summary, CLU1 and CLU2 are the primary CLU isoforms in brain and are predicted to encode intracellular and secreted proteins, respectively.thumbnail&#10;Figure 1. CLU1 and CLU2 are the primary CLU isoforms expressed in human brain.The exon layout for the CLU1 and CLU2 isoforms is shown (A). Coding and non-coding exonic regions are represented by black and white boxes, respectively, while introns are shown as thin black lines. The first ATG site in each isoform is shown as well. Evaluation of CLU splicing by RT-PCR identified only CLU1 and CLU2 in human brain cDNA (B), i.e., single PCR products are observed upon amplification from exon 1a – exon 5 (lane 1), exon 1b – exon 5 (lane 2), exon 4 – exon 6 (lane 3) and exon5 – exon 9 (lane 4). Molecular weight markers are shown at the left. The predicted protein sequences encoded by CLU1 and CLU2, beginning with the initial ATG sites shown in A, are shown in panel C. The sequence in gray font is unique to CLU1 while sequence in black font is common to CLU1 and CLU2. The boxed amino acid sequence represents signal sequence that is removed from clusterin-2 upon its translocation to the ER. Two nuclear localization sequences, as predicted by PSORT II (http://psort.ims.u-tokyo.ac.jp/form2.htm l), are underlined. The asterisk shows the clusterin cleavage site that separates the α- and β- subunits.doi:10.1371/journal.pone.0033923.g001 To evaluate whether rs11136000, the primary AD-related CLU SNP [15], [16], [17], [18], [19], is associated with CLU expression, we quantified CLU1 and CLU2 expression in a series of brain samples. The CLU isoforms were quantified in separate real-time PCR assays that used forward primers corresponding to their unique exon 1 and a common reverse primer that targeted the exon 2–3 boundary. Copy numbers were determined relative to a standard curve for each isoform and normalized to the geometric mean of housekeeping genes [23], [32]. The expression of CLU1 and CLU2 were modestly coordinately regulated (Figure 2A), with CLU2 being consistently greater than CLU1; the overall CLU2: CLU1 ratio was 3.35±1.84 (mean ± SD, n = 51). To gain further insights into CLU isoform expression, we quantified CLU1 and CLU2 in a series of single human fetal tissue samples as well as a set of six adult choroid plexus samples (Figure 2B). Among the fetal tissues, the CLU2: CLU1 ratio varied widely from 0.3 (skin) to 6.2 (kidney) (Figure 2B). The CLU2:CLU1 ratio in choroid plexus, which produces cerebrospinal fluid, was 5.72±0.65 (mean ± SD, n = 6).thumbnail&#10;Figure 2. Expression of CLU isoforms in human tissues.CLU1 and CLU2 isoforms were quantified by isoform-specific RT-PCR in a series of adult human cingulate and choroid plexus samples (A–B) as well as a human fetal tissues (B). Within A, each marker reflects the expression of CLU1 and CLU2, normalized to housekeeping genes, in a single brain sample. Within B, the value in parentheses following the tissue name is the CLU1:CLU2 ratio. CLU1 expression shows a positive association with AD neuropathology and rs11136000T allele (C). CLU2 expression was increased in individuals with AD pathology and decreased with age (D–E).doi:10.1371/journal.pone.0033923.g002 We next evaluated CLU isoform expression as a function of AD neuropathology, rs11136000 status, sex and age. We found that CLU1 expression was significantly increased with high AD neuropathology and the minor rs11136000T allele (Figure 2C, Table 2). In contrast, CLU2 expression was significantly increased with AD neuropathology but not rs11136000 genotype, and decreased with age (Figure 2D–E, Table 3). Overall, both CLU1 and CLU2 expression was increased with AD, confirming prior reports. However, only CLU1 expression was associated with rs11136000. Since the minor rs11136000T allele was associated with both increased CLU1 expression and reduced AD risk [15], [16], [17], [18], [19], we interpret these results as suggesting that increased CLU1 expression is associated with reduced AD risk.thumbnail&#10;Table 2. Analysis of CLU1 Expression.doi:10.1371/journal.pone.0033923.t002 thumbnail&#10;Table 3. Analysis of CLU2 Expression.doi:10.1371/journal.pone.0033923.t003 CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively (Figure 1). Therefore, we evaluated the proteins produced by CLU1 and CLU2 transfected cells to discern whether these corresponded to the intracellular and secreted forms of clusterin that have been reported [4], [8], [33]. When each isoform was transiently transfected into neural SH-SY5Y cells, immunofluorescence analyses showed a similar subcellular localization pattern (Figure 3). The proteins produced by CLU1 and CLU2 tended to concentrate within the Golgi apparatus, as established by double-labeling with an antibody against trans-Golgi network protein 46 (TGN46) (Figure 3A). Relatively modest amounts of clusterin were also detected within the endoplasmic reticulum (ER), as established by double labeling with calnexin (Figure 3B). Nuclear, cytosolic, or mitochondrial-associated clusterin was not observed. Hence, the clusterin produced by CLU1 and CLU2 manifests an intracellular localization that includes the ER and Golgi, consistent with a possible secretory pathway for both proteins.thumbnail&#10;Figure 3. CLU1 and CLU2 encoded proteins are localized to the ER and Golgi.SH-SY5Y cells were transfected with vectors encoding CLU1 and CLU2; the resultant clusterin expression was localized by a vector-derived V5 epitope tag. The subcellular localization for both proteins overlapped with the Golgi, as shown by co-labeling with antibody against TGN46 (A) and with the ER, as shown by co-labeling with an antibody against calnexin (B).doi:10.1371/journal.pone.0033923.g003 CLU1 is predicted to encode a 501 amino acid protein with a molecular weight of 57.8 kDa while CLU2 is predicted to encode 449 amino acids, totaling 52.5 kDa. During maturation of secreted clusterin, the protein is N-glycosylated and proteolyzed to generate a heterodimer that is maintained by disulfide bonds [20]. To compare the size of the proteins produced by CLU1 and CLU2, we performed Western blot analyses of transfected SH-SY5Y cells; ectopic clusterin was detected via a V5 epitope tag (Figure 4 A–B). Cell lysates contained both intact and cleaved clusterin while conditioned medium contained only cleaved clusterin; the clusterin protein produced by CLU1 and CLU2 appeared equal in size (Figure 4A). To discern whether glycosylation differences may obscure differences in the clusterin molecular weight derived from their primary sequence, the protein mixtures were digested with PNGase F to remove N-linked sugars prior to electrophoresis; the size of the proteins produced by CLU1 and CLU2 transfected cells were both decreased similarly by PNGase treatment (Figure 4B). We considered the possibility that CLU translation may show cell-type specificity, and therefore repeated this study in an unrelated cell line by transfecting CLU1 and CLU2 into HepG2 cells. As with the SH-SY5Y cells, CLU1 and CLU2 transfected cells produced clusterin of similar size, even after PNGase F digestion (Figure 4C). Hence, we found no evidence to suggest that the proteins produced by CLU1 and CLU2 differ in cellular localization, size, glycosylation, or proteolytic cleavage. Rather, when these Western blot studies are considered in combination with the immunofluorescence studies, CLU1 and CLU2 appear to produce equivalent proteins that are similarly translated, glycosylated, and cleaved as they pass through the ER and Golgi in the secretory pathway to the extracellular space.thumbnail&#10;Figure 4. CLU1 and CLU2 produce clusterin proteins that are similar to each other and to clusterin in human brain.Transfection of CLU1 and CLU2 resulted in proteins of similar size, appearing as both intact and cleaved clusterin in cell lysates and conditioned media; the proteins resulting from CLU transfection were detected via their V5 epitope tag (A–B). PNGase F treatment prior to electrophoresis reduced the size of the proteins produced by CLU1 and CLU2 similarly (B). The apparent doublet in the protein encoded by CLU1 at 37 kDa was variable between experiments and likely reflects incomplete glycosylation as the doublet collapsed to a single band after PNGase F digestion. Results similar to those depicted in B were obtained when CLU1 and CLU2 were transfected into HepG2 cells (C). When transfected and endogenous clusterin proteins were detected with an antibody raised against a carboxyl-terminal clusterin epitope (D–E), intact clusterin from transfection (T-labeled arrow) was slightly larger than endogenous clusterin (E-labeled arrow), reflecting the ~5.1 kDa V5 epitope and His tags in the ectopic clusterin (D). The bands labeled “Fragments” are clusterin alpha subunits derived from variably glycosylated endogenous and transfected clusterin. Overall, the cellular clusterin proteins are similar in size to the human brain clusterin, as discerned for the intact and cleaved clusterin under reducing conditions (D) or as the heterodimeric clusterin under non-reducing conditions (E).doi:10.1371/journal.pone.0033923.g004 To evaluate whether the clusterin proteins produced by CLU1 and CLU2 in vitro are similar to those produced in vivo, we compared ectopic clusterin with endogenous clusterin in SH-SY5Y cells and in human brain by Western blotting with a clusterin antibody. Endogenous clusterin in SH-SY5Y cells migrates at a slightly lower molecular weight than that resulting from CLU transfection, reflecting the 5.1 kDa V5/His tag encoded by the pcDNA3.1 vector expressing transfected CLU (Figure 4D). Importantly, this 5.1 kDa size difference between endogenous and transfected clusterin is similar to the size difference between the CLU1 and CLU2-predicted proteins, indicating that if the proteins encoded by CLU1 and CLU2 differed by 5 kDa, the proteins would be resolved easily under these experimental conditions. The endogenous SH-SY5Y clusterin migrates similarly to the intact protein detected in brain homogenates suggesting these cellular forms are similar to those present in vivo (Figure 4D). To extend this analysis to the heterodimeric form of clusterin, we also performed electrophoresis under non-reducing conditions. We found that heterodimeric protein from CLU1 and CLU2 transfected cells appeared similar in size to each other and to the forms found in brain (Figure 4E). Hence, CLU1 and CLU2 produce proteins in vitro that are similar in size to endogenous clusterin in vitro and human brain.Discussion Top The main findings of this report are several. First, CLU1 and CLU2 are the primary CLU isoforms in human brain and differ in their first exon and proximal promoter. Second, the expression of only CLU1 was associated with rs11136000 while both CLU1 and CLU2 were increased with robust AD neuropathology. Third, CLU1 and CLU2 produce secreted clusterin proteins that are similar to each other and to clusterin in human brain. Since CLU is increased in AD and CLU1 is increased with the minor rs11136000T allele, which is also associated with reduced AD risk, we interpret our results as suggesting that increased CLU expression throughout life may reduce AD risk. Overall, these results identify a possible means underlying the association of rs11136000 with AD risk.The association between CLU expression and rs11136000 was discerned because the CLU isoforms were analyzed separately. For example, when we analyzed total CLU expression in the same fashion as reported here, total CLU was not associated with rs11136000 (p = 0.51) although a robust association with AD pathology was observed (p = 0.005, Ling et al., unpublished observations). The lack of a significant association between rs11136000 and total CLU is somewhat disconcerting since CLU1 and CLU2 appear to produce a similar protein. We speculate that (i) the threshold for clusterin biological significance may be less than the threshold for overall CLU statistical significance and/or (ii) CLU1 may be enriched in a cell type different than CLU2, which may affect its functionality. We note that the lack of an association between total CLU and rs11136000 was similar to prior reports that total CLU mRNA or clusterin protein were not associated with rs11136000 [17], [34]. As the clusterin produced by CLU1 and CLU2 appears similar, discerning an association between rs11136000 and clusterin would be especially challenging in tissues with a large proportion of CLU2. In this regard, CLU2 was the major isoform in choroid plexus, suggesting that an association between cerebrospinal fluid clusterin and rs11136000 would be difficult to detect. The differential regulation of CLU1 and CLU2 was not unexpected because CLU1 and CLU2 have separate proximal promoter regions. Consistent with this observation, Cochrane et al found that androgen-treatment in a prostate cancer cell line decreased CLU1 expression while enhancing CLU2 expression [35]. Although the identification of the functional SNPs and transcription factors that modulate CLU expression is beyond the scope of this report, we note that rs11136000 resides within intron 3 and is common to both CLU1 and CLU2. Hence, rs11136000 is likely not functional but rather is in linkage with a functional SNP more proximal to the CLU1 promoter. In summary, the association between rs11136000 and CLU1 was dependent upon analyzing the two CLU isoforms separately.Since earlier predictions were that CLU2 encodes a secreted protein while the additional 52 amino-terminal residues encoded by CLU1 would result in its intracellular localization [20], we expected clusterin in CLU1 and CLU2 transfected cells to differ in cellular locale and size. In support of this prediction, the ATG translation initiation sites in the CLU1-specific exon 1a as well as the common exon 2 both satisfy Kozak consensus sequence requirements (http://bioinfo.iitk.ac.in/AUGPred/). However, clusterin in CLU1 and CLU2 transfected cells was localized to the secretory pathway and was equivalent in size under conditions that would easily discern their predicted five kDa size difference, especially after PNGase F treatment to remove sugar residues. Hence, CLU1 and CLU2 produce similar secreted proteins in vitro. Comparable results were obtained in two cell types, suggesting that CLU1 and CLU2 generally produce soluble clusterin protein. The most parsimonious interpretation of these data is that CLU1 translation is generally initiated at the common exon 2 ATG. The possibility exists that a portion of CLU1 translation is initiated at the exon 1a ATG at levels too low to be readily detected or that produce an unstable protein which is rapidly degraded. Distinguishing among these possibilities is a future direction for this work. Overall, we summarize our current results by noting that the proteins produced from CLU1 and CLU2 in vitro are similar to each other, and similar in size to those present in human brain, leading us to interpret our data as supporting the possibility that CLU1 and CLU2 generally produce secreted clusterin protein in vitro and in vivo.A logical extension of the finding that AD risk is reduced with a genetic variant that correlates with increased CLU expression is that other factors that increase CLU expression may also reduce AD risk. Furthermore, since CLU expression is increased in AD without reversing the disease, we speculate that enhanced CLU expression reduces AD risk only if CLU expression is increased well before AD onset, mimicking the likely SNP effects. One possible modulator of interest is age-dependent changes in sex hormones since CLU isoforms are differentially regulated by androgens [35]. Stress has also been shown to upregulate CLU in many instances [36] and may cause the AD-associated increase in CLU observed here. In terms of possible therapeutic agents, multiple histone deacetylase inhibitors increase CLU expression robustly in vitro [37]. Interestingly, one member of this class, valproate, increases CLU expression in human astrocytes [37] and reduces amyloid accumulation as well as behavioral deficits in mouse amyloid models [38], [39]. While valproate may also act via other mechanisms [38], the actions of valproate on CLU expression may be relevant to its neuroprotection and merit further exploration to reduce AD risk.Limitations of this study include that rs11136000 and AD neuropathological status capture only ~20% of the variance in CLU expression. Identifying the unknown factors that account for the additional variance, which could include epigenetic factors, will facilitate understanding of CLU expression. Moreover, variability in these factors could facilitate or obscure the SNP association with CLU1 expression described here, suggesting that replication of these data in additional samples is necessary for their acceptance by the research community. Additionally, since the nuclear form of clusterin arising from an isoform lacking exon 2 has been associated with apoptosis [21], [22], this isoform may be transientlyexpressed and hence below our limits of detection, especially in comparison with CLU1 and CLU2.In conclusion, the AD-protective allele of rs11136000 was associated with increased expression of CLU1 but not CLU2 in our dataset. Both CLU1 and CLU2 produce a soluble, secreted clusterin protein that is similar to that observed in human brain. Discerning the association between rs11136000 and CLU1 depended upon analyzing these two CLU isoforms separately.Acknowledgments Top The authors gratefully acknowledge tissue supplied by the University of Kentucky AD Center and Ishita Parikh for technical assistance.Author Contributions Top Conceived and designed the experiments: IL SE. Performed the experiments: IF JB JS. Analyzed the data: IL JB JF DF SE. Wrote the paper: IF SE.References Top Sala A, Bettuzzi S, Pucci S, Chayka O, Dews M, et al. (2009) Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Adv Cancer Res 105: 115–132. Find this article online Redondo M, Tellez T, Roldan MJ (2009) The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas. Adv Cancer Res 105: 21–43. Find this article online Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009) Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 61: 89–104. Find this article online Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, et al. (2000) Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech 50: 305–315. Find this article online May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, et al. (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 5: 831–839. Find this article online Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM (2011) Plasma clusterin and the risk of Alzheimer disease. JAMA: the Journal of the American Medical Association 305: 1322–1326. Find this article online Choi-Miura NH, Ihara Y, Fukuchi K, Takeda M, Nakano Y, et al. (1992) SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol 83: 260–264. Find this article online Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, et al. (2005) Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7: 909–915. Find this article online Falgarone G, Chiocchia G (2009) Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity. Adv Cancer Res 104: 139–170. Find this article online Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, et al. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 21: 2312–2322. Find this article online Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, et al. (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27: 909–918. Find this article online Holtzman DM (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J Mol Neurosci 23: 247–254. Find this article online Bertram L, Tanzi REAlzheimer disease: New light on an old CLU. Nat Rev Neurol 6: 11–13. Find this article online van Es MA, van den Berg LH (2009) Alzheimer's disease beyond APOE. Nat Genet 41: 1047–1048. Find this article online Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094–1099. Find this article online Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088–1093. Find this article online Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, et al. (2010) Genetic variability in CLU and its association with Alzheimer's disease. PLoS One 5: e9510. Find this article online Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Archives of Neurology 67: 961–964. Find this article online Jun G, Naj AC, Beecham GW, Wang LS, Buros J, et al. (2010) Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67: 1473–1484. Find this article online Rizzi F, Bettuzzi S (2010) The clusterin paradigm in prostate and breast carcinogenesis. Endocr Relat Cancer 17: R1–17. Find this article online Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278: 11590–11600. Find this article online Kimura K, Yamamoto M (1996) Modification of the alternative splicing process of testosterone-repressed prostate message-2 (TRPM-2) gene by protein synthesis inhibitors and heat shock treatment. Biochim Biophys Acta 1307: 83–88. Find this article online Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, et al. (2009) Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Mol Neurodegener 4: 46. Find this article online Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, et al. (2008) Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet 17: 929–935. Find this article online (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiology of aging 18: S1–2. Find this article online Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68: 1–14. Find this article online Burchett M, Ling I-F, Estus S (2011) FBN1 isoform expression varies in a tissue and development-specific fashion. Biochem Biophys Res Commun 411: 323–328. Find this article online Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 162: 156–159. Find this article online Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, et al. (1999) The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease. Neurochem Res 24: 767–774. Find this article online Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, et al. (2007) A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. Hum Mol Genet 16: 1765–1772. Find this article online Schepeler T, Mansilla F, Christensen LL, Orntoft TF, Andersen CL (2007) Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling. Journal of Molecular Signaling 2: 6. Find this article online Ling IF, Estus S (2010) Role of SFRS13A in low-density lipoprotein receptor splicing. Hum Mutat 31: 702–709. Find this article online Reddy KB, Jin G, Karode MC, Harmony JA, Howe PH (1996) Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35: 6157–6163. Find this article online Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, et al. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Archives of General Psychiatry 67: 739–748. Find this article online Cochrane DR, Wang Z, Muramaki M, Gleave ME, Nelson CC (2007) Differential regulation of clusterin and its isoforms by androgens in prostate cells. J Biol Chem 282: 2278–2287. Find this article online Michel D, Chatelain G, North S, Brun G (1997) Stress-induced transcription of the clusterin/apoJ gene. Biochem J 328(Pt 1): 45–50. Find this article online Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2010) Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease. Neuroscience Letters 475: 64–68. Find this article online Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, et al. (2008) Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med 205: 2781–2789. Find this article online Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, et al. (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35: 870–880. Find this article online" id="QA4MRE-2012_BIOMEDICAL_GS.xml_1" filteredText="Genetics of Clusterin Isoform Expression and Alzheimer's Disease RiskI-Fang Ling1, Jiraganya Bhongsatiern1, James F. Simpson1, David W. Fardo2, Steven Estus1*1 Department of Physiology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America, 2 Department of Biostatistics, University of Kentucky, Lexington, Kentucky, United States of America&#10;Abstract Top The minor allele of rs11136000 within CLU is strongly associated with reduced Alzheimer's disease (AD) risk.&#10;The mechanism underlying this association is unclear.&#10;Here, we report that CLU1 and CLU2 are the two primary CLU isoforms in human brain; CLU1 and CLU2 share exons 2–9 but differ in exon 1 and proximal promoters.&#10;The expression of both CLU1 and CLU2 was increased in individuals with significant AD neuropathology.&#10;However, only CLU1 was associated with the rs11136000 genotype, with the minor “protective” rs11136000T allele being associated with increased CLU1 expression.&#10;Since CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively, we compared their expression; for both CLU1 and CLU2 transfected cells, clusterin is present in the secretory pathway, accumulates in the extracellular media, and is similar in size to clusterin in human brain.&#10;Overall, we interpret these results as indicating that the AD-protective minor rs11136000T allele is associated with increased CLU1 expression.&#10;Since CLU1 and CLU2 appear to produce similar proteins and are increased in AD, the AD-protection afforded by the rs11136000T allele may reflect increased soluble clusterin throughout life.&#10;Editor: Tsuneya Ikezu, Boston University School of Medicine, United States of America&#10;Copyright: © 2012 Ling et al.&#10;This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.&#10;Funding: This work was funded by the NIH (P01AG030128 and P30AG028383).&#10;The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing interests: The authors have declared that no competing interests exist.&#10;* E-mail: steve.estus@uky.edu&#10;Introduction Top Clusterin (CLU, APOJ) has been implicated in diseases ranging from cancer to Alzheimer's disease (AD) (reviewed in [1], [2], [3], [4]).&#10;Although the primary role of clusterin in AD is unclear, CLU is implicated in AD by several lines of evidence, including (I) CLU mRNA and clusterin protein is increased in AD [5], [6], (ii) clusterin is a component of plaques [4], [5], [7], (iii) clusterin modulates AD-related pathways such as inflammation and apoptosis [1], [8], [9] and (iv) clusterin acts as an amyloid-beta (Aß) chaperone to alter Aß aggregation and/or clearance ([10], [11], reviewed in [4], [12], [13], [14]).&#10;The physiologic relevance of CLU to AD was confirmed recently when CLU single nucleotide polymorphisms (SNP)s were associated with AD risk [15], [16], [17], [18], [19].&#10;Overall, CLU genetic variation is essentially unequivocally associated with AD given the robust statistical power of the initial genome-wide association studies and subsequent replication studies [15], [16], [17], [18], [19].&#10;Two CLU isoforms, CLU1 and CLU2, have been reported that consist of nine exons and differ only in their first exons and associated proximal promoters; CLU1 is predicted to encode a nuclear protein and CLU2a secreted protein (reviewed in [20]).&#10;Additional reported isoforms include a CLU isoform that lacks exon 5 and a CLU isoform that lacks exon two, which encodes the leader sequence, resulting in another nuclear clusterin [21], [22].&#10;Here, we investigated the hypothesis that CLU isoforms are differentially modulated by AD status and AD-associated SNPs.&#10;We identified CLU1 and CLU2 as the major CLU isoforms in human brain.&#10;Quantitative expression studies show that both CLU1 and CLU2 are increased in AD but only CLU1 is associated with rs11136000.&#10;Lastly, although CLU1 and CLU2 are predicted to produce intracellular and secreted proteins, respectively, immunofluorescence and Western blot studies indicate that CLU1 and CLU2 both produce secreted proteins that are similar to those detected in the human brain.&#10;Overall, we interpret our results as suggesting that SNP-mediated increases in secreted, soluble clusterin expression may act to reduce AD risk.&#10;The work described here was performed with approval from the University of Kentucky Institutional Review Board.&#10;Cell CultureSH-SY5Y (human neuroblastoma) and HepG2 (human hepatocellular carcinoma) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 50 U/ml penicillin and 50 µg/ml streptomycin at 37°C in a humidified 5% CO2 - 95% air atmosphere.&#10;Expression plasmids encoding CLU1 and CLU2 were generated from SH-SY5Y cellular mRNA that was reverse transcribed by using the primer 5′-TAGGTGCAAAAGCAACAT-3′ which corresponds to sequence just after the CLU stop codon.&#10;CLU1 and CLU2 cDNAs were then amplified by PCR with forward primers 5′-TGAGTCATGCAGGTTTGCAG-3′ (CLU1) and 5′-ATGATGAAGACTCTGCTGCTG-3′ (CLU2) used in combination with the common reverse primer 5′-CTCCTCCCGGTGCTTTTTG-3′.&#10;Clones encoding CLU1 and CLU2 were detected by PCR screening and clone integrity confirmed by sequencing.&#10;De-identified human brain specimens were provided by the University of Kentucky AD Center Neuropathology Core [23], [24].&#10;AD and non-AD designations followed NIARI neuropathology guidelines, which include indices of neuritic senile plaques and neurofibrillary tangles, and provide a likelihood staging of AD neuropathological diagnosis [25], [26].&#10;Individuals with “low” AD neuropathology were cognitively intact prior to death and had no or low likelihood of AD by NIARI criteria; their average age at death was 81.8±10.2 (mean ±SD, n = 17).&#10;Individuals with “high” AD neuropathology represented a combination of demented individuals with high likelihood of AD by NIARI criteria (n = 27) and cognitively intact individuals that were found to have moderate or high AD neuropathology at death (n = 7); their average age at death was 81.9±6.2 (mean ±SD, n = 34).&#10;Fetal tissue RNA samples were obtained commercially (Stratagene, Santa Clara, CA) and have been described previously [27].&#10;Total RNA was extracted from human brain specimens and converted to cDNA in 1 µg aliquots with random hexamers and reverse transcriptase (SuperScript III, Invitrogen), essentially as we described previously [24], [28], [29], [30].&#10;PCR primers were designed such that the splicing of each internal CLU exon as well as CLU1 and CLU2 were evaluated (Table 1).&#10;PCR products were separated by polyacrylamide gel electrophoresis, stained with SYBR Gold and visualized by using a fluorescence imager (Fuji FLA-2000).&#10;The identity of the PCR products was confirmed by direct sequencing (Davis Sequencing, Davis, CA).&#10;PCR Primers for evaluating splice variation.&#10;t001 Real-time PCRThe expression level of CLU1 and CLU2 was quantified by real-time PCR.&#10;Each isoform was specifically amplified by using a sense primer corresponding to sequence within their respective exon 1, i.e., 5′-GCGAGCAGAGCGCTATAAAT-3′ for CLU1 and 5′-AGATGGATTCGGTGTGAAGG-3′ for CLU2′, and an antisense primer corresponding to sequence at the exon 2–3 boundary, i.e., 5′-GACATTTCCTGGAGCTCATTG-3′.&#10;Note that the CLU1 sense primer contains the TATA sequence suggested by Schepeler et al to be present only in a longer “CLU34” isoform [31].&#10;The 20 µl real-time PCR mixture containing approximately 20 ng of brain cDNA, 1 µM of each primer and 1× Perfec&#10;Taq PCRSupermix (Quanta Biosciences, Gaithersburg, MD) was subjected to real-time PCR (Bio-Rad, Hercules, CA).&#10;The PCR product copy number in each sample was determined relative to standard curves that were amplified in parallel and were based upon previously purified and quantified PCR products.&#10;The copy numbers were then normalized to the geometric mean of the copy numbers of hypoxanthine-guanine phosphoribosyltransferase 1 and ribosomal protein L13A as described (Vandesompele et al., 2002; Zhang et al., 2005).&#10;All real-time PCR assays were repeated twice.&#10;GenotypingDNA samples were genotyped for rs11136000 by using unlabeled PCR primers and TaqMan FAM and VIC dye-labeled MGB probes (Pre-designed SNP Genotyping Assay, Applied Biosystems, Foster City, CA) on a real-time PCR machine (Bio-Rad, Hercules, CA).&#10;Variation in CLU isoform expression were analyzed as a function of rs11136000 genotype, AD neuropathology, sex and age by using a general linear model (SPSS v.18 (IBM, Somers, NY)).&#10;A dominant mode of inheritance was assumed to maximize statistical power.&#10;ImmunofluorescenceCLU expression plasmids were transfected into SH-SY5Y cells by using FuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences, Indianapolis, IN).&#10;Briefly, 3.75×104 cells/well were maintained in a poly-L-lysine treated 8-well chamber coverglass (Lab-Tek, Nunc, Rochester, NY) and transfected the next day with CLU1 or CLU2 expression plasmid.&#10;Twenty-four hours after transfection, cells were washed with phosphate buffered saline (PBS) and fixed with ice-cold methanol for 5 minutes.&#10;Non-specific antibody binding sites were blocked by incubating the cells with 5% goat serum in PBS with 0.1% Tween-20 (PBST) for 1 hour and the cells were then incubated with mouse anti-V5 antibody (1:1000 dilution, ab27671, Abcam, Cambridge, MA) and either rabbit anti-calnexin antibody (1:200 dilution, SPA-860, Stressgen, Victoria, BC, Canada) or rabbit anti-TGN46 antibody (1:1000 dilution, ab16052, Abcam) in 5% goat serum at 4°C overnight.&#10;The next day, cells were washed with PBST three times and incubated with a mixture containing Alexa-488 goat anti-mouse IgG antibody (1:200 dilution, Molecular Probes, Carlsbad, CA) and Alexa-568 goat anti-rabbit IgG antibody (1:200 dilution, Molecular Probes) in 5% goat serum at room temperature for an hour.&#10;After washing with PBST, cells were stained with 10 µg/ml of Hoechst 33258 (Molecular Probes) for 30 minutes, washed with PBS, and subjected to fluorescence microscopy.&#10;Western BlotSH-SY5Y cells or HepG2 cells were grown in a 100 mm dish (2.6×106 cells/dish) for 24 hours and then transfected with CLU1 or CLU2 expression plasmid by using&#10;FuGene HD Transfection Reagent as directed by the manufacturer (Roche Applied Sciences).&#10;Twenty-four hours after transfection, cell medium was replaced with Opti-MEM (Invitrogen) and cells maintained for another 24 hours.&#10;The conditioned medium was collected and the cells washed with 5 ml of room-temperature PBS.&#10;Conditioned medium was centrifuged at 250×g for 10 minutes and 0.5 ml of the supernatant was collected and supplemented with 1× protease inhibitor cocktail (Roche Applied Science).&#10;Human brain anterior cingulate tissue samples were prepared by homogenizing ~0.5 mg tissue in RIPA buffer supplemented with 1× protease inhibitor cocktail, centrifuging at 14,000×g for 10 minutes at 4°C, and then collecting the supernatant.&#10;After the protein concentration of each sample was determined (Micro BCA Protein Assay Reagent Kit, Pierce, Rockford, IL), 15 or 20 µg protein were mixed with SDS sample loading buffer containing β-mercaptoethanol, boiled for 5 minutes and subjected to polyacrylamide gel electrophoresis on a 7.5% polyacrylamide gel.&#10;Proteins were transferred to nitrocellulose membranes (Bio-Rad).&#10;The blots were then incubated with 5% nonfat dry milk for 1 hour at room temperature and probed overnight with mouse anti-V5 antibody (1:5000 dilution, Abcam) or mouse anti-clusterin antibody (1:200, B-5 Santa-Cruz) at 4°C. After washing with PBST four times for 5 minutes each, the blots were incubated with peroxidase-conjugated sheep anti-mouse antibody (1:1,000 dilution, Jackson ImmunoResearch) for 1 hour at room temperature.&#10;Bound peroxidase was visualized by using a Super&#10;Signal West Pico kit (Pierce) and a molecular imager (ChemiDoc XRS System, Bio-Rad).&#10;For studies involving PNGase F digestion, each protein sample was treated with PNGase F as directed by the manufacturer (New England Biolabs, Ipswich, MA).&#10;Samples were then analyzed by Western blot as described above.&#10;Results Top To begin to evaluate CLU expression, we screened human brain cDNA to identify CLU isoforms present in brain.&#10;Previously reported isoforms include CLU1 and CLU2, which are identical in exons 2–9 but differ in exon 1, as well as isoforms lacking exons 2 or 5 ([21], [22], reviewed in [20]).&#10;RT-PCR analyses of pooled human brain cDNA samples detected only CLU1 and CLU2 (Figure 1A–1B).&#10;CLU2 translation is predicted to result in a secreted protein, beginning at the initial ATG in exon 2 that is common to both CLU2 and CLU1 (Figure 1C).&#10;In contrast, CLU1 translation is predicted to initiate at an ATG within its exon 1, which is in-frame with the ATG site in the common exon 2.&#10;Hence, CLU1 is predicted to encode a protein identical to that encoded by CLU2 except that the CLU1 protein would contain 52 additional amino acids at its amino terminus (Figure 1C).&#10;This change is predicted by PSORTII to result in an intracellular and likely nuclear, form of clusterin (reviewed in [20]).&#10;In summary, CLU1 and CLU2 are the primary CLU isoforms in brain and are predicted to encode intracellular and secreted proteins, respectively.&#10;CLU1 and CLU2 are the primary CLU isoforms expressed in human brain.&#10;The exon layout for the CLU1 and CLU2 isoforms is shown (A).&#10;Coding and non-coding exonic regions are represented by black and white boxes, respectively, while introns are shown as thin black lines.&#10;The first ATG site in each isoform is shown as well.&#10;Evaluation of CLU splicing by RT-PCR identified only CLU1 and CLU2 in human brain cDNA (B), i.e., single PCR products are observed upon amplification from exon 1a – exon 5 (lane 1), exon 1b – exon 5 (lane 2), exon 4 – exon 6 (lane 3) and exon5 – exon 9 (lane 4).&#10;Molecular weight markers are shown at the left.&#10;The predicted protein sequences encoded by CLU1 and CLU2, beginning with the initial ATG sites shown in A, are shown in panel C. The sequence in gray font is unique to CLU1 while sequence in black font is common to CLU1 and CLU2.&#10;The boxed amino acid sequence represents signal sequence that is removed from clusterin-2 upon its translocation to the ER.&#10;Two nuclear localization sequences, as predicted by PSORT II (http://psort.ims.u-tokyo.ac.jp/form2.htm l), are underlined.&#10;The asterisk shows the clusterin cleavage site that separates the α- and β- subunits.&#10;g001 To evaluate whether rs11136000, the primary AD-related CLU SNP [15], [16], [17], [18], [19], is associated with CLU expression, we quantified CLU1 and CLU2 expression in a series of brain samples.&#10;The CLU isoforms were quantified in separate real-time PCR assays that used forward primers corresponding to their unique exon 1 and a common reverse primer that targeted the exon 2–3 boundary.&#10;Copy numbers were determined relative to a standard curve for each isoform and normalized to the geometric mean of housekeeping genes [23], [32].&#10;The expression of CLU1 and CLU2 were modestly coordinately regulated (Figure 2A), with CLU2 being consistently greater than CLU1; the overall CLU2: CLU1 ratio was 3.35±1.84 (mean ± SD, n = 51).&#10;To gain further insights into CLU isoform expression, we quantified CLU1 and CLU2 in a series of single human fetal tissue samples as well as a set of six adult choroid plexus samples (Figure 2B).&#10;Among the fetal tissues, the CLU2: CLU1 ratio varied widely from 0.3 (skin) to 6.2 (kidney) (Figure 2B).&#10;The CLU2:CLU1 ratio in choroid plexus, which produces cerebrospinal fluid, was 5.72±0.65 (mean ± SD, n = 6).&#10;Expression of CLU isoforms in human tissues.&#10;CLU1 and CLU2 isoforms were quantified by isoform-specific RT-PCR in a series of adult human cingulate and choroid plexus samples (A–B) as well as a human fetal tissues (B).&#10;Within A, each marker reflects the expression of CLU1 and CLU2, normalized to housekeeping genes, in a single brain sample.&#10;Within B, the value in parentheses following the tissue name is the CLU1:CLU2 ratio.&#10;CLU1 expression shows a positive association with AD neuropathology and rs11136000T allele (C).&#10;CLU2 expression was increased in individuals with AD pathology and decreased with age (D–E).&#10;g002 We next evaluated CLU isoform expression as a function of AD neuropathology, rs11136000 status, sex and age.&#10;We found that CLU1 expression was significantly increased with high AD neuropathology and the minor rs11136000T allele (Figure 2C, Table 2).&#10;In contrast, CLU2 expression was significantly increased with AD neuropathology but not rs11136000 genotype, and decreased with age (Figure 2D–E, Table 3).&#10;Overall, both CLU1 and CLU2 expression was increased with AD, confirming prior reports.&#10;However, only CLU1 expression was associated with rs11136000.&#10;Since the minor rs11136000T allele was associated with both increased CLU1 expression and reduced AD risk [15], [16], [17], [18], [19], we interpret these results as suggesting that increased CLU1 expression is associated with reduced AD risk.&#10;t003 CLU1 and CLU2 are predicted to encode intracellular and secreted proteins, respectively (Figure 1).&#10;Therefore, we evaluated the proteins produced by CLU1 and CLU2 transfected cells to discern whether these corresponded to the intracellular and secreted forms of clusterin that have been reported [4], [8], [33].&#10;When each isoform was transiently transfected into neural SH-SY5Y cells, immunofluorescence analyses showed a similar subcellular localization pattern (Figure 3).&#10;The proteins produced by CLU1 and CLU2 tended to concentrate within the Golgi apparatus, as established by double-labeling with an antibody against trans-Golgi network protein 46 (TGN46) (Figure 3A).&#10;Relatively modest amounts of clusterin were also detected within the endoplasmic reticulum (ER), as established by double labeling with calnexin (Figure 3B).&#10;Nuclear, cytosolic, or mitochondrial-associated clusterin was not observed.&#10;Hence, the clusterin produced by CLU1 and CLU2 manifests an intracellular localization that includes the ER and Golgi, consistent with a possible secretory pathway for both proteins.&#10;CLU1 and CLU2 encoded proteins are localized to the ER and Golgi.SH-SY5Y cells were transfected with vectors encoding CLU1 and CLU2; the resultant clusterin expression was localized by a vector-derived V5 epitope tag.&#10;The subcellular localization for both proteins overlapped with the Golgi, as shown by co-labeling with antibody against TGN46 (A) and with the ER, as shown by co-labeling with an antibody against calnexin (B).&#10;g003 CLU1 is predicted to encode a 501 amino acid protein with a molecular weight of 57.8 kDa while CLU2 is predicted to encode 449 amino acids, totaling 52.5 kDa.&#10;During maturation of secreted clusterin, the protein is N-glycosylated and proteolyzed to generate a heterodimer that is maintained by disulfide bonds [20].&#10;To compare the size of the proteins produced by CLU1 and CLU2, we performed Western blot analyses of transfected SH-SY5Y cells; ectopic clusterin was detected via a V5 epitope tag (Figure 4 A–B).&#10;Cell lysates contained both intact and cleaved clusterin while conditioned medium contained only cleaved clusterin; the clusterin protein produced by CLU1 and CLU2 appeared equal in size (Figure 4A).&#10;To discern whether glycosylation differences may obscure differences in the clusterin molecular weight derived from their primary sequence, the protein mixtures were digested with PNGase F to remove N-linked sugars prior to electrophoresis; the size of the proteins produced by CLU1 and CLU2 transfected cells were both decreased similarly by PNGase treatment (Figure 4B).&#10;We considered the possibility that CLU translation may show cell-type specificity, and therefore repeated this study in an unrelated cell line by transfecting CLU1 and CLU2 into HepG2 cells.&#10;As with the SH-SY5Y cells, CLU1 and CLU2 transfected cells produced clusterin of similar size, even after PNGase F digestion (Figure 4C).&#10;Hence, we found no evidence to suggest that the proteins produced by CLU1 and CLU2 differ in cellular localization, size, glycosylation, or proteolytic cleavage.&#10;Rather, when these Western blot studies are considered in combination with the immunofluorescence studies, CLU1 and CLU2 appear to produce equivalent proteins that are similarly translated, glycosylated, and cleaved as they pass through the ER and Golgi in the secretory pathway to the extracellular space.&#10;CLU1 and CLU2 produce clusterin proteins that are similar to each other and to clusterin in human brain.&#10;Transfection of CLU1 and CLU2 resulted in proteins of similar size, appearing as both intact and cleaved clusterin in cell lysates and conditioned media; the proteins resulting from CLU transfection were detected via their V5 epitope tag (A–B).&#10;PNGase F treatment prior to electrophoresis reduced the size of the proteins produced by CLU1 and CLU2 similarly (B).&#10;The apparent doublet in the protein encoded by CLU1 at 37 kDa was variable between experiments and likely reflects incomplete glycosylation as the doublet collapsed to a single band after PNGase F digestion.&#10;Results similar to those depicted in B were obtained when CLU1 and CLU2 were transfected into HepG2 cells (C).&#10;When transfected and endogenous clusterin proteins were detected with an antibody raised against a carboxyl-terminal clusterin epitope (D–E), intact clusterin from transfection (T-labeled arrow) was slightly larger than endogenous clusterin (E-labeled arrow), reflecting the ~5.1 kDa V5 epitope and His tags in the ectopic clusterin (D).&#10;The bands labeled “Fragments” are clusterin alpha subunits derived from variably glycosylated endogenous and transfected clusterin.&#10;Overall, the cellular clusterin proteins are similar in size to the human brain clusterin, as discerned for the intact and cleaved clusterin under reducing conditions (D) or as the heterodimeric clusterin under non-reducing conditions (E).&#10;g004 To evaluate whether the clusterin proteins produced by CLU1 and CLU2 in vitro are similar to those produced in vivo, we compared ectopic clusterin with endogenous clusterin in SH-SY5Y cells and in human brain by Western blotting with a clusterin antibody.&#10;Endogenous clusterin in SH-SY5Y cells migrates at a slightly lower molecular weight than that resulting from CLU transfection, reflecting the 5.1 kDa V5/His tag encoded by the pcDNA3.1 vector expressing transfected CLU (Figure 4D).&#10;Importantly, this 5.1 kDa size difference between endogenous and transfected clusterin is similar to the size difference between the CLU1 and CLU2-predicted proteins, indicating that if the proteins encoded by CLU1 and CLU2 differed by 5 kDa, the proteins would be resolved easily under these experimental conditions.&#10;The endogenous SH-SY5Y clusterin migrates similarly to the intact protein detected in brain homogenates suggesting these cellular forms are similar to those present in vivo (Figure 4D).&#10;To extend this analysis to the heterodimeric form of clusterin, we also performed electrophoresis under non-reducing conditions.&#10;We found that heterodimeric protein from CLU1 and CLU2 transfected cells appeared similar in size to each other and to the forms found in brain (Figure 4E).&#10;Hence, CLU1 and CLU2 produce proteins in vitro that are similar in size to endogenous clusterin in vitro and human brain.&#10;Discussion Top The main findings of this report are several.&#10;First, CLU1 and CLU2 are the primary CLU isoforms in human brain and differ in their first exon and proximal promoter.&#10;Second, the expression of only CLU1 was associated with rs11136000 while both CLU1 and CLU2 were increased with robust AD neuropathology.&#10;Third, CLU1 and CLU2 produce secreted clusterin proteins that are similar to each other and to clusterin in human brain.&#10;Since CLU is increased in AD and CLU1 is increased with the minor rs11136000T allele, which is also associated with reduced AD risk, we interpret our results as suggesting that increased CLU expression throughout life may reduce AD risk.&#10;Overall, these results identify a possible means underlying the association of rs11136000 with AD risk.&#10;The association between CLU expression and rs11136000 was discerned because the CLU isoforms were analyzed separately.&#10;For example, when we analyzed total CLU expression in the same fashion as reported here, total CLU was not associated with rs11136000 (p = 0.51) although a robust association with AD pathology was observed (p = 0.005, Ling et al., unpublished observations).&#10;The lack of a significant association between rs11136000 and total CLU is somewhat disconcerting since CLU1 and CLU2 appear to produce a similar protein.&#10;We speculate that (i) the threshold for clusterin biological significance may be less than the threshold for overall CLU statistical significance and/or (ii) CLU1 may be enriched in a cell type different than CLU2, which may affect its functionality.&#10;We note that the lack of an association between total CLU and rs11136000 was similar to prior reports that total CLU mRNA or clusterin protein were not associated with rs11136000 [17], [34].&#10;As the clusterin produced by CLU1 and CLU2 appears similar, discerning an association between rs11136000 and clusterin would be especially challenging in tissues with a large proportion of CLU2.&#10;In this regard, CLU2 was the major isoform in choroid plexus, suggesting that an association between cerebrospinal fluid clusterin and rs11136000 would be difficult to detect.&#10;The differential regulation of CLU1 and CLU2 was not unexpected because CLU1 and CLU2 have separate proximal promoter regions.&#10;Consistent with this observation, Cochrane et al found that androgen-treatment in a prostate cancer cell line decreased CLU1 expression while enhancing CLU2 expression [35].&#10;Although the identification of the functional SNPs and transcription factors that modulate CLU expression is beyond the scope of this report, we note that rs11136000 resides within intron 3 and is common to both CLU1 and CLU2.&#10;Hence, rs11136000 is likely not functional but rather is in linkage with a functional SNP more proximal to the CLU1 promoter.&#10;In summary, the association between rs11136000 and CLU1 was dependent upon analyzing the two CLU isoforms separately.&#10;Since earlier predictions were that CLU2 encodes a secreted protein while the additional 52 amino-terminal residues encoded by CLU1 would result in its intracellular localization [20], we expected clusterin in CLU1 and CLU2 transfected cells to differ in cellular locale and size.&#10;In support of this prediction, the ATG translation initiation sites in the CLU1-specific exon 1a as well as the common exon 2 both satisfy Kozak consensus sequence requirements (http://bioinfo.iitk.ac.in/AUGPred/).&#10;However, clusterin in CLU1 and CLU2 transfected cells was localized to the secretory pathway and was equivalent in size under conditions that would easily discern their predicted five kDa size difference, especially after PNGase F treatment to remove sugar residues.&#10;Hence, CLU1 and CLU2 produce similar secreted proteins in vitro.&#10;Comparable results were obtained in two cell types, suggesting that CLU1 and CLU2 generally produce soluble clusterin protein.&#10;The most parsimonious interpretation of these data is that CLU1 translation is generally initiated at the common exon 2 ATG.&#10;The possibility exists that a portion of CLU1 translation is initiated at the exon 1a ATG at levels too low to be readily detected or that produce an unstable protein which is rapidly degraded.&#10;Distinguishing among these possibilities is a future direction for this work.&#10;Overall, we summarize our current results by noting that the proteins produced from CLU1 and CLU2 in vitro are similar to each other, and similar in size to those present in human brain, leading us to interpret our data as supporting the possibility that CLU1 and CLU2 generally produce secreted clusterin protein in vitro and in vivo.&#10;A logical extension of the finding that AD risk is reduced with a genetic variant that correlates with increased CLU expression is that other factors that increase CLU expression may also reduce AD risk.&#10;Furthermore, since CLU expression is increased in AD without reversing the disease, we speculate that enhanced CLU expression reduces AD risk only if CLU expression is increased well before AD onset, mimicking the likely SNP effects.&#10;One possible modulator of interest is age-dependent changes in sex hormones since CLU isoforms are differentially regulated by androgens [35].&#10;Stress has also been shown to upregulate CLU in many instances [36] and may cause the AD-associated increase in CLU observed here.&#10;In terms of possible therapeutic agents, multiple histone deacetylase inhibitors increase CLU expression robustly in vitro [37].&#10;Interestingly, one member of this class, valproate, increases CLU expression in human astrocytes [37] and reduces amyloid accumulation as well as behavioral deficits in mouse amyloid models [38], [39].&#10;While valproate may also act via other mechanisms [38], the actions of valproate on CLU expression may be relevant to its neuroprotection and merit further exploration to reduce AD risk.&#10;Limitations of this study include that rs11136000 and AD neuropathological status capture only ~20% of the variance in CLU expression.&#10;Identifying the unknown factors that account for the additional variance, which could include epigenetic factors, will facilitate understanding of CLU expression.&#10;Moreover, variability in these factors could facilitate or obscure the SNP association with CLU1 expression described here, suggesting that replication of these data in additional samples is necessary for their acceptance by the research community.&#10;Additionally, since the nuclear form of clusterin arising from an isoform lacking exon 2 has been associated with apoptosis [21], [22], this isoform may be transientlyexpressed and hence below our limits of detection, especially in comparison with CLU1 and CLU2.&#10;In conclusion, the AD-protective allele of rs11136000 was associated with increased expression of CLU1 but not CLU2 in our dataset.&#10;Both CLU1 and CLU2 produce a soluble, secreted clusterin protein that is similar to that observed in human brain.&#10;Discerning the association between rs11136000 and CLU1 depended upon analyzing these two CLU isoforms separately.&#10;Acknowledgments Top The authors gratefully acknowledge tissue supplied by the University of Kentucky AD Center and Ishita Parikh for technical assistance.&#10;Author Contributions Top Conceived and designed the experiments: IL SE.&#10;Find this article online Holtzman DM (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.&#10;Find this article online Bertram L, Tanzi REAlzheimer disease: New light on an old CLU.&#10;Find this article online (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease.&#10;The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.&#10;Find this article online Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, et al. (1999) The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.&#10;" sentenceList="13 854 7266 7281 7296 7311 7326 7341 7356 2051 4656 7377 7392 7407 7422 222 7440 7455 7470 7485 7500 7515 7530 7545 7560 7575 908 7593 129 7611 7626 894 7644 7659 7674 7689 79 7707 7722 7737 7752 7767 7782 7797 7812 922 7830 7845 7860 7875 182 7893 7908 7923 7938 7953 7968 7983 7998 2037 8016 8031 8046 8061 8076 8091 8106 8121 2065 8139 8154 8169 8184 8199 8214 8229 8244 8259 8274 8289 8304 8319 8334 8349 8364 8379 8394 8409 8424 8439 8454 8469 8484 8499 8514 8529 8544 8559 8574 8589 8604 8619 8634 8649 8664 8679 8694 8709 8724 8739 8754 8769 8784 8799 8814 8829 8844 8859 8874 8889 8904 8919 8934 8949 8964 8979 8994 9009 9024 9039 9054 9069 9084 9099 9114 9129 9144 9159 9174 9189 9204 9219 9234 9249 9264 9279 9294 9309 9324 9339 9354 9369 9384 9399 9414 9429 9444 9459 9474 9489 9504 9519 9534 9549 9564 9579 9594 9609 9624 9639 9654 9669 9684 9699 9714 9729 9744 9759 9774 9789 9804 9819 9834 9849 9864 9879 9894 9909 9924" qaList="7002 7012 7022 7032 7042 7052 7062 7072 7082 7092"/><types:CurrentExecution xmi:id="14668" sofa="1" begin="0" end="0" idHash="6655a117e4ce9d8ea30cf971997f534c"/><types:CurrentExecution xmi:id="14673" sofa="1" begin="0" end="0" idHash="343e8909cfcacdf757b628d5a60f47eb"/><types:CurrentExecution xmi:id="14678" sofa="1" begin="0" end="0" idHash="3a6ee6312f95e4140cf2e8cca3f0efd8"/><types:CurrentExecution xmi:id="14683" sofa="1" begin="0" end="0" idHash="5569fe35b1b4ecfe9e233fd932cadebb"/><types:CurrentExecution xmi:id="14688" sofa="1" begin="0" end="0" idHash="13217d6e4edab97ed6adf46ffadeb14c"/><types:CurrentExecution xmi:id="14693" sofa="1" begin="0" end="0" idHash="54f20794eb777b72410f03891b1f9154"/><types:CurrentExecution xmi:id="14698" sofa="1" begin="0" end="0" idHash="35321652e6660c232b7d54a26cc75f66"/><types:CurrentExecution xmi:id="14703" sofa="1" begin="0" end="0" idHash="8399bc3343b6f2500625f8c4dc561be2"/><types:CurrentExecution xmi:id="14708" sofa="1" begin="0" end="0" idHash="1dc33221de6d653e3e22c2a750187307"/><types:CurrentExecution xmi:id="14713" sofa="1" begin="0" end="0" idHash="a08066e9b74229e73b6fb8c5ffd64727"/><types:CurrentExecution xmi:id="17675" sofa="1" begin="0" end="0" idHash="85c0fe4dac184ec7ff3bd6f9c53809c0"/><types:InputElement xmi:id="14718" sofa="1" begin="0" end="0" sequenceId="0" dataset="QA4MRE-ALZHEIMER"/><types:ProcessingStep xmi:id="14727" sofa="1" begin="0" end="0" phaseId="1" component="TextSegmenter[NOISE_THRESHOLD:0.2]" casId="6655a117e4ce9d8ea30cf971997f534c"/><types:ProcessingStep xmi:id="14734" sofa="1" begin="0" end="0" phaseId="9" component="QuestionNEAnnotator" casId="343e8909cfcacdf757b628d5a60f47eb"/><types:ProcessingStep xmi:id="14741" sofa="1" begin="0" end="0" phaseId="10" component="SynonymAnnotator[FILE_NAME:model/synonym/gene_ontology_ext.obo#GIGA_WORD:model/synonym/cmudict.0.7a.gigaword.freq]" casId="3a6ee6312f95e4140cf2e8cca3f0efd8"/><types:ProcessingStep xmi:id="14748" sofa="1" begin="0" end="0" phaseId="7" component="QuestionPhraseAnnotator" casId="5569fe35b1b4ecfe9e233fd932cadebb"/><types:ProcessingStep xmi:id="14755" sofa="1" begin="0" end="0" phaseId="3" component="NoiseFilter[QUALITY_THRESHOLD:0.75#MIN_WORDS:5#MIN_LENGTH:25]" casId="13217d6e4edab97ed6adf46ffadeb14c"/><types:ProcessingStep xmi:id="14762" sofa="1" begin="0" end="0" phaseId="11" component="QASynonymAnnotator[FILE_NAME:data/gene_ontology_ext.obo#GIGA_WORD:data/cmudict.0.7a.gigaword.freq]" casId="54f20794eb777b72410f03891b1f9154"/><types:ProcessingStep xmi:id="14769" sofa="1" begin="0" end="0" phaseId="6" component="PhraseAnnotator" casId="35321652e6660c232b7d54a26cc75f66"/><types:ProcessingStep xmi:id="14776" sofa="1" begin="0" end="0" phaseId="2" component="StanfordSentenceAnnotator[NOISE_THRESHOLD:0.2]" casId="8399bc3343b6f2500625f8c4dc561be2"/><types:ProcessingStep xmi:id="14783" sofa="1" begin="0" end="0" phaseId="8" component="NEAnnotator" casId="1dc33221de6d653e3e22c2a750187307"/><types:ProcessingStep xmi:id="14790" sofa="1" begin="0" end="0" phaseId="5" component="StanfordQuestionNLPAnnotator[NOISE_THRESHOLD:0.2]" casId="a08066e9b74229e73b6fb8c5ffd64727"/><types2:Synonym xmi:id="121" sofa="1" begin="0" end="0" text="RNA-directed DNA polymerase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="9966" sofa="1" begin="0" end="0" text="beta-NADH dehydrogenase dinucleotide" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="9976" sofa="1" begin="0" end="0" text="dihydrocodehydrogenase I dehydrogenase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="9986" sofa="1" begin="0" end="0" text="dihydronicotinamide adenine dinucleotide dehydrogenase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="9996" sofa="1" begin="0" end="0" text="diphosphopyridine diaphorase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10006" sofa="1" begin="0" end="0" text="diphosphopyrinase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10016" sofa="1" begin="0" end="0" text="DPNH diaphorase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10026" sofa="1" begin="0" end="0" text="NADH diaphorase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10036" sofa="1" begin="0" end="0" text="NADH hydrogenase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10046" sofa="1" begin="0" end="0" text="NADH oxidoreductase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10056" sofa="1" begin="0" end="0" text="NADH-menadione oxidoreductase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10066" sofa="1" begin="0" end="0" text="NADH2 dehydrogenase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10076" sofa="1" begin="0" end="0" text="NADH:(acceptor) oxidoreductase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10086" sofa="1" begin="0" end="0" text="NADH:acceptor oxidoreductase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10096" sofa="1" begin="0" end="0" text="NADH:cytochrome c oxidoreductase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10106" sofa="1" begin="0" end="0" text="reduced diphosphopyridine nucleotide diaphorase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10116" sofa="1" begin="0" end="0" text="NADH:plastoquinone reductase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10127" sofa="1" begin="0" end="0" text="cytochrome-c oxidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="10403" sofa="1" begin="0" end="0" text="HDAC" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="11788" sofa="1" begin="0" end="0" text="peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="12056" sofa="1" begin="0" end="0" text="peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="12208" sofa="1" begin="0" end="0" text="endoplasmic reticulum" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="12297" sofa="1" begin="0" end="0" text="endoplasmic reticulum" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13443" sofa="1" begin="0" end="0" text="bacterial catalase-peroxidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13453" sofa="1" begin="0" end="0" text="donor:hydrogen-peroxide oxidoreductase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13463" sofa="1" begin="0" end="0" text="eosinophil peroxidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13473" sofa="1" begin="0" end="0" text="lactoperoxidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13483" sofa="1" begin="0" end="0" text="myeloperoxidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13493" sofa="1" begin="0" end="0" text="oxyperoxidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13503" sofa="1" begin="0" end="0" text="secretory plant peroxidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13560" sofa="1" begin="0" end="0" text="peptidase" source="gigaword-pubmed" weight="1.0"/><types2:Synonym xmi:id="13585" sofa="1" begin="0" end="0" text="peptidase" source="gigaword-pubmed" weight="1.0"/><cas:NonEmptyFSList xmi:id="259" head="520" tail="527"/><cas:NonEmptyFSList xmi:id="266" head="269" tail="276"/><cas:NonEmptyFSList xmi:id="946" head="1192" tail="1199"/><cas:NonEmptyFSList xmi:id="955" head="958" tail="965"/><cas:NonEmptyFSList xmi:id="1536" head="1751" tail="1758"/><cas:NonEmptyFSList xmi:id="1545" head="1548" tail="1555"/><cas:NonEmptyFSList xmi:id="2126" head="2338" tail="2345"/><cas:NonEmptyFSList xmi:id="2135" head="2138" tail="2145"/><cas:NonEmptyFSList xmi:id="2634" head="2785" tail="2792"/><cas:NonEmptyFSList xmi:id="2643" head="2646" tail="2653"/><cas:NonEmptyFSList xmi:id="2985" head="3127" tail="3134"/><cas:NonEmptyFSList xmi:id="2994" head="2997" tail="3004"/><cas:NonEmptyFSList xmi:id="3279" head="3420" tail="3427"/><cas:NonEmptyFSList xmi:id="3288" head="3291" tail="3298"/><cas:NonEmptyFSList xmi:id="3620" head="3772" tail="3779"/><cas:NonEmptyFSList xmi:id="3629" head="3632" tail="3639"/><cas:NonEmptyFSList xmi:id="3948" head="4100" tail="4107"/><cas:NonEmptyFSList xmi:id="3957" head="3960" tail="3967"/><cas:NonEmptyFSList xmi:id="4276" head="4417" tail="4424"/><cas:NonEmptyFSList xmi:id="4285" head="4288" tail="4295"/><cas:NonEmptyFSList xmi:id="4626" head="4629" tail="4636"/><cas:NonEmptyFSList xmi:id="4689" head="4692" tail="4699"/><cas:NonEmptyFSList xmi:id="4748" head="4751" tail="4758"/><cas:NonEmptyFSList xmi:id="4797" head="4800" tail="4807"/><cas:NonEmptyFSList xmi:id="4889" head="4892" tail="4899"/><cas:NonEmptyFSList xmi:id="4959" head="4962" tail="4969"/><cas:NonEmptyFSList xmi:id="5008" head="5011" tail="5018"/><cas:NonEmptyFSList xmi:id="5057" head="5060" tail="5067"/><cas:NonEmptyFSList xmi:id="5106" head="5109" tail="5116"/><cas:NonEmptyFSList xmi:id="5167" head="5170" tail="5177"/><cas:NonEmptyFSList xmi:id="5218" head="5221" tail="5228"/><cas:NonEmptyFSList xmi:id="5312" head="5315" tail="5322"/><cas:NonEmptyFSList xmi:id="5361" head="5364" tail="5371"/><cas:NonEmptyFSList xmi:id="5422" head="5425" tail="5432"/><cas:NonEmptyFSList xmi:id="5471" head="5474" tail="5481"/><cas:NonEmptyFSList xmi:id="5510" head="5513" tail="5520"/><cas:NonEmptyFSList xmi:id="5549" head="5552" tail="5559"/><cas:NonEmptyFSList xmi:id="5588" head="5591" tail="5598"/><cas:NonEmptyFSList xmi:id="5627" head="5630" tail="5637"/><cas:NonEmptyFSList xmi:id="5666" head="5669" tail="5676"/><cas:NonEmptyFSList xmi:id="5705" head="5708" tail="5715"/><cas:NonEmptyFSList xmi:id="5744" head="5747" tail="5754"/><cas:NonEmptyFSList xmi:id="5783" head="5786" tail="5793"/><cas:NonEmptyFSList xmi:id="5870" head="5873" tail="5880"/><cas:NonEmptyFSList xmi:id="5909" head="5912" tail="5919"/><cas:NonEmptyFSList xmi:id="5948" head="5951" tail="5958"/><cas:NonEmptyFSList xmi:id="5987" head="5990" tail="5997"/><cas:NonEmptyFSList xmi:id="6060" head="6063" tail="6070"/><cas:NonEmptyFSList xmi:id="6090" head="6093" tail="6100"/><cas:NonEmptyFSList xmi:id="6129" head="6132" tail="6139"/><cas:NonEmptyFSList xmi:id="6168" head="6171" tail="6178"/><cas:NonEmptyFSList xmi:id="6207" head="6210" tail="6217"/><cas:NonEmptyFSList xmi:id="6246" head="6249" tail="6256"/><cas:NonEmptyFSList xmi:id="6285" head="6288" tail="6295"/><cas:NonEmptyFSList xmi:id="6324" head="6327" tail="6334"/><cas:NonEmptyFSList xmi:id="6363" head="6366" tail="6373"/><cas:NonEmptyFSList xmi:id="6404" head="6407" tail="6414"/><cas:NonEmptyFSList xmi:id="6454" head="6457" tail="6464"/><cas:NonEmptyFSList xmi:id="6493" head="6496" tail="6503"/><cas:NonEmptyFSList xmi:id="6534" head="6537" tail="6544"/><cas:NonEmptyFSList xmi:id="6584" head="6587" tail="6594"/><cas:NonEmptyFSList xmi:id="6623" head="6626" tail="6633"/><cas:NonEmptyFSList xmi:id="6664" head="6667" tail="6674"/><cas:NonEmptyFSList xmi:id="6716" head="6719" tail="6726"/><cas:NonEmptyFSList xmi:id="6766" head="6769" tail="6776"/><cas:NonEmptyFSList xmi:id="6805" head="6808" tail="6815"/><cas:NonEmptyFSList xmi:id="6844" head="6847" tail="6854"/><cas:NonEmptyFSList xmi:id="6883" head="6886" tail="6893"/><cas:NonEmptyFSList xmi:id="6922" head="6925" tail="6932"/><cas:NonEmptyFSList xmi:id="6961" head="6964" tail="6971"/><cas:NonEmptyFSList xmi:id="16225" head="2092" tail="16228"/><cas:NonEmptyFSList xmi:id="17183" head="1126" tail="17186"/><cas:NonEmptyFSList xmi:id="17196" head="3085" tail="17199"/><cas:NonEmptyFSList xmi:id="17206" head="2296" tail="17209"/><cas:NonEmptyFSList xmi:id="17216" head="467" tail="17219"/><cas:NonEmptyFSList xmi:id="17232" head="2754" tail="17235"/><cas:NonEmptyFSList xmi:id="17239" head="3389" tail="17242"/><cas:NonEmptyFSList xmi:id="17246" head="3730" tail="17249"/><cas:NonEmptyFSList xmi:id="17256" head="4058" tail="17259"/><cas:NonEmptyFSList xmi:id="17266" head="1696" tail="17269"/><cas:NonEmptyFSList xmi:id="17276" head="4386" tail="17279"/><cas:NonEmptyFSList xmi:id="17283" head="4720" tail="17286"/><cas:NonEmptyFSList xmi:id="17287" head="6855" tail="17290"/><cas:NonEmptyFSList xmi:id="17291" head="4769" tail="17294"/><cas:NonEmptyFSList xmi:id="17295" head="5188" tail="17298"/><cas:NonEmptyFSList xmi:id="17299" head="4647" tail="17302"/><cas:NonEmptyFSList xmi:id="17303" head="4848" tail="17306"/><cas:NonEmptyFSList xmi:id="17310" head="5443" tail="17313"/><cas:NonEmptyFSList xmi:id="17314" head="6140" tail="17317"/><cas:NonEmptyFSList xmi:id="17318" head="5078" tail="17321"/><cas:NonEmptyFSList xmi:id="17322" head="5382" tail="17325"/><cas:NonEmptyFSList xmi:id="17326" head="6335" tail="17329"/><cas:NonEmptyFSList xmi:id="17330" head="5881" tail="17333"/><cas:NonEmptyFSList xmi:id="17334" head="6738" tail="17337"/><cas:NonEmptyFSList xmi:id="17338" head="4980" tail="17341"/><cas:NonEmptyFSList xmi:id="17342" head="6426" tail="17345"/><cas:NonEmptyFSList xmi:id="17346" head="6465" tail="17349"/><cas:NonEmptyFSList xmi:id="17350" head="5521" tail="17353"/><cas:NonEmptyFSList xmi:id="17354" head="5959" tail="17357"/><cas:NonEmptyFSList xmi:id="17358" head="6777" tail="17361"/><cas:NonEmptyFSList xmi:id="17362" head="5273" tail="17365"/><cas:NonEmptyFSList xmi:id="17369" head="5998" tail="17372"/><cas:NonEmptyFSList xmi:id="17373" head="5560" tail="17376"/><cas:NonEmptyFSList xmi:id="17377" head="5127" tail="17380"/><cas:NonEmptyFSList xmi:id="17381" head="6933" tail="17384"/><cas:NonEmptyFSList xmi:id="17385" head="6686" tail="17388"/><cas:NonEmptyFSList xmi:id="17389" head="4931" tail="17392"/><cas:NonEmptyFSList xmi:id="17393" head="6634" tail="17396"/><cas:NonEmptyFSList xmi:id="17397" head="6257" tail="17400"/><cas:NonEmptyFSList xmi:id="17401" head="6296" tail="17404"/><cas:NonEmptyFSList xmi:id="17405" head="5333" tail="17408"/><cas:NonEmptyFSList xmi:id="17409" head="6595" tail="17412"/><cas:NonEmptyFSList xmi:id="17413" head="6894" tail="17416"/><cas:NonEmptyFSList xmi:id="17417" head="5794" tail="17420"/><cas:NonEmptyFSList xmi:id="17421" head="6101" tail="17424"/><cas:NonEmptyFSList xmi:id="17425" head="5482" tail="17428"/><cas:NonEmptyFSList xmi:id="17429" head="5599" tail="17432"/><cas:NonEmptyFSList xmi:id="17433" head="5755" tail="17436"/><cas:NonEmptyFSList xmi:id="17437" head="5716" tail="17440"/><cas:NonEmptyFSList xmi:id="17441" head="5677" tail="17444"/><cas:NonEmptyFSList xmi:id="17445" head="5638" tail="17448"/><cas:NonEmptyFSList xmi:id="17449" head="6556" tail="17452"/><cas:NonEmptyFSList xmi:id="17453" head="5029" tail="17456"/><cas:NonEmptyFSList xmi:id="17457" head="5920" tail="17460"/><cas:NonEmptyFSList xmi:id="17461" head="6179" tail="17464"/><cas:NonEmptyFSList xmi:id="17465" head="6816" tail="17468"/><cas:NonEmptyFSList xmi:id="17469" head="6218" tail="17472"/><cas:NonEmptyFSList xmi:id="17473" head="6374" tail="17476"/><cas:NonEmptyFSList xmi:id="17477" head="6504" tail="17480"/><cas:NonEmptyFSList xmi:id="17481" head="6972" tail="17484"/><cas:EmptyFSList xmi:id="17485"/><cas:EmptyFSList xmi:id="17486"/><cas:EmptyFSList xmi:id="17487"/><cas:EmptyFSList xmi:id="17488"/><cas:EmptyFSList xmi:id="17489"/><cas:EmptyFSList xmi:id="17490"/><cas:EmptyFSList xmi:id="17491"/><cas:EmptyFSList xmi:id="17492"/><cas:EmptyFSList xmi:id="17493"/><cas:EmptyFSList xmi:id="17494"/><cas:EmptyFSList xmi:id="17495"/><cas:EmptyFSList xmi:id="17496"/><cas:EmptyFSList xmi:id="17497"/><cas:EmptyFSList xmi:id="17498"/><cas:EmptyFSList xmi:id="17499"/><cas:EmptyFSList xmi:id="17500"/><cas:EmptyFSList xmi:id="17501"/><cas:EmptyFSList xmi:id="17502"/><cas:EmptyFSList xmi:id="17503"/><cas:EmptyFSList xmi:id="17504"/><cas:EmptyFSList xmi:id="17505"/><cas:EmptyFSList xmi:id="17506"/><cas:EmptyFSList xmi:id="17507"/><cas:EmptyFSList xmi:id="17508"/><cas:EmptyFSList xmi:id="17509"/><cas:EmptyFSList xmi:id="17510"/><cas:EmptyFSList xmi:id="17511"/><cas:EmptyFSList xmi:id="17512"/><cas:EmptyFSList xmi:id="17513"/><cas:EmptyFSList xmi:id="17514"/><cas:EmptyFSList xmi:id="17515"/><cas:EmptyFSList xmi:id="17516"/><cas:EmptyFSList xmi:id="17517"/><cas:EmptyFSList xmi:id="17518"/><cas:EmptyFSList xmi:id="17519"/><cas:EmptyFSList xmi:id="17520"/><cas:EmptyFSList xmi:id="17521"/><cas:EmptyFSList xmi:id="17522"/><cas:EmptyFSList xmi:id="17523"/><cas:EmptyFSList xmi:id="17524"/><cas:EmptyFSList xmi:id="17525"/><cas:EmptyFSList xmi:id="17526"/><cas:EmptyFSList xmi:id="17527"/><cas:EmptyFSList xmi:id="17528"/><cas:EmptyFSList xmi:id="17529"/><cas:EmptyFSList xmi:id="17530"/><cas:EmptyFSList xmi:id="17531"/><cas:EmptyFSList xmi:id="17532"/><cas:EmptyFSList xmi:id="17533"/><cas:EmptyFSList xmi:id="17534"/><cas:EmptyFSList xmi:id="17535"/><cas:EmptyFSList xmi:id="17536"/><cas:EmptyFSList xmi:id="17537"/><cas:EmptyFSList xmi:id="17538"/><cas:EmptyFSList xmi:id="17539"/><cas:EmptyFSList xmi:id="17540"/><cas:EmptyFSList xmi:id="17541"/><cas:EmptyFSList xmi:id="17542"/><cas:EmptyFSList xmi:id="17543"/><cas:EmptyFSList xmi:id="17544"/><cas:EmptyFSList xmi:id="17545"/><cas:EmptyFSList xmi:id="17546"/><cas:EmptyFSList xmi:id="17547"/><cas:EmptyFSList xmi:id="17548"/><cas:EmptyFSList xmi:id="17549"/><cas:EmptyFSList xmi:id="17550"/><cas:EmptyFSList xmi:id="17551"/><cas:EmptyFSList xmi:id="17552"/><cas:EmptyFSList xmi:id="17553"/><cas:EmptyFSList xmi:id="17554"/><cas:EmptyFSList xmi:id="17555"/><cas:EmptyFSList xmi:id="17556"/><cas:EmptyFSList xmi:id="17557"/><cas:EmptyFSList xmi:id="17558"/><cas:EmptyFSList xmi:id="17559"/><cas:EmptyFSList xmi:id="17560"/><cas:EmptyFSList xmi:id="17561"/><cas:EmptyFSList xmi:id="17562"/><cas:EmptyFSList xmi:id="17563"/><cas:EmptyFSList xmi:id="17564"/><cas:EmptyFSList xmi:id="17565"/><cas:EmptyFSList xmi:id="17566"/><cas:EmptyFSList xmi:id="17567"/><cas:EmptyFSList xmi:id="17568"/><cas:EmptyFSList xmi:id="17569"/><cas:EmptyFSList xmi:id="17570"/><cas:EmptyFSList xmi:id="17571"/><cas:EmptyFSList xmi:id="17572"/><cas:EmptyFSList xmi:id="17573"/><cas:EmptyFSList xmi:id="17574"/><cas:EmptyFSList xmi:id="17575"/><cas:EmptyFSList xmi:id="17576"/><cas:EmptyFSList xmi:id="17577"/><cas:EmptyFSList xmi:id="17578"/><cas:EmptyFSList xmi:id="17579"/><cas:EmptyFSList xmi:id="17580"/><cas:EmptyFSList xmi:id="17581"/><cas:EmptyFSList xmi:id="17582"/><cas:EmptyFSList xmi:id="17583"/><cas:EmptyFSList xmi:id="17584"/><cas:EmptyFSList xmi:id="17585"/><cas:EmptyFSList xmi:id="17586"/><cas:EmptyFSList xmi:id="17587"/><cas:EmptyFSList xmi:id="17588"/><cas:EmptyFSList xmi:id="17589"/><cas:EmptyFSList xmi:id="17590"/><cas:EmptyFSList xmi:id="17591"/><cas:EmptyFSList xmi:id="17592"/><cas:EmptyFSList xmi:id="17593"/><cas:EmptyFSList xmi:id="17594"/><cas:EmptyFSList xmi:id="17595"/><cas:EmptyFSList xmi:id="17596"/><cas:EmptyFSList xmi:id="17597"/><cas:EmptyFSList xmi:id="17598"/><cas:EmptyFSList xmi:id="17599"/><cas:EmptyFSList xmi:id="17600"/><cas:EmptyFSList xmi:id="17601"/><cas:EmptyFSList xmi:id="17602"/><cas:EmptyFSList xmi:id="17603"/><cas:EmptyFSList xmi:id="17604"/><cas:EmptyFSList xmi:id="17605"/><cas:EmptyFSList xmi:id="17606"/><cas:EmptyFSList xmi:id="17607"/><cas:EmptyFSList xmi:id="17608"/><cas:EmptyFSList xmi:id="17609"/><cas:EmptyFSList xmi:id="17610"/><cas:EmptyFSList xmi:id="17611"/><cas:EmptyFSList xmi:id="17612"/><cas:EmptyFSList xmi:id="17613"/><cas:EmptyFSList xmi:id="17614"/><cas:EmptyFSList xmi:id="17615"/><cas:EmptyFSList xmi:id="17616"/><cas:EmptyFSList xmi:id="17617"/><cas:EmptyFSList xmi:id="17618"/><cas:EmptyFSList xmi:id="17619"/><cas:EmptyFSList xmi:id="17620"/><cas:EmptyFSList xmi:id="17621"/><cas:EmptyFSList xmi:id="17622"/><cas:EmptyFSList xmi:id="17623"/><cas:EmptyFSList xmi:id="17624"/><cas:EmptyFSList xmi:id="17625"/><cas:EmptyFSList xmi:id="17626"/><cas:EmptyFSList xmi:id="17627"/><cas:EmptyFSList xmi:id="17628"/><cas:EmptyFSList xmi:id="17629"/><cas:EmptyFSList xmi:id="17630"/><cas:EmptyFSList xmi:id="17631"/><cas:EmptyFSList xmi:id="17632"/><cas:EmptyFSList xmi:id="17633"/><cas:EmptyFSList xmi:id="17634"/><cas:EmptyFSList xmi:id="17635"/><cas:EmptyFSList xmi:id="17636"/><cas:EmptyFSList xmi:id="17637"/><cas:EmptyFSList xmi:id="17638"/><cas:EmptyFSList xmi:id="17639"/><cas:EmptyFSList xmi:id="17640"/><cas:EmptyFSList xmi:id="17641"/><cas:EmptyFSList xmi:id="17642"/><cas:EmptyFSList xmi:id="17643"/><cas:EmptyFSList xmi:id="17644"/><cas:EmptyFSList xmi:id="17645"/><cas:EmptyFSList xmi:id="17646"/><cas:EmptyFSList xmi:id="17647"/><cas:EmptyFSList xmi:id="17648"/><cas:EmptyFSList xmi:id="17649"/><cas:EmptyFSList xmi:id="17650"/><cas:EmptyFSList xmi:id="17651"/><cas:EmptyFSList xmi:id="17652"/><cas:EmptyFSList xmi:id="17653"/><cas:EmptyFSList xmi:id="17654"/><cas:EmptyFSList xmi:id="17655"/><cas:EmptyFSList xmi:id="17656"/><cas:EmptyFSList xmi:id="17657"/><cas:EmptyFSList xmi:id="17658"/><cas:EmptyFSList xmi:id="17659"/><cas:EmptyFSList xmi:id="17660"/><cas:EmptyFSList xmi:id="17661"/><cas:EmptyFSList xmi:id="17662"/><cas:EmptyFSList xmi:id="17663"/><cas:EmptyFSList xmi:id="17664"/><cas:EmptyFSList xmi:id="17665"/><cas:EmptyFSList xmi:id="17666"/><cas:EmptyFSList xmi:id="17667"/><cas:EmptyFSList xmi:id="17668"/><cas:EmptyFSList xmi:id="17669"/><cas:EmptyFSList xmi:id="17670"/><cas:EmptyFSList xmi:id="17671"/><cas:EmptyFSList xmi:id="17672"/><cas:EmptyFSList xmi:id="17673"/><cas:EmptyFSList xmi:id="17674"/><cas:EmptyFSList xmi:id="17484"/><cas:EmptyFSList xmi:id="17480"/><cas:EmptyFSList xmi:id="17476"/><cas:EmptyFSList xmi:id="17472"/><cas:EmptyFSList xmi:id="17468"/><cas:EmptyFSList xmi:id="17464"/><cas:EmptyFSList xmi:id="17460"/><cas:EmptyFSList xmi:id="17456"/><cas:EmptyFSList xmi:id="17452"/><cas:EmptyFSList xmi:id="17448"/><cas:EmptyFSList xmi:id="17444"/><cas:EmptyFSList xmi:id="17440"/><cas:EmptyFSList xmi:id="17436"/><cas:EmptyFSList xmi:id="17432"/><cas:EmptyFSList xmi:id="17428"/><cas:EmptyFSList xmi:id="17424"/><cas:EmptyFSList xmi:id="17420"/><cas:EmptyFSList xmi:id="17416"/><cas:EmptyFSList xmi:id="17412"/><cas:EmptyFSList xmi:id="17408"/><cas:EmptyFSList xmi:id="17404"/><cas:EmptyFSList xmi:id="17400"/><cas:EmptyFSList xmi:id="17396"/><cas:EmptyFSList xmi:id="17392"/><cas:EmptyFSList xmi:id="17388"/><cas:EmptyFSList xmi:id="17384"/><cas:EmptyFSList xmi:id="17380"/><cas:EmptyFSList xmi:id="17376"/><cas:EmptyFSList xmi:id="17372"/><cas:EmptyFSList xmi:id="17368"/><cas:NonEmptyFSList xmi:id="17365" head="5283" tail="17368"/><cas:EmptyFSList xmi:id="17361"/><cas:EmptyFSList xmi:id="17357"/><cas:EmptyFSList xmi:id="17353"/><cas:EmptyFSList xmi:id="17349"/><cas:EmptyFSList xmi:id="17345"/><cas:EmptyFSList xmi:id="17341"/><cas:EmptyFSList xmi:id="17337"/><cas:EmptyFSList xmi:id="17333"/><cas:EmptyFSList xmi:id="17329"/><cas:EmptyFSList xmi:id="17325"/><cas:EmptyFSList xmi:id="17321"/><cas:EmptyFSList xmi:id="17317"/><cas:EmptyFSList xmi:id="17313"/><cas:EmptyFSList xmi:id="17309"/><cas:NonEmptyFSList xmi:id="17306" head="4858" tail="17309"/><cas:EmptyFSList xmi:id="17302"/><cas:EmptyFSList xmi:id="17298"/><cas:EmptyFSList xmi:id="17294"/><cas:EmptyFSList xmi:id="17290"/><cas:EmptyFSList xmi:id="17286"/><cas:EmptyFSList xmi:id="17282"/><cas:NonEmptyFSList xmi:id="17279" head="4396" tail="17282"/><cas:EmptyFSList xmi:id="17275"/><cas:NonEmptyFSList xmi:id="17272" head="1716" tail="17275"/><cas:NonEmptyFSList xmi:id="17269" head="1706" tail="17272"/><cas:EmptyFSList xmi:id="17265"/><cas:NonEmptyFSList xmi:id="17262" head="4078" tail="17265"/><cas:NonEmptyFSList xmi:id="17259" head="4068" tail="17262"/><cas:EmptyFSList xmi:id="17255"/><cas:NonEmptyFSList xmi:id="17252" head="3750" tail="17255"/><cas:NonEmptyFSList xmi:id="17249" head="3740" tail="17252"/><cas:EmptyFSList xmi:id="17245"/><cas:NonEmptyFSList xmi:id="17242" head="3399" tail="17245"/><cas:EmptyFSList xmi:id="17238"/><cas:NonEmptyFSList xmi:id="17235" head="2764" tail="17238"/><cas:EmptyFSList xmi:id="17231"/><cas:NonEmptyFSList xmi:id="17228" head="507" tail="17231"/><cas:NonEmptyFSList xmi:id="17225" head="497" tail="17228"/><cas:NonEmptyFSList xmi:id="17222" head="487" tail="17225"/><cas:NonEmptyFSList xmi:id="17219" head="477" tail="17222"/><cas:EmptyFSList xmi:id="17215"/><cas:NonEmptyFSList xmi:id="17212" head="2316" tail="17215"/><cas:NonEmptyFSList xmi:id="17209" head="2306" tail="17212"/><cas:EmptyFSList xmi:id="17205"/><cas:NonEmptyFSList xmi:id="17202" head="3105" tail="17205"/><cas:NonEmptyFSList xmi:id="17199" head="3095" tail="17202"/><cas:EmptyFSList xmi:id="17195"/><cas:NonEmptyFSList xmi:id="17192" head="1156" tail="17195"/><cas:NonEmptyFSList xmi:id="17189" head="1146" tail="17192"/><cas:NonEmptyFSList xmi:id="17186" head="1136" tail="17189"/><cas:EmptyFSList xmi:id="17182"/><cas:NonEmptyFSList xmi:id="17179" head="16213" tail="17182"/><cas:NonEmptyFSList xmi:id="17176" head="16201" tail="17179"/><cas:NonEmptyFSList xmi:id="17173" head="16189" tail="17176"/><cas:NonEmptyFSList xmi:id="17170" head="16177" tail="17173"/><cas:NonEmptyFSList xmi:id="17167" head="16165" tail="17170"/><cas:NonEmptyFSList xmi:id="17164" head="16153" tail="17167"/><cas:NonEmptyFSList xmi:id="17161" head="16141" tail="17164"/><cas:NonEmptyFSList xmi:id="17158" head="16129" tail="17161"/><cas:NonEmptyFSList xmi:id="17155" head="16117" tail="17158"/><cas:NonEmptyFSList xmi:id="17152" head="16105" tail="17155"/><cas:NonEmptyFSList xmi:id="17149" head="16093" tail="17152"/><cas:NonEmptyFSList xmi:id="17146" head="16081" tail="17149"/><cas:NonEmptyFSList xmi:id="17143" head="16069" tail="17146"/><cas:NonEmptyFSList xmi:id="17140" head="16057" tail="17143"/><cas:NonEmptyFSList xmi:id="17137" head="16045" tail="17140"/><cas:NonEmptyFSList xmi:id="17134" head="16033" tail="17137"/><cas:NonEmptyFSList xmi:id="17131" head="16021" tail="17134"/><cas:NonEmptyFSList xmi:id="17128" head="16009" tail="17131"/><cas:NonEmptyFSList xmi:id="17125" head="15997" tail="17128"/><cas:NonEmptyFSList xmi:id="17122" head="15985" tail="17125"/><cas:NonEmptyFSList xmi:id="17119" head="15973" tail="17122"/><cas:NonEmptyFSList xmi:id="17116" head="15961" tail="17119"/><cas:NonEmptyFSList xmi:id="17113" head="9924" tail="17116"/><cas:NonEmptyFSList xmi:id="17110" head="15949" tail="17113"/><cas:NonEmptyFSList xmi:id="17107" head="15937" tail="17110"/><cas:NonEmptyFSList xmi:id="17104" head="15925" tail="17107"/><cas:NonEmptyFSList xmi:id="17101" head="15913" tail="17104"/><cas:NonEmptyFSList xmi:id="17098" head="15901" tail="17101"/><cas:NonEmptyFSList xmi:id="17095" head="15889" tail="17098"/><cas:NonEmptyFSList xmi:id="17092" head="15877" tail="17095"/><cas:NonEmptyFSList xmi:id="17089" head="9909" tail="17092"/><cas:NonEmptyFSList xmi:id="17086" head="9894" tail="17089"/><cas:NonEmptyFSList xmi:id="17083" head="15865" tail="17086"/><cas:NonEmptyFSList xmi:id="17080" head="15853" tail="17083"/><cas:NonEmptyFSList xmi:id="17077" head="15841" tail="17080"/><cas:NonEmptyFSList xmi:id="17074" head="15829" tail="17077"/><cas:NonEmptyFSList xmi:id="17071" head="15817" tail="17074"/><cas:NonEmptyFSList xmi:id="17068" head="15805" tail="17071"/><cas:NonEmptyFSList xmi:id="17065" head="15793" tail="17068"/><cas:NonEmptyFSList xmi:id="17062" head="15781" tail="17065"/><cas:NonEmptyFSList xmi:id="17059" head="15769" tail="17062"/><cas:NonEmptyFSList xmi:id="17056" head="15757" tail="17059"/><cas:NonEmptyFSList xmi:id="17053" head="15745" tail="17056"/><cas:NonEmptyFSList xmi:id="17050" head="15733" tail="17053"/><cas:NonEmptyFSList xmi:id="17047" head="15721" tail="17050"/><cas:NonEmptyFSList xmi:id="17044" head="15709" tail="17047"/><cas:NonEmptyFSList xmi:id="17041" head="15697" tail="17044"/><cas:NonEmptyFSList xmi:id="17038" head="15685" tail="17041"/><cas:NonEmptyFSList xmi:id="17035" head="15673" tail="17038"/><cas:NonEmptyFSList xmi:id="17032" head="15661" tail="17035"/><cas:NonEmptyFSList xmi:id="17029" head="15649" tail="17032"/><cas:NonEmptyFSList xmi:id="17026" head="15637" tail="17029"/><cas:NonEmptyFSList xmi:id="17023" head="15625" tail="17026"/><cas:NonEmptyFSList xmi:id="17020" head="15613" tail="17023"/><cas:NonEmptyFSList xmi:id="17017" head="15601" tail="17020"/><cas:NonEmptyFSList xmi:id="17014" head="9879" tail="17017"/><cas:NonEmptyFSList xmi:id="17011" head="15589" tail="17014"/><cas:NonEmptyFSList xmi:id="17008" head="9864" tail="17011"/><cas:NonEmptyFSList xmi:id="17005" head="15577" tail="17008"/><cas:NonEmptyFSList xmi:id="17002" head="15565" tail="17005"/><cas:NonEmptyFSList xmi:id="16999" head="15553" tail="17002"/><cas:NonEmptyFSList xmi:id="16996" head="15541" tail="16999"/><cas:NonEmptyFSList xmi:id="16993" head="15529" tail="16996"/><cas:NonEmptyFSList xmi:id="16990" head="15517" tail="16993"/><cas:NonEmptyFSList xmi:id="16987" head="15505" tail="16990"/><cas:NonEmptyFSList xmi:id="16984" head="15493" tail="16987"/><cas:NonEmptyFSList xmi:id="16981" head="15481" tail="16984"/><cas:NonEmptyFSList xmi:id="16978" head="15469" tail="16981"/><cas:NonEmptyFSList xmi:id="16975" head="15457" tail="16978"/><cas:NonEmptyFSList xmi:id="16972" head="15445" tail="16975"/><cas:NonEmptyFSList xmi:id="16969" head="15433" tail="16972"/><cas:NonEmptyFSList xmi:id="16966" head="15421" tail="16969"/><cas:NonEmptyFSList xmi:id="16963" head="15409" tail="16966"/><cas:NonEmptyFSList xmi:id="16960" head="15397" tail="16963"/><cas:NonEmptyFSList xmi:id="16957" head="15385" tail="16960"/><cas:NonEmptyFSList xmi:id="16954" head="15373" tail="16957"/><cas:NonEmptyFSList xmi:id="16951" head="15361" tail="16954"/><cas:NonEmptyFSList xmi:id="16948" head="15349" tail="16951"/><cas:NonEmptyFSList xmi:id="16945" head="15337" tail="16948"/><cas:NonEmptyFSList xmi:id="16942" head="15325" tail="16945"/><cas:NonEmptyFSList xmi:id="16939" head="15313" tail="16942"/><cas:NonEmptyFSList xmi:id="16936" head="15301" tail="16939"/><cas:NonEmptyFSList xmi:id="16933" head="15289" tail="16936"/><cas:NonEmptyFSList xmi:id="16930" head="9849" tail="16933"/><cas:NonEmptyFSList xmi:id="16927" head="9834" tail="16930"/><cas:NonEmptyFSList xmi:id="16924" head="9819" tail="16927"/><cas:NonEmptyFSList xmi:id="16921" head="9804" tail="16924"/><cas:NonEmptyFSList xmi:id="16918" head="9789" tail="16921"/><cas:NonEmptyFSList xmi:id="16915" head="9774" tail="16918"/><cas:NonEmptyFSList xmi:id="16912" head="9759" tail="16915"/><cas:NonEmptyFSList xmi:id="16909" head="9744" tail="16912"/><cas:NonEmptyFSList xmi:id="16906" head="9729" tail="16909"/><cas:NonEmptyFSList xmi:id="16903" head="9714" tail="16906"/><cas:NonEmptyFSList xmi:id="16900" head="9699" tail="16903"/><cas:NonEmptyFSList xmi:id="16897" head="9684" tail="16900"/><cas:NonEmptyFSList xmi:id="16894" head="9669" tail="16897"/><cas:NonEmptyFSList xmi:id="16891" head="9654" tail="16894"/><cas:NonEmptyFSList xmi:id="16888" head="9639" tail="16891"/><cas:NonEmptyFSList xmi:id="16885" head="9624" tail="16888"/><cas:NonEmptyFSList xmi:id="16882" head="9609" tail="16885"/><cas:NonEmptyFSList xmi:id="16879" head="9594" tail="16882"/><cas:NonEmptyFSList xmi:id="16876" head="9579" tail="16879"/><cas:NonEmptyFSList xmi:id="16873" head="9564" tail="16876"/><cas:NonEmptyFSList xmi:id="16870" head="9549" tail="16873"/><cas:NonEmptyFSList xmi:id="16867" head="9534" tail="16870"/><cas:NonEmptyFSList xmi:id="16864" head="9519" tail="16867"/><cas:NonEmptyFSList xmi:id="16861" head="9504" tail="16864"/><cas:NonEmptyFSList xmi:id="16858" head="9489" tail="16861"/><cas:NonEmptyFSList xmi:id="16855" head="9474" tail="16858"/><cas:NonEmptyFSList xmi:id="16852" head="9459" tail="16855"/><cas:NonEmptyFSList xmi:id="16849" head="9444" tail="16852"/><cas:NonEmptyFSList xmi:id="16846" head="9429" tail="16849"/><cas:NonEmptyFSList xmi:id="16843" head="9414" tail="16846"/><cas:NonEmptyFSList xmi:id="16840" head="9399" tail="16843"/><cas:NonEmptyFSList xmi:id="16837" head="9384" tail="16840"/><cas:NonEmptyFSList xmi:id="16834" head="9369" tail="16837"/><cas:NonEmptyFSList xmi:id="16831" head="9354" tail="16834"/><cas:NonEmptyFSList xmi:id="16828" head="9339" tail="16831"/><cas:NonEmptyFSList xmi:id="16825" head="9324" tail="16828"/><cas:NonEmptyFSList xmi:id="16822" head="9309" tail="16825"/><cas:NonEmptyFSList xmi:id="16819" head="9294" tail="16822"/><cas:NonEmptyFSList xmi:id="16816" head="9279" tail="16819"/><cas:NonEmptyFSList xmi:id="16813" head="9264" tail="16816"/><cas:NonEmptyFSList xmi:id="16810" head="9249" tail="16813"/><cas:NonEmptyFSList xmi:id="16807" head="9234" tail="16810"/><cas:NonEmptyFSList xmi:id="16804" head="9219" tail="16807"/><cas:NonEmptyFSList xmi:id="16801" head="9204" tail="16804"/><cas:NonEmptyFSList xmi:id="16798" head="9189" tail="16801"/><cas:NonEmptyFSList xmi:id="16795" head="9174" tail="16798"/><cas:NonEmptyFSList xmi:id="16792" head="9159" tail="16795"/><cas:NonEmptyFSList xmi:id="16789" head="9144" tail="16792"/><cas:NonEmptyFSList xmi:id="16786" head="9129" tail="16789"/><cas:NonEmptyFSList xmi:id="16783" head="9114" tail="16786"/><cas:NonEmptyFSList xmi:id="16780" head="15229" tail="16783"/><cas:NonEmptyFSList xmi:id="16777" head="15217" tail="16780"/><cas:NonEmptyFSList xmi:id="16774" head="9099" tail="16777"/><cas:NonEmptyFSList xmi:id="16771" head="9084" tail="16774"/><cas:NonEmptyFSList xmi:id="16768" head="9069" tail="16771"/><cas:NonEmptyFSList xmi:id="16765" head="9054" tail="16768"/><cas:NonEmptyFSList xmi:id="16762" head="9039" tail="16765"/><cas:NonEmptyFSList xmi:id="16759" head="9024" tail="16762"/><cas:NonEmptyFSList xmi:id="16756" head="9009" tail="16759"/><cas:NonEmptyFSList xmi:id="16753" head="8994" tail="16756"/><cas:NonEmptyFSList xmi:id="16750" head="5827" tail="16753"/><cas:NonEmptyFSList xmi:id="16747" head="15265" tail="16750"/><cas:NonEmptyFSList xmi:id="16744" head="8979" tail="16747"/><cas:NonEmptyFSList xmi:id="16741" head="8964" tail="16744"/><cas:NonEmptyFSList xmi:id="16738" head="8949" tail="16741"/><cas:NonEmptyFSList xmi:id="16735" head="8934" tail="16738"/><cas:NonEmptyFSList xmi:id="16732" head="8919" tail="16735"/><cas:NonEmptyFSList xmi:id="16729" head="8904" tail="16732"/><cas:NonEmptyFSList xmi:id="16726" head="8889" tail="16729"/><cas:NonEmptyFSList xmi:id="16723" head="8874" tail="16726"/><cas:NonEmptyFSList xmi:id="16720" head="8859" tail="16723"/><cas:NonEmptyFSList xmi:id="16717" head="14989" tail="16720"/><cas:NonEmptyFSList xmi:id="16714" head="14965" tail="16717"/><cas:NonEmptyFSList xmi:id="16711" head="8844" tail="16714"/><cas:NonEmptyFSList xmi:id="16708" head="8829" tail="16711"/><cas:NonEmptyFSList xmi:id="16705" head="5815" tail="16708"/><cas:NonEmptyFSList xmi:id="16702" head="15109" tail="16705"/><cas:NonEmptyFSList xmi:id="16699" head="8814" tail="16702"/><cas:NonEmptyFSList xmi:id="16696" head="8799" tail="16699"/><cas:NonEmptyFSList xmi:id="16693" head="8784" tail="16696"/><cas:NonEmptyFSList xmi:id="16690" head="8769" tail="16693"/><cas:NonEmptyFSList xmi:id="16687" head="8754" tail="16690"/><cas:NonEmptyFSList xmi:id="16684" head="8739" tail="16687"/><cas:NonEmptyFSList xmi:id="16681" head="8724" tail="16684"/><cas:NonEmptyFSList xmi:id="16678" head="14869" tail="16681"/><cas:NonEmptyFSList xmi:id="16675" head="14833" tail="16678"/><cas:NonEmptyFSList xmi:id="16672" head="14809" tail="16675"/><cas:NonEmptyFSList xmi:id="16669" head="6019" tail="16672"/><cas:NonEmptyFSList xmi:id="16666" head="14881" tail="16669"/><cas:NonEmptyFSList xmi:id="16663" head="14857" tail="16666"/><cas:NonEmptyFSList xmi:id="16660" head="14821" tail="16663"/><cas:NonEmptyFSList xmi:id="16657" head="14797" tail="16660"/><cas:NonEmptyFSList xmi:id="16654" head="6031" tail="16657"/><cas:NonEmptyFSList xmi:id="16651" head="15205" tail="16654"/><cas:NonEmptyFSList xmi:id="16648" head="8709" tail="16651"/><cas:NonEmptyFSList xmi:id="16645" head="8694" tail="16648"/><cas:NonEmptyFSList xmi:id="16642" head="8679" tail="16645"/><cas:NonEmptyFSList xmi:id="16639" head="8664" tail="16642"/><cas:NonEmptyFSList xmi:id="16636" head="8649" tail="16639"/><cas:NonEmptyFSList xmi:id="16633" head="8634" tail="16636"/><cas:NonEmptyFSList xmi:id="16630" head="15037" tail="16633"/><cas:NonEmptyFSList xmi:id="16627" head="15013" tail="16630"/><cas:NonEmptyFSList xmi:id="16624" head="8619" tail="16627"/><cas:NonEmptyFSList xmi:id="16621" head="8604" tail="16624"/><cas:NonEmptyFSList xmi:id="16618" head="8589" tail="16621"/><cas:NonEmptyFSList xmi:id="16615" head="8574" tail="16618"/><cas:NonEmptyFSList xmi:id="16612" head="8559" tail="16615"/><cas:NonEmptyFSList xmi:id="16609" head="8544" tail="16612"/><cas:NonEmptyFSList xmi:id="16606" head="5839" tail="16609"/><cas:NonEmptyFSList xmi:id="16603" head="15277" tail="16606"/><cas:NonEmptyFSList xmi:id="16600" head="8529" tail="16603"/><cas:NonEmptyFSList xmi:id="16597" head="8514" tail="16600"/><cas:NonEmptyFSList xmi:id="16594" head="8499" tail="16597"/><cas:NonEmptyFSList xmi:id="16591" head="8484" tail="16594"/><cas:NonEmptyFSList xmi:id="16588" head="8469" tail="16591"/><cas:NonEmptyFSList xmi:id="16585" head="8454" tail="16588"/><cas:NonEmptyFSList xmi:id="16582" head="8439" tail="16585"/><cas:NonEmptyFSList xmi:id="16579" head="15133" tail="16582"/><cas:NonEmptyFSList xmi:id="16576" head="15121" tail="16579"/><cas:NonEmptyFSList xmi:id="16573" head="8424" tail="16576"/><cas:NonEmptyFSList xmi:id="16570" head="8409" tail="16573"/><cas:NonEmptyFSList xmi:id="16567" head="8394" tail="16570"/><cas:NonEmptyFSList xmi:id="16564" head="8379" tail="16567"/><cas:NonEmptyFSList xmi:id="16561" head="8364" tail="16564"/><cas:NonEmptyFSList xmi:id="16558" head="8349" tail="16561"/><cas:NonEmptyFSList xmi:id="16555" head="8334" tail="16558"/><cas:NonEmptyFSList xmi:id="16552" head="8319" tail="16555"/><cas:NonEmptyFSList xmi:id="16549" head="8304" tail="16552"/><cas:NonEmptyFSList xmi:id="16546" head="8289" tail="16549"/><cas:NonEmptyFSList xmi:id="16543" head="5803" tail="16546"/><cas:NonEmptyFSList xmi:id="16540" head="15241" tail="16543"/><cas:NonEmptyFSList xmi:id="16537" head="8274" tail="16540"/><cas:NonEmptyFSList xmi:id="16534" head="8259" tail="16537"/><cas:NonEmptyFSList xmi:id="16531" head="8244" tail="16534"/><cas:NonEmptyFSList xmi:id="16528" head="8229" tail="16531"/><cas:NonEmptyFSList xmi:id="16525" head="8214" tail="16528"/><cas:NonEmptyFSList xmi:id="16522" head="8199" tail="16525"/><cas:NonEmptyFSList xmi:id="16519" head="8184" tail="16522"/><cas:NonEmptyFSList xmi:id="16516" head="8169" tail="16519"/><cas:NonEmptyFSList xmi:id="16513" head="8154" tail="16516"/><cas:NonEmptyFSList xmi:id="16510" head="14917" tail="16513"/><cas:NonEmptyFSList xmi:id="16507" head="8139" tail="16510"/><cas:NonEmptyFSList xmi:id="16504" head="2065" tail="16507"/><cas:NonEmptyFSList xmi:id="16501" head="8121" tail="16504"/><cas:NonEmptyFSList xmi:id="16498" head="8106" tail="16501"/><cas:NonEmptyFSList xmi:id="16495" head="8091" tail="16498"/><cas:NonEmptyFSList xmi:id="16492" head="8076" tail="16495"/><cas:NonEmptyFSList xmi:id="16489" head="8061" tail="16492"/><cas:NonEmptyFSList xmi:id="16486" head="8046" tail="16489"/><cas:NonEmptyFSList xmi:id="16483" head="15001" tail="16486"/><cas:NonEmptyFSList xmi:id="16480" head="14929" tail="16483"/><cas:NonEmptyFSList xmi:id="16477" head="8031" tail="16480"/><cas:NonEmptyFSList xmi:id="16474" head="8016" tail="16477"/><cas:NonEmptyFSList xmi:id="16471" head="2037" tail="16474"/><cas:NonEmptyFSList xmi:id="16468" head="7998" tail="16471"/><cas:NonEmptyFSList xmi:id="16465" head="7983" tail="16468"/><cas:NonEmptyFSList xmi:id="16462" head="7968" tail="16465"/><cas:NonEmptyFSList xmi:id="16459" head="7953" tail="16462"/><cas:NonEmptyFSList xmi:id="16456" head="7938" tail="16459"/><cas:NonEmptyFSList xmi:id="16453" head="7923" tail="16456"/><cas:NonEmptyFSList xmi:id="16450" head="7908" tail="16453"/><cas:NonEmptyFSList xmi:id="16447" head="7893" tail="16450"/><cas:NonEmptyFSList xmi:id="16444" head="182" tail="16447"/><cas:NonEmptyFSList xmi:id="16441" head="15097" tail="16444"/><cas:NonEmptyFSList xmi:id="16438" head="7875" tail="16441"/><cas:NonEmptyFSList xmi:id="16435" head="7860" tail="16438"/><cas:NonEmptyFSList xmi:id="16432" head="7845" tail="16435"/><cas:NonEmptyFSList xmi:id="16429" head="7830" tail="16432"/><cas:NonEmptyFSList xmi:id="16426" head="14905" tail="16429"/><cas:NonEmptyFSList xmi:id="16423" head="922" tail="16426"/><cas:NonEmptyFSList xmi:id="16420" head="7812" tail="16423"/><cas:NonEmptyFSList xmi:id="16417" head="7797" tail="16420"/><cas:NonEmptyFSList xmi:id="16414" head="7782" tail="16417"/><cas:NonEmptyFSList xmi:id="16411" head="7767" tail="16414"/><cas:NonEmptyFSList xmi:id="16408" head="14893" tail="16411"/><cas:NonEmptyFSList xmi:id="16405" head="14845" tail="16408"/><cas:NonEmptyFSList xmi:id="16402" head="7752" tail="16405"/><cas:NonEmptyFSList xmi:id="16399" head="6007" tail="16402"/><cas:NonEmptyFSList xmi:id="16396" head="15061" tail="16399"/><cas:NonEmptyFSList xmi:id="16393" head="7737" tail="16396"/><cas:NonEmptyFSList xmi:id="16390" head="7722" tail="16393"/><cas:NonEmptyFSList xmi:id="16387" head="14941" tail="16390"/><cas:NonEmptyFSList xmi:id="16384" head="7707" tail="16387"/><cas:NonEmptyFSList xmi:id="16381" head="79" tail="16384"/><cas:NonEmptyFSList xmi:id="16378" head="15157" tail="16381"/><cas:NonEmptyFSList xmi:id="16375" head="7689" tail="16378"/><cas:NonEmptyFSList xmi:id="16372" head="15085" tail="16375"/><cas:NonEmptyFSList xmi:id="16369" head="15049" tail="16372"/><cas:NonEmptyFSList xmi:id="16366" head="7674" tail="16369"/><cas:NonEmptyFSList xmi:id="16363" head="7659" tail="16366"/><cas:NonEmptyFSList xmi:id="16360" head="7644" tail="16363"/><cas:NonEmptyFSList xmi:id="16357" head="894" tail="16360"/><cas:NonEmptyFSList xmi:id="16354" head="15025" tail="16357"/><cas:NonEmptyFSList xmi:id="16351" head="7626" tail="16354"/><cas:NonEmptyFSList xmi:id="16348" head="14977" tail="16351"/><cas:NonEmptyFSList xmi:id="16345" head="7611" tail="16348"/><cas:NonEmptyFSList xmi:id="16342" head="129" tail="16345"/><cas:NonEmptyFSList xmi:id="16339" head="14953" tail="16342"/><cas:NonEmptyFSList xmi:id="16336" head="7593" tail="16339"/><cas:NonEmptyFSList xmi:id="16333" head="908" tail="16336"/><cas:NonEmptyFSList xmi:id="16330" head="15253" tail="16333"/><cas:NonEmptyFSList xmi:id="16327" head="7575" tail="16330"/><cas:NonEmptyFSList xmi:id="16324" head="7560" tail="16327"/><cas:NonEmptyFSList xmi:id="16321" head="7545" tail="16324"/><cas:NonEmptyFSList xmi:id="16318" head="7530" tail="16321"/><cas:NonEmptyFSList xmi:id="16315" head="7515" tail="16318"/><cas:NonEmptyFSList xmi:id="16312" head="7500" tail="16315"/><cas:NonEmptyFSList xmi:id="16309" head="7485" tail="16312"/><cas:NonEmptyFSList xmi:id="16306" head="15073" tail="16309"/><cas:NonEmptyFSList xmi:id="16303" head="7470" tail="16306"/><cas:NonEmptyFSList xmi:id="16300" head="7455" tail="16303"/><cas:NonEmptyFSList xmi:id="16297" head="7440" tail="16300"/><cas:NonEmptyFSList xmi:id="16294" head="222" tail="16297"/><cas:NonEmptyFSList xmi:id="16291" head="7422" tail="16294"/><cas:NonEmptyFSList xmi:id="16288" head="7407" tail="16291"/><cas:NonEmptyFSList xmi:id="16285" head="7392" tail="16288"/><cas:NonEmptyFSList xmi:id="16282" head="7377" tail="16285"/><cas:NonEmptyFSList xmi:id="16279" head="4656" tail="16282"/><cas:NonEmptyFSList xmi:id="16276" head="2104" tail="16279"/><cas:NonEmptyFSList xmi:id="16273" head="2051" tail="16276"/><cas:NonEmptyFSList xmi:id="16270" head="15193" tail="16273"/><cas:NonEmptyFSList xmi:id="16267" head="15181" tail="16270"/><cas:NonEmptyFSList xmi:id="16264" head="15169" tail="16267"/><cas:NonEmptyFSList xmi:id="16261" head="15145" tail="16264"/><cas:NonEmptyFSList xmi:id="16258" head="7356" tail="16261"/><cas:NonEmptyFSList xmi:id="16255" head="7341" tail="16258"/><cas:NonEmptyFSList xmi:id="16252" head="7326" tail="16255"/><cas:NonEmptyFSList xmi:id="16249" head="7311" tail="16252"/><cas:NonEmptyFSList xmi:id="16246" head="7296" tail="16249"/><cas:NonEmptyFSList xmi:id="16243" head="7281" tail="16246"/><cas:NonEmptyFSList xmi:id="16240" head="7266" tail="16243"/><cas:NonEmptyFSList xmi:id="16237" head="854" tail="16240"/><cas:NonEmptyFSList xmi:id="16234" head="13" tail="16237"/><cas:NonEmptyFSList xmi:id="16231" head="5136" tail="16234"/><cas:NonEmptyFSList xmi:id="16228" head="5391" tail="16231"/><cas:EmptyFSList xmi:id="6971"/><cas:EmptyFSList xmi:id="6932"/><cas:EmptyFSList xmi:id="6893"/><cas:EmptyFSList xmi:id="6854"/><cas:EmptyFSList xmi:id="6815"/><cas:EmptyFSList xmi:id="6776"/><cas:EmptyFSList xmi:id="6726"/><cas:EmptyFSList xmi:id="6674"/><cas:EmptyFSList xmi:id="6633"/><cas:EmptyFSList xmi:id="6594"/><cas:EmptyFSList xmi:id="6544"/><cas:EmptyFSList xmi:id="6503"/><cas:EmptyFSList xmi:id="6464"/><cas:EmptyFSList xmi:id="6414"/><cas:EmptyFSList xmi:id="6373"/><cas:EmptyFSList xmi:id="6334"/><cas:EmptyFSList xmi:id="6295"/><cas:EmptyFSList xmi:id="6256"/><cas:EmptyFSList xmi:id="6217"/><cas:EmptyFSList xmi:id="6178"/><cas:EmptyFSList xmi:id="6139"/><cas:EmptyFSList xmi:id="6100"/><cas:EmptyFSList xmi:id="6070"/><cas:EmptyFSList xmi:id="5997"/><cas:EmptyFSList xmi:id="5958"/><cas:EmptyFSList xmi:id="5919"/><cas:EmptyFSList xmi:id="5880"/><cas:EmptyFSList xmi:id="5793"/><cas:EmptyFSList xmi:id="5754"/><cas:EmptyFSList xmi:id="5715"/><cas:EmptyFSList xmi:id="5676"/><cas:EmptyFSList xmi:id="5637"/><cas:EmptyFSList xmi:id="5598"/><cas:EmptyFSList xmi:id="5559"/><cas:EmptyFSList xmi:id="5520"/><cas:EmptyFSList xmi:id="5481"/><cas:EmptyFSList xmi:id="5442"/><cas:NonEmptyFSList xmi:id="5432" head="5435" tail="5442"/><cas:EmptyFSList xmi:id="5381"/><cas:NonEmptyFSList xmi:id="5371" head="5374" tail="5381"/><cas:EmptyFSList xmi:id="5332"/><cas:NonEmptyFSList xmi:id="5322" head="5325" tail="5332"/><cas:EmptyFSList xmi:id="5248"/><cas:NonEmptyFSList xmi:id="5238" head="5241" tail="5248"/><cas:NonEmptyFSList xmi:id="5228" head="5231" tail="5238"/><cas:EmptyFSList xmi:id="5187"/><cas:NonEmptyFSList xmi:id="5177" head="5180" tail="5187"/><cas:EmptyFSList xmi:id="5126"/><cas:NonEmptyFSList xmi:id="5116" head="5119" tail="5126"/><cas:EmptyFSList xmi:id="5077"/><cas:NonEmptyFSList xmi:id="5067" head="5070" tail="5077"/><cas:EmptyFSList xmi:id="5028"/><cas:NonEmptyFSList xmi:id="5018" head="5021" tail="5028"/><cas:EmptyFSList xmi:id="4979"/><cas:NonEmptyFSList xmi:id="4969" head="4972" tail="4979"/><cas:EmptyFSList xmi:id="4919"/><cas:NonEmptyFSList xmi:id="4909" head="4912" tail="4919"/><cas:NonEmptyFSList xmi:id="4899" head="4902" tail="4909"/><cas:EmptyFSList xmi:id="4847"/><cas:NonEmptyFSList xmi:id="4837" head="4840" tail="4847"/><cas:NonEmptyFSList xmi:id="4827" head="4830" tail="4837"/><cas:NonEmptyFSList xmi:id="4817" head="4820" tail="4827"/><cas:NonEmptyFSList xmi:id="4807" head="4810" tail="4817"/><cas:EmptyFSList xmi:id="4768"/><cas:NonEmptyFSList xmi:id="4758" head="4761" tail="4768"/><cas:EmptyFSList xmi:id="4719"/><cas:NonEmptyFSList xmi:id="4709" head="4712" tail="4719"/><cas:NonEmptyFSList xmi:id="4699" head="4702" tail="4709"/><cas:EmptyFSList xmi:id="4646"/><cas:NonEmptyFSList xmi:id="4636" head="4639" tail="4646"/><cas:EmptyFSList xmi:id="4385"/><cas:NonEmptyFSList xmi:id="4375" head="4378" tail="4385"/><cas:NonEmptyFSList xmi:id="4365" head="4368" tail="4375"/><cas:NonEmptyFSList xmi:id="4355" head="4358" tail="4365"/><cas:NonEmptyFSList xmi:id="4345" head="4348" tail="4355"/><cas:NonEmptyFSList xmi:id="4335" head="4338" tail="4345"/><cas:NonEmptyFSList xmi:id="4325" head="4328" tail="4335"/><cas:NonEmptyFSList xmi:id="4315" head="4318" tail="4325"/><cas:NonEmptyFSList xmi:id="4305" head="4308" tail="4315"/><cas:NonEmptyFSList xmi:id="4295" head="4298" tail="4305"/><cas:EmptyFSList xmi:id="4494"/><cas:NonEmptyFSList xmi:id="4484" head="4487" tail="4494"/><cas:NonEmptyFSList xmi:id="4474" head="4477" tail="4484"/><cas:NonEmptyFSList xmi:id="4464" head="4467" tail="4474"/><cas:NonEmptyFSList xmi:id="4454" head="4457" tail="4464"/><cas:NonEmptyFSList xmi:id="4444" head="4447" tail="4454"/><cas:NonEmptyFSList xmi:id="4434" head="4437" tail="4444"/><cas:NonEmptyFSList xmi:id="4424" head="4427" tail="4434"/><cas:EmptyFSList xmi:id="4057"/><cas:NonEmptyFSList xmi:id="4047" head="4050" tail="4057"/><cas:NonEmptyFSList xmi:id="4037" head="4040" tail="4047"/><cas:NonEmptyFSList xmi:id="4027" head="4030" tail="4037"/><cas:NonEmptyFSList xmi:id="4017" head="4020" tail="4027"/><cas:NonEmptyFSList xmi:id="4007" head="4010" tail="4017"/><cas:NonEmptyFSList xmi:id="3997" head="4000" tail="4007"/><cas:NonEmptyFSList xmi:id="3987" head="3990" tail="3997"/><cas:NonEmptyFSList xmi:id="3977" head="3980" tail="3987"/><cas:NonEmptyFSList xmi:id="3967" head="3970" tail="3977"/><cas:EmptyFSList xmi:id="4167"/><cas:NonEmptyFSList xmi:id="4157" head="4160" tail="4167"/><cas:NonEmptyFSList xmi:id="4147" head="4150" tail="4157"/><cas:NonEmptyFSList xmi:id="4137" head="4140" tail="4147"/><cas:NonEmptyFSList xmi:id="4127" head="4130" tail="4137"/><cas:NonEmptyFSList xmi:id="4117" head="4120" tail="4127"/><cas:NonEmptyFSList xmi:id="4107" head="4110" tail="4117"/><cas:EmptyFSList xmi:id="3729"/><cas:NonEmptyFSList xmi:id="3719" head="3722" tail="3729"/><cas:NonEmptyFSList xmi:id="3709" head="3712" tail="3719"/><cas:NonEmptyFSList xmi:id="3699" head="3702" tail="3709"/><cas:NonEmptyFSList xmi:id="3689" head="3692" tail="3699"/><cas:NonEmptyFSList xmi:id="3679" head="3682" tail="3689"/><cas:NonEmptyFSList xmi:id="3669" head="3672" tail="3679"/><cas:NonEmptyFSList xmi:id="3659" head="3662" tail="3669"/><cas:NonEmptyFSList xmi:id="3649" head="3652" tail="3659"/><cas:NonEmptyFSList xmi:id="3639" head="3642" tail="3649"/><cas:EmptyFSList xmi:id="3839"/><cas:NonEmptyFSList xmi:id="3829" head="3832" tail="3839"/><cas:NonEmptyFSList xmi:id="3819" head="3822" tail="3829"/><cas:NonEmptyFSList xmi:id="3809" head="3812" tail="3819"/><cas:NonEmptyFSList xmi:id="3799" head="3802" tail="3809"/><cas:NonEmptyFSList xmi:id="3789" head="3792" tail="3799"/><cas:NonEmptyFSList xmi:id="3779" head="3782" tail="3789"/><cas:EmptyFSList xmi:id="3388"/><cas:NonEmptyFSList xmi:id="3378" head="3381" tail="3388"/><cas:NonEmptyFSList xmi:id="3368" head="3371" tail="3378"/><cas:NonEmptyFSList xmi:id="3358" head="3361" tail="3368"/><cas:NonEmptyFSList xmi:id="3348" head="3351" tail="3358"/><cas:NonEmptyFSList xmi:id="3338" head="3341" tail="3348"/><cas:NonEmptyFSList xmi:id="3328" head="3331" tail="3338"/><cas:NonEmptyFSList xmi:id="3318" head="3321" tail="3328"/><cas:NonEmptyFSList xmi:id="3308" head="3311" tail="3318"/><cas:NonEmptyFSList xmi:id="3298" head="3301" tail="3308"/><cas:EmptyFSList xmi:id="3497"/><cas:NonEmptyFSList xmi:id="3487" head="3490" tail="3497"/><cas:NonEmptyFSList xmi:id="3477" head="3480" tail="3487"/><cas:NonEmptyFSList xmi:id="3467" head="3470" tail="3477"/><cas:NonEmptyFSList xmi:id="3457" head="3460" tail="3467"/><cas:NonEmptyFSList xmi:id="3447" head="3450" tail="3457"/><cas:NonEmptyFSList xmi:id="3437" head="3440" tail="3447"/><cas:NonEmptyFSList xmi:id="3427" head="3430" tail="3437"/><cas:EmptyFSList xmi:id="3084"/><cas:NonEmptyFSList xmi:id="3074" head="3077" tail="3084"/><cas:NonEmptyFSList xmi:id="3064" head="3067" tail="3074"/><cas:NonEmptyFSList xmi:id="3054" head="3057" tail="3064"/><cas:NonEmptyFSList xmi:id="3044" head="3047" tail="3054"/><cas:NonEmptyFSList xmi:id="3034" head="3037" tail="3044"/><cas:NonEmptyFSList xmi:id="3024" head="3027" tail="3034"/><cas:NonEmptyFSList xmi:id="3014" head="3017" tail="3024"/><cas:NonEmptyFSList xmi:id="3004" head="3007" tail="3014"/><cas:EmptyFSList xmi:id="3184"/><cas:NonEmptyFSList xmi:id="3174" head="3177" tail="3184"/><cas:NonEmptyFSList xmi:id="3164" head="3167" tail="3174"/><cas:NonEmptyFSList xmi:id="3154" head="3157" tail="3164"/><cas:NonEmptyFSList xmi:id="3144" head="3147" tail="3154"/><cas:NonEmptyFSList xmi:id="3134" head="3137" tail="3144"/><cas:EmptyFSList xmi:id="2753"/><cas:NonEmptyFSList xmi:id="2743" head="2746" tail="2753"/><cas:NonEmptyFSList xmi:id="2733" head="2736" tail="2743"/><cas:NonEmptyFSList xmi:id="2723" head="2726" tail="2733"/><cas:NonEmptyFSList xmi:id="2713" head="2716" tail="2723"/><cas:NonEmptyFSList xmi:id="2703" head="2706" tail="2713"/><cas:NonEmptyFSList xmi:id="2693" head="2696" tail="2703"/><cas:NonEmptyFSList xmi:id="2683" head="2686" tail="2693"/><cas:NonEmptyFSList xmi:id="2673" head="2676" tail="2683"/><cas:NonEmptyFSList xmi:id="2663" head="2666" tail="2673"/><cas:NonEmptyFSList xmi:id="2653" head="2656" tail="2663"/><cas:EmptyFSList xmi:id="2862"/><cas:NonEmptyFSList xmi:id="2852" head="2855" tail="2862"/><cas:NonEmptyFSList xmi:id="2842" head="2845" tail="2852"/><cas:NonEmptyFSList xmi:id="2832" head="2835" tail="2842"/><cas:NonEmptyFSList xmi:id="2822" head="2825" tail="2832"/><cas:NonEmptyFSList xmi:id="2812" head="2815" tail="2822"/><cas:NonEmptyFSList xmi:id="2802" head="2805" tail="2812"/><cas:NonEmptyFSList xmi:id="2792" head="2795" tail="2802"/><cas:EmptyFSList xmi:id="2295"/><cas:NonEmptyFSList xmi:id="2285" head="2288" tail="2295"/><cas:NonEmptyFSList xmi:id="2275" head="2278" tail="2285"/><cas:NonEmptyFSList xmi:id="2265" head="2268" tail="2275"/><cas:NonEmptyFSList xmi:id="2255" head="2258" tail="2265"/><cas:NonEmptyFSList xmi:id="2245" head="2248" tail="2255"/><cas:NonEmptyFSList xmi:id="2235" head="2238" tail="2245"/><cas:NonEmptyFSList xmi:id="2225" head="2228" tail="2235"/><cas:NonEmptyFSList xmi:id="2215" head="2218" tail="2225"/><cas:NonEmptyFSList xmi:id="2205" head="2208" tail="2215"/><cas:NonEmptyFSList xmi:id="2195" head="2198" tail="2205"/><cas:NonEmptyFSList xmi:id="2185" head="2188" tail="2195"/><cas:NonEmptyFSList xmi:id="2175" head="2178" tail="2185"/><cas:NonEmptyFSList xmi:id="2165" head="2168" tail="2175"/><cas:NonEmptyFSList xmi:id="2155" head="2158" tail="2165"/><cas:NonEmptyFSList xmi:id="2145" head="2148" tail="2155"/><cas:EmptyFSList xmi:id="2455"/><cas:NonEmptyFSList xmi:id="2445" head="2448" tail="2455"/><cas:NonEmptyFSList xmi:id="2435" head="2438" tail="2445"/><cas:NonEmptyFSList xmi:id="2425" head="2428" tail="2435"/><cas:NonEmptyFSList xmi:id="2415" head="2418" tail="2425"/><cas:NonEmptyFSList xmi:id="2405" head="2408" tail="2415"/><cas:NonEmptyFSList xmi:id="2395" head="2398" tail="2405"/><cas:NonEmptyFSList xmi:id="2385" head="2388" tail="2395"/><cas:NonEmptyFSList xmi:id="2375" head="2378" tail="2385"/><cas:NonEmptyFSList xmi:id="2365" head="2368" tail="2375"/><cas:NonEmptyFSList xmi:id="2355" head="2358" tail="2365"/><cas:NonEmptyFSList xmi:id="2345" head="2348" tail="2355"/><cas:EmptyFSList xmi:id="1695"/><cas:NonEmptyFSList xmi:id="1685" head="1688" tail="1695"/><cas:NonEmptyFSList xmi:id="1675" head="1678" tail="1685"/><cas:NonEmptyFSList xmi:id="1665" head="1668" tail="1675"/><cas:NonEmptyFSList xmi:id="1655" head="1658" tail="1665"/><cas:NonEmptyFSList xmi:id="1645" head="1648" tail="1655"/><cas:NonEmptyFSList xmi:id="1635" head="1638" tail="1645"/><cas:NonEmptyFSList xmi:id="1625" head="1628" tail="1635"/><cas:NonEmptyFSList xmi:id="1615" head="1618" tail="1625"/><cas:NonEmptyFSList xmi:id="1605" head="1608" tail="1615"/><cas:NonEmptyFSList xmi:id="1595" head="1598" tail="1605"/><cas:NonEmptyFSList xmi:id="1585" head="1588" tail="1595"/><cas:NonEmptyFSList xmi:id="1575" head="1578" tail="1585"/><cas:NonEmptyFSList xmi:id="1565" head="1568" tail="1575"/><cas:NonEmptyFSList xmi:id="1555" head="1558" tail="1565"/><cas:EmptyFSList xmi:id="1868"/><cas:NonEmptyFSList xmi:id="1858" head="1861" tail="1868"/><cas:NonEmptyFSList xmi:id="1848" head="1851" tail="1858"/><cas:NonEmptyFSList xmi:id="1838" head="1841" tail="1848"/><cas:NonEmptyFSList xmi:id="1828" head="1831" tail="1838"/><cas:NonEmptyFSList xmi:id="1818" head="1821" tail="1828"/><cas:NonEmptyFSList xmi:id="1808" head="1811" tail="1818"/><cas:NonEmptyFSList xmi:id="1798" head="1801" tail="1808"/><cas:NonEmptyFSList xmi:id="1788" head="1791" tail="1798"/><cas:NonEmptyFSList xmi:id="1778" head="1781" tail="1788"/><cas:NonEmptyFSList xmi:id="1768" head="1771" tail="1778"/><cas:NonEmptyFSList xmi:id="1758" head="1761" tail="1768"/><cas:EmptyFSList xmi:id="1125"/><cas:NonEmptyFSList xmi:id="1115" head="1118" tail="1125"/><cas:NonEmptyFSList xmi:id="1105" head="1108" tail="1115"/><cas:NonEmptyFSList xmi:id="1095" head="1098" tail="1105"/><cas:NonEmptyFSList xmi:id="1085" head="1088" tail="1095"/><cas:NonEmptyFSList xmi:id="1075" head="1078" tail="1085"/><cas:NonEmptyFSList xmi:id="1065" head="1068" tail="1075"/><cas:NonEmptyFSList xmi:id="1055" head="1058" tail="1065"/><cas:NonEmptyFSList xmi:id="1045" head="1048" tail="1055"/><cas:NonEmptyFSList xmi:id="1035" head="1038" tail="1045"/><cas:NonEmptyFSList xmi:id="1025" head="1028" tail="1035"/><cas:NonEmptyFSList xmi:id="1015" head="1018" tail="1025"/><cas:NonEmptyFSList xmi:id="1005" head="1008" tail="1015"/><cas:NonEmptyFSList xmi:id="995" head="998" tail="1005"/><cas:NonEmptyFSList xmi:id="985" head="988" tail="995"/><cas:NonEmptyFSList xmi:id="975" head="978" tail="985"/><cas:NonEmptyFSList xmi:id="965" head="968" tail="975"/><cas:EmptyFSList xmi:id="1329"/><cas:NonEmptyFSList xmi:id="1319" head="1322" tail="1329"/><cas:NonEmptyFSList xmi:id="1309" head="1312" tail="1319"/><cas:NonEmptyFSList xmi:id="1299" head="1302" tail="1309"/><cas:NonEmptyFSList xmi:id="1289" head="1292" tail="1299"/><cas:NonEmptyFSList xmi:id="1279" head="1282" tail="1289"/><cas:NonEmptyFSList xmi:id="1269" head="1272" tail="1279"/><cas:NonEmptyFSList xmi:id="1259" head="1262" tail="1269"/><cas:NonEmptyFSList xmi:id="1249" head="1252" tail="1259"/><cas:NonEmptyFSList xmi:id="1239" head="1242" tail="1249"/><cas:NonEmptyFSList xmi:id="1229" head="1232" tail="1239"/><cas:NonEmptyFSList xmi:id="1219" head="1222" tail="1229"/><cas:NonEmptyFSList xmi:id="1209" head="1212" tail="1219"/><cas:NonEmptyFSList xmi:id="1199" head="1202" tail="1209"/><cas:EmptyFSList xmi:id="466"/><cas:NonEmptyFSList xmi:id="456" head="459" tail="466"/><cas:NonEmptyFSList xmi:id="446" head="449" tail="456"/><cas:NonEmptyFSList xmi:id="436" head="439" tail="446"/><cas:NonEmptyFSList xmi:id="426" head="429" tail="436"/><cas:NonEmptyFSList xmi:id="416" head="419" tail="426"/><cas:NonEmptyFSList xmi:id="406" head="409" tail="416"/><cas:NonEmptyFSList xmi:id="396" head="399" tail="406"/><cas:NonEmptyFSList xmi:id="386" head="389" tail="396"/><cas:NonEmptyFSList xmi:id="376" head="379" tail="386"/><cas:NonEmptyFSList xmi:id="366" head="369" tail="376"/><cas:NonEmptyFSList xmi:id="356" head="359" tail="366"/><cas:NonEmptyFSList xmi:id="346" head="349" tail="356"/><cas:NonEmptyFSList xmi:id="336" head="339" tail="346"/><cas:NonEmptyFSList xmi:id="326" head="329" tail="336"/><cas:NonEmptyFSList xmi:id="316" head="319" tail="326"/><cas:NonEmptyFSList xmi:id="306" head="309" tail="316"/><cas:NonEmptyFSList xmi:id="296" head="299" tail="306"/><cas:NonEmptyFSList xmi:id="286" head="289" tail="296"/><cas:NonEmptyFSList xmi:id="276" head="279" tail="286"/><cas:EmptyFSList xmi:id="657"/><cas:NonEmptyFSList xmi:id="647" head="650" tail="657"/><cas:NonEmptyFSList xmi:id="637" head="640" tail="647"/><cas:NonEmptyFSList xmi:id="627" head="630" tail="637"/><cas:NonEmptyFSList xmi:id="617" head="620" tail="627"/><cas:NonEmptyFSList xmi:id="607" head="610" tail="617"/><cas:NonEmptyFSList xmi:id="597" head="600" tail="607"/><cas:NonEmptyFSList xmi:id="587" head="590" tail="597"/><cas:NonEmptyFSList xmi:id="577" head="580" tail="587"/><cas:NonEmptyFSList xmi:id="567" head="570" tail="577"/><cas:NonEmptyFSList xmi:id="557" head="560" tail="567"/><cas:NonEmptyFSList xmi:id="547" head="550" tail="557"/><cas:NonEmptyFSList xmi:id="537" head="540" tail="547"/><cas:NonEmptyFSList xmi:id="527" head="530" tail="537"/><types2:QuestionAnswerSet xmi:id="7092" sofa="1" begin="0" end="0" question="4266" answerList="6786 6188 6344 6474 6942"/><types2:QuestionAnswerSet xmi:id="7082" sofa="1" begin="0" end="0" question="1526" answerList="5608 6513 4989 5890 6149"/><types2:QuestionAnswerSet xmi:id="7072" sofa="1" begin="0" end="0" question="3938" answerList="5452 5569 5725 5686 5647"/><types2:QuestionAnswerSet xmi:id="7062" sofa="1" begin="0" end="0" question="3610" answerList="5293 6565 6864 5764 6071"/><types2:QuestionAnswerSet xmi:id="7052" sofa="1" begin="0" end="0" question="3269" answerList="6643 4868 6604 6227 6266"/><types2:QuestionAnswerSet xmi:id="7042" sofa="1" begin="0" end="0" question="2624" answerList="5197 5968 5530 5087 6903"/><types2:QuestionAnswerSet xmi:id="7032" sofa="1" begin="0" end="0" question="249" answerList="6383 6435 5491 5929 6747"/><types2:QuestionAnswerSet xmi:id="7022" sofa="1" begin="0" end="0" question="2116" answerList="5342 6305 5851 6695 4940"/><types2:QuestionAnswerSet xmi:id="7012" sofa="1" begin="0" end="0" question="2975" answerList="4778 5403 6110 5038 6043"/><types2:QuestionAnswerSet xmi:id="7002" sofa="1" begin="0" end="0" question="936" answerList="4670 6825 4729 5148 4607"/><types2:NounPhrase xmi:id="6972" sofa="1" begin="0" end="0" text="6" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6933" sofa="1" begin="0" end="0" text="AD" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6894" sofa="1" begin="0" end="0" text="AD" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6855" sofa="1" begin="0" end="0" text="ER" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6816" sofa="1" begin="0" end="0" text="449" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6777" sofa="1" begin="0" end="0" text="CLU" weight="0.0" synonyms=""/><types2:NER xmi:id="6727" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6738" sofa="1" begin="0" end="0" text="CLU2" weight="0.0" synonyms=""/><types2:NER xmi:id="6675" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6686" sofa="1" begin="0" end="0" text="CLU2" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6634" sofa="1" begin="0" end="0" text="CLU1" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6595" sofa="1" begin="0" end="0" text="cDNA" weight="0.0" synonyms=""/><types2:NER xmi:id="6545" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6556" sofa="1" begin="0" end="0" text="CLU2" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6504" sofa="1" begin="0" end="0" text="52.5" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6465" sofa="1" begin="0" end="0" text="SNPs" weight="0.0" synonyms=""/><types2:NER xmi:id="6415" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6426" sofa="1" begin="0" end="0" text="CLU2" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6374" sofa="1" begin="0" end="0" text="82.3" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6335" sofa="1" begin="0" end="0" text="CLU1" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6296" sofa="1" begin="0" end="0" text="PNGase" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6257" sofa="1" begin="0" end="0" text="allele" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6218" sofa="1" begin="0" end="0" text="protein" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6179" sofa="1" begin="0" end="0" text="amyloid" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6140" sofa="1" begin="0" end="0" text="anibody" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="6101" sofa="1" begin="0" end="0" text="androgen" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5998" sofa="1" begin="0" end="0" text="clusterin" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5959" sofa="1" begin="0" end="0" text="clusterin" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5920" sofa="1" begin="0" end="0" text="valproate" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5881" sofa="1" begin="0" end="0" text="clusterin" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5794" sofa="1" begin="0" end="0" text="rs11136000" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5755" sofa="1" begin="0" end="0" text="inhibition" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5716" sofa="1" begin="0" end="0" text="activation" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5677" sofa="1" begin="0" end="0" text="expression" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5638" sofa="1" begin="0" end="0" text="astrocytes" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5599" sofa="1" begin="0" end="0" text="repression" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5560" sofa="1" begin="0" end="0" text="rs11136000" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5521" sofa="1" begin="0" end="0" text="rs11136000T" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5482" sofa="1" begin="0" end="0" text="association" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5443" sofa="1" begin="0" end="0" text="epitope tag" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5382" sofa="1" begin="0" end="0" text="fetal tissue" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5333" sofa="1" begin="0" end="0" text="real-time PCR" weight="0.0" synonyms=""/><types2:NER xmi:id="5261" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="5249" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5283" sofa="1" begin="0" end="0" text="CLU2" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5273" sofa="1" begin="0" end="0" text="CLU1" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5188" sofa="1" begin="0" end="0" text="Golgi apparatus" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5127" sofa="1" begin="0" end="0" text="proteins" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5078" sofa="1" begin="0" end="0" text="secretory pathway" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="5029" sofa="1" begin="0" end="0" text="therapeutic agents" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4980" sofa="1" begin="0" end="0" text="cerebrospinal fluid" weight="0.0" synonyms=""/><types2:NER xmi:id="4920" sofa="1" begin="0" end="0" text="ribosomal protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4931" sofa="1" begin="0" end="0" text="ribosomal protein L13A" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4858" sofa="1" begin="0" end="0" text="Golgi apparatus" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4848" sofa="1" begin="0" end="0" text="ER" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4769" sofa="1" begin="0" end="0" text="intracellular localization" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4720" sofa="1" begin="0" end="0" text="intracellular" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4647" sofa="1" begin="0" end="0" text="immunofluorescence experiments" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4396" sofa="1" begin="0" end="0" text="CLU2 protein sequence" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4386" sofa="1" begin="0" end="0" text="many residues" weight="0.0" synonyms=""/><types2:NER xmi:id="4406" sofa="1" begin="0" end="0" text="CLU2 protein sequence" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4078" sofa="1" begin="0" end="0" text="CLU2 gene expression" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4068" sofa="1" begin="0" end="0" text="androgens" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="4058" sofa="1" begin="0" end="0" text="effect" weight="0.0" synonyms=""/><types2:NER xmi:id="4089" sofa="1" begin="0" end="0" text="CLU2 gene" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3750" sofa="1" begin="0" end="0" text="CLU isoforms" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3740" sofa="1" begin="0" end="0" text="expression" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3730" sofa="1" begin="0" end="0" text="hormone" weight="0.0" synonyms=""/><types2:NER xmi:id="3761" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3399" sofa="1" begin="0" end="0" text="higher gene expression" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3389" sofa="1" begin="0" end="0" text="CLU isoform" weight="0.0" synonyms=""/><types2:NER xmi:id="3409" sofa="1" begin="0" end="0" text="CLU isoform" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3105" sofa="1" begin="0" end="0" text="clusterin proteins" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3095" sofa="1" begin="0" end="0" text="cell" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="3085" sofa="1" begin="0" end="0" text="compartments" weight="0.0" synonyms=""/><types2:NER xmi:id="3116" sofa="1" begin="0" end="0" text="clusterin proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="2764" sofa="1" begin="0" end="0" text="brain" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="2754" sofa="1" begin="0" end="0" text="CLU protein isoforms" weight="0.0" synonyms=""/><types2:NER xmi:id="2774" sofa="1" begin="0" end="0" text="CLU protein isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="2316" sofa="1" begin="0" end="0" text="choroid plexus" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="2306" sofa="1" begin="0" end="0" text="main one" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="2296" sofa="1" begin="0" end="0" text="two CLU isoforms" weight="0.0" synonyms=""/><types2:NER xmi:id="2327" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="1716" sofa="1" begin="0" end="0" text="CLU" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="1706" sofa="1" begin="0" end="0" text="expression" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="1696" sofa="1" begin="0" end="0" text="particular histone deacetylase inhibitor" weight="0.0" synonyms=""/><types2:NER xmi:id="1739" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="1727" sofa="1" begin="0" end="0" text="particular histone deacetylase" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="1156" sofa="1" begin="0" end="0" text="CLU2 gene products" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="1146" sofa="1" begin="0" end="0" text="CLU1" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="1136" sofa="1" begin="0" end="0" text="cellular locations" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="1126" sofa="1" begin="0" end="0" text="technique" weight="0.0" synonyms=""/><types2:NER xmi:id="1180" sofa="1" begin="0" end="0" text="CLU2 gene products" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="1168" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="507" sofa="1" begin="0" end="0" text="disease" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="497" sofa="1" begin="0" end="0" text="Alzheimer" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="487" sofa="1" begin="0" end="0" text="risk" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="477" sofa="1" begin="0" end="0" text="reduction" weight="0.0" synonyms=""/><types2:NounPhrase xmi:id="467" sofa="1" begin="0" end="0" text="clusterin single nucleotide polymorphism" weight="0.0" synonyms=""/><types2:NER xmi:id="9953" sofa="1" begin="0" end="0" text="NADH dehydrogenase" tag="B-PROTEIN" weight="0.0" synonyms="9966 9976 9986 9996 10006 10016 10026 10036 10046 10056 10066 10076 10086 10096 10106 10116"/><types2:NER xmi:id="9941" sofa="1" begin="0" end="0" text="cytochrome c oxidase" tag="B-PROTEIN" weight="0.0" synonyms="10127"/><types2:NER xmi:id="10145" sofa="1" begin="0" end="0" text="ApoE" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10188" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10176" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10164" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10229" sofa="1" begin="0" end="0" text="clusterin protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10217" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10205" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10270" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10258" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10246" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10299" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10287" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10315" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10330" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10345" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10360" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10375" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10390" sofa="1" begin="0" end="0" text="histone deacetylase" tag="B-PROTEIN" weight="0.0" synonyms="10403"/><types2:NER xmi:id="10417" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10444" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10432" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10472" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10460" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10536" sofa="1" begin="0" end="0" text="clusterin protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10524" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10512" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10500" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10488" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10557" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10572" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10611" sofa="1" begin="0" end="0" text="clusterin protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10599" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10587" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10640" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10628" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10680" sofa="1" begin="0" end="0" text="PNGase F" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10668" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10656" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10709" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10697" sofa="1" begin="0" end="0" text="ATG translation initiation sites" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10749" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10737" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10725" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10790" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10778" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10766" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10819" sofa="1" begin="0" end="0" text="CLU1 promoter" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10807" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10871" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10859" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10847" sofa="1" begin="0" end="0" text="rs11136000 resides within intron 3" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10835" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10901" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10889" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10953" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10941" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10929" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10917" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10971" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11022" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11010" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10998" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="10986" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11064" sofa="1" begin="0" end="0" text="clusterin protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11052" sofa="1" begin="0" end="0" text="CLU mRNA" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11040" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11093" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11081" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11133" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11121" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11109" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11150" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11189" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11177" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11165" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11206" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11245" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11233" sofa="1" begin="0" end="0" text="rs11136000T allele" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11221" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11286" sofa="1" begin="0" end="0" text="clusterin proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11274" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11262" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11339" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11327" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11315" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11303" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11381" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11369" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11357" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11412" sofa="1" begin="0" end="0" text="CLU2 produce proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11400" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11440" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11428" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11456" sofa="1" begin="0" end="0" text="clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11471" sofa="1" begin="0" end="0" text="SH-SY5Y clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11522" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11510" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11498" sofa="1" begin="0" end="0" text="CLU2 -predicted proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11486" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11540" sofa="1" begin="0" end="0" text="V5 / His" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11591" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11579" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11567" sofa="1" begin="0" end="0" text="clusterin proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11555" sofa="1" begin="0" end="0" text="g004" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11621" sofa="1" begin="0" end="0" text="human brain clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11609" sofa="1" begin="0" end="0" text="cellular clusterin proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11675" sofa="1" begin="0" end="0" text="V5 epitope" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11663" sofa="1" begin="0" end="0" text="clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11651" sofa="1" begin="0" end="0" text="carboxyl-terminal clusterin epitope" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11639" sofa="1" begin="0" end="0" text="endogenous clusterin proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11705" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11693" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11733" sofa="1" begin="0" end="0" text="PNGase F" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11721" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11773" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11761" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11749" sofa="1" begin="0" end="0" text="PNGase" tag="B-PROTEIN" weight="0.0" synonyms="11788"/><types2:NER xmi:id="11812" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11800" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11852" sofa="1" begin="0" end="0" text="clusterin proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11840" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11828" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11881" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11869" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11909" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11897" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11949" sofa="1" begin="0" end="0" text="PNGase F digestion ( Figure 4 C" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11937" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11925" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11990" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11978" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="11966" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12043" sofa="1" begin="0" end="0" text="PNGase" tag="B-PROTEIN" weight="0.0" synonyms="12056"/><types2:NER xmi:id="12031" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12019" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12007" sofa="1" begin="0" end="0" text="PNGase F" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12095" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12083" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12071" sofa="1" begin="0" end="0" text="clusterin protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12136" sofa="1" begin="0" end="0" text="V5" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12124" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12112" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12167" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12155" sofa="1" begin="0" end="0" text="g003 CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12195" sofa="1" begin="0" end="0" text="ER" tag="B-PROTEIN" weight="0.0" synonyms="12208"/><types2:NER xmi:id="12183" sofa="1" begin="0" end="0" text="TGN46" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12281" sofa="1" begin="0" end="0" text="resultant clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12269" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12257" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12245" sofa="1" begin="0" end="0" text="ER" tag="B-PROTEIN" weight="0.0" synonyms="12297"/><types2:NER xmi:id="12233" sofa="1" begin="0" end="0" text="CLU2 encoded proteins" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12221" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12323" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12311" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12341" sofa="1" begin="0" end="0" text="clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12380" sofa="1" begin="0" end="0" text="TGN46" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12368" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12356" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12411" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12399" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12439" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12427" sofa="1" begin="0" end="0" text="t003 CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12467" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12455" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12495" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12483" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12523" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12511" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12551" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12539" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12579" sofa="1" begin="0" end="0" text="Figure 2 C" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12567" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12607" sofa="1" begin="0" end="0" text="CLU isoform" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12595" sofa="1" begin="0" end="0" text="g002" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12623" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12650" sofa="1" begin="0" end="0" text="rs11136000T allele" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12638" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12666" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12693" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12681" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12721" sofa="1" begin="0" end="0" text="CLU2 isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12709" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12737" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12752" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12767" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12806" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12794" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12782" sofa="1" begin="0" end="0" text="CLU isoform" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12871" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12859" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12847" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12835" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12823" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12892" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12955" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12943" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12931" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12919" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12907" sofa="1" begin="0" end="0" text="g001" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12976" sofa="1" begin="0" end="0" text="PSORT II" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13041" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13029" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13017" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13005" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="12993" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13086" sofa="1" begin="0" end="0" text="exon5 – exon 9" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13074" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13062" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13119" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13107" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13159" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13147" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13135" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13200" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13188" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13176" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13243" sofa="1" begin="0" end="0" text="CLU1 protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13231" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13219" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13272" sofa="1" begin="0" end="0" text="ATG site" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13260" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13312" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13300" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13288" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13341" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13329" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13369" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13357" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13385" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13414" sofa="1" begin="0" end="0" text="PNGase F" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13402" sofa="1" begin="0" end="0" text="PNGase F" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13430" sofa="1" begin="0" end="0" text="peroxidase" tag="B-PROTEIN" weight="0.0" synonyms="13443 13453 13463 13473 13483 13493 13503"/><types2:NER xmi:id="13527" sofa="1" begin="0" end="0" text="mouse anti-clusterin antibody" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13515" sofa="1" begin="0" end="0" text="mouse anti-V5 antibody" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13547" sofa="1" begin="0" end="0" text="protease" tag="B-PROTEIN" weight="0.0" synonyms="13560"/><types2:NER xmi:id="13572" sofa="1" begin="0" end="0" text="protease" tag="B-PROTEIN" weight="0.0" synonyms="13585"/><types2:NER xmi:id="13613" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13601" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13643" sofa="1" begin="0" end="0" text="Alexa-568 goat anti-rabbit IgG antibody" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13631" sofa="1" begin="0" end="0" text="Alexa-488 goat anti-mouse IgG antibody" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13707" sofa="1" begin="0" end="0" text="ab16052" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13695" sofa="1" begin="0" end="0" text="rabbit anti-TGN46 antibody" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13683" sofa="1" begin="0" end="0" text="rabbit anti-calnexin antibody" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13671" sofa="1" begin="0" end="0" text="ab27671" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13659" sofa="1" begin="0" end="0" text="mouse anti-V5 antibody" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13740" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13728" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13756" sofa="1" begin="0" end="0" text="ImmunofluorescenceCLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13797" sofa="1" begin="0" end="0" text="Pre-designed SNP" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13785" sofa="1" begin="0" end="0" text="TaqMan FAM" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13773" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13816" sofa="1" begin="0" end="0" text="hypoxanthine-guanine phosphoribosyltransferase 1 and ribosomal protein L13A" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13835" sofa="1" begin="0" end="0" text="CLU34" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13862" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13850" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13902" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13890" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13878" sofa="1" begin="0" end="0" text="t001 Real-time PCRThe" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13937" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13925" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13973" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13961" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14025" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14013" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14001" sofa="1" begin="0" end="0" text="CLU2 cDNAs" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="13989" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14083" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14071" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14059" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14047" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14137" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14125" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14113" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14101" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14179" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14167" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14155" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14196" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14223" sofa="1" begin="0" end="0" text="CLU isoform" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14211" sofa="1" begin="0" end="0" text="CLU isoform" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14287" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14275" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14263" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14251" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14239" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14334" sofa="1" begin="0" end="0" text="clusterin protein" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14322" sofa="1" begin="0" end="0" text="CLU mRNA" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14310" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14367" sofa="1" begin="0" end="0" text="P30AG028383" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14355" sofa="1" begin="0" end="0" text="P01AG030128" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14409" sofa="1" begin="0" end="0" text="rs11136000T allele" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14397" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14385" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14438" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14426" sofa="1" begin="0" end="0" text="AD-protective minor rs11136000T allele" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14502" sofa="1" begin="0" end="0" text="clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14490" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14478" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14466" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14454" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14557" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14545" sofa="1" begin="0" end="0" text="rs11136000T allele" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14533" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14521" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14587" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14575" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14651" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14639" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14627" sofa="1" begin="0" end="0" text="CLU isoforms" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14615" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="14603" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="2081" sofa="1" begin="0" end="0" text="ChemiDoc XRS" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="882" sofa="1" begin="0" end="0" text="CLU" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="870" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="238" sofa="1" begin="0" end="0" text="Top Clusterin" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="210" sofa="1" begin="0" end="0" text="rs11136000" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="198" sofa="1" begin="0" end="0" text="CLU isoform" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="169" sofa="1" begin="0" end="0" text="SH-SY5Y cellular mRNA" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="157" sofa="1" begin="0" end="0" text="CLU2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="145" sofa="1" begin="0" end="0" text="CLU1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="107" sofa="1" begin="0" end="0" text="SuperScript III" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="95" sofa="1" begin="0" end="0" text="reverse transcriptase" tag="B-PROTEIN" weight="0.0" synonyms="121"/><types2:NER xmi:id="65" sofa="1" begin="0" end="0" text="David W. Fardo2" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="53" sofa="1" begin="0" end="0" text="James F. Simpson1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="41" sofa="1" begin="0" end="0" text="Jiraganya Bhongsatiern1" tag="B-PROTEIN" weight="0.0" synonyms=""/><types2:NER xmi:id="29" sofa="1" begin="0" end="0" text="Clusterin Isoform Expression and Alzheimer 's Disease RiskI-Fang Ling1" tag="B-PROTEIN" weight="0.0" synonyms=""/><cas:View sofa="1" members="8 13 79 129 182 222 854 894 908 922 2037 2051 2065 2092 2104 4656 5136 5391 5803 5815 5827 5839 6007 6019 6031 7266 7281 7296 7311 7326 7341 7356 7377 7392 7407 7422 7440 7455 7470 7485 7500 7515 7530 7545 7560 7575 7593 7611 7626 7644 7659 7674 7689 7707 7722 7737 7752 7767 7782 7797 7812 7830 7845 7860 7875 7893 7908 7923 7938 7953 7968 7983 7998 8016 8031 8046 8061 8076 8091 8106 8121 8139 8154 8169 8184 8199 8214 8229 8244 8259 8274 8289 8304 8319 8334 8349 8364 8379 8394 8409 8424 8439 8454 8469 8484 8499 8514 8529 8544 8559 8574 8589 8604 8619 8634 8649 8664 8679 8694 8709 8724 8739 8754 8769 8784 8799 8814 8829 8844 8859 8874 8889 8904 8919 8934 8949 8964 8979 8994 9009 9024 9039 9054 9069 9084 9099 9114 9129 9144 9159 9174 9189 9204 9219 9234 9249 9264 9279 9294 9309 9324 9339 9354 9369 9384 9399 9414 9429 9444 9459 9474 9489 9504 9519 9534 9549 9564 9579 9594 9609 9624 9639 9654 9669 9684 9699 9714 9729 9744 9759 9774 9789 9804 9819 9834 9849 9864 9879 9894 9909 9924 14797 14809 14821 14833 14845 14857 14869 14881 14893 14905 14917 14929 14941 14953 14965 14977 14989 15001 15013 15025 15037 15049 15061 15073 15085 15097 15109 15121 15133 15145 15157 15169 15181 15193 15205 15217 15229 15241 15253 15265 15277 15289 15301 15313 15325 15337 15349 15361 15373 15385 15397 15409 15421 15433 15445 15457 15469 15481 15493 15505 15517 15529 15541 15553 15565 15577 15589 15601 15613 15625 15637 15649 15661 15673 15685 15697 15709 15721 15733 15745 15757 15769 15781 15793 15805 15817 15829 15841 15853 15865 15877 15889 15901 15913 15925 15937 15949 15961 15973 15985 15997 16009 16021 16033 16045 16057 16069 16081 16093 16105 16117 16129 16141 16153 16165 16177 16189 16201 16213 249 936 1526 2116 2624 2975 3269 3610 3938 4266 4607 4670 4729 4778 4868 4940 4989 5038 5087 5148 5197 5293 5342 5403 5452 5491 5530 5569 5608 5647 5686 5725 5764 5851 5890 5929 5968 6043 6071 6110 6149 6188 6227 6266 6305 6344 6383 6435 6474 6513 6565 6604 6643 6695 6747 6786 6825 6864 6903 6942 269 279 289 299 309 319 329 339 349 359 369 379 389 399 409 419 429 439 449 459 658 665 672 679 686 693 700 707 714 721 728 735 742 749 756 763 770 777 784 791 798 805 812 819 826 833 840 847 958 968 978 988 998 1008 1018 1028 1038 1048 1058 1068 1078 1088 1098 1108 1118 1330 1337 1344 1351 1358 1365 1372 1379 1386 1393 1400 1407 1414 1421 1428 1435 1442 1449 1456 1463 1470 1477 1484 1491 1498 1505 1512 1519 1548 1558 1568 1578 1588 1598 1608 1618 1628 1638 1648 1658 1668 1678 1688 1869 1876 1883 1890 1897 1904 1911 1918 1925 1932 1939 1946 1953 1960 1967 1974 1981 1988 1995 2002 2009 2016 2023 2030 2138 2148 2158 2168 2178 2188 2198 2208 2218 2228 2238 2248 2258 2268 2278 2288 2456 2463 2470 2477 2484 2491 2498 2505 2512 2519 2526 2533 2540 2547 2554 2561 2568 2575 2582 2589 2596 2603 2610 2617 2646 2656 2666 2676 2686 2696 2706 2716 2726 2736 2746 2863 2870 2877 2884 2891 2898 2905 2912 2919 2926 2933 2940 2947 2954 2961 2968 2997 3007 3017 3027 3037 3047 3057 3067 3077 3185 3192 3199 3206 3213 3220 3227 3234 3241 3248 3255 3262 3291 3301 3311 3321 3331 3341 3351 3361 3371 3381 3498 3505 3512 3519 3526 3533 3540 3547 3554 3561 3568 3575 3582 3589 3596 3603 3632 3642 3652 3662 3672 3682 3692 3702 3712 3722 3840 3847 3854 3861 3868 3875 3882 3889 3896 3903 3910 3917 3924 3931 3960 3970 3980 3990 4000 4010 4020 4030 4040 4050 4168 4175 4182 4189 4196 4203 4210 4217 4224 4231 4238 4245 4252 4259 4288 4298 4308 4318 4328 4338 4348 4358 4368 4378 4495 4502 4509 4516 4523 4530 4537 4544 4551 4558 4565 4572 4579 4586 4593 4600 4629 4639 4692 4702 4712 4751 4761 4800 4810 4820 4830 4840 4892 4902 4912 4962 4972 5011 5021 5060 5070 5109 5119 5170 5180 5221 5231 5241 5315 5325 5364 5374 5425 5435 5474 5513 5552 5591 5630 5669 5708 5747 5786 5873 5912 5951 5990 6063 6093 6132 6171 6210 6249 6288 6327 6366 6407 6457 6496 6537 6587 6626 6667 6719 6769 6808 6847 6886 6925 6964 520 530 540 550 560 570 580 590 600 610 620 630 640 650 1192 1202 1212 1222 1232 1242 1252 1262 1272 1282 1292 1302 1312 1322 1751 1761 1771 1781 1791 1801 1811 1821 1831 1841 1851 1861 2338 2348 2358 2368 2378 2388 2398 2408 2418 2428 2438 2448 2785 2795 2805 2815 2825 2835 2845 2855 3127 3137 3147 3157 3167 3177 3420 3430 3440 3450 3460 3470 3480 3490 3772 3782 3792 3802 3812 3822 3832 4100 4110 4120 4130 4140 4150 4160 4417 4427 4437 4447 4457 4467 4477 4487 6981 6987 14668 14673 14678 14683 14688 14693 14698 14703 14708 14713 17675 14718 14727 14734 14741 14748 14755 14762 14769 14776 14783 14790 121 9966 9976 9986 9996 10006 10016 10026 10036 10046 10056 10066 10076 10086 10096 10106 10116 10127 10403 11788 12056 12208 12297 13443 13453 13463 13473 13483 13493 13503 13560 13585 259 266 946 955 1536 1545 2126 2135 2634 2643 2985 2994 3279 3288 3620 3629 3948 3957 4276 4285 4626 4689 4748 4797 4889 4959 5008 5057 5106 5167 5218 5312 5361 5422 5471 5510 5549 5588 5627 5666 5705 5744 5783 5870 5909 5948 5987 6060 6090 6129 6168 6207 6246 6285 6324 6363 6404 6454 6493 6534 6584 6623 6664 6716 6766 6805 6844 6883 6922 6961 16225 17183 17196 17206 17216 17232 17239 17246 17256 17266 17276 17283 17287 17291 17295 17299 17303 17310 17314 17318 17322 17326 17330 17334 17338 17342 17346 17350 17354 17358 17362 17369 17373 17377 17381 17385 17389 17393 17397 17401 17405 17409 17413 17417 17421 17425 17429 17433 17437 17441 17445 17449 17453 17457 17461 17465 17469 17473 17477 17481 17485 17486 17487 17488 17489 17490 17491 17492 17493 17494 17495 17496 17497 17498 17499 17500 17501 17502 17503 17504 17505 17506 17507 17508 17509 17510 17511 17512 17513 17514 17515 17516 17517 17518 17519 17520 17521 17522 17523 17524 17525 17526 17527 17528 17529 17530 17531 17532 17533 17534 17535 17536 17537 17538 17539 17540 17541 17542 17543 17544 17545 17546 17547 17548 17549 17550 17551 17552 17553 17554 17555 17556 17557 17558 17559 17560 17561 17562 17563 17564 17565 17566 17567 17568 17569 17570 17571 17572 17573 17574 17575 17576 17577 17578 17579 17580 17581 17582 17583 17584 17585 17586 17587 17588 17589 17590 17591 17592 17593 17594 17595 17596 17597 17598 17599 17600 17601 17602 17603 17604 17605 17606 17607 17608 17609 17610 17611 17612 17613 17614 17615 17616 17617 17618 17619 17620 17621 17622 17623 17624 17625 17626 17627 17628 17629 17630 17631 17632 17633 17634 17635 17636 17637 17638 17639 17640 17641 17642 17643 17644 17645 17646 17647 17648 17649 17650 17651 17652 17653 17654 17655 17656 17657 17658 17659 17660 17661 17662 17663 17664 17665 17666 17667 17668 17669 17670 17671 17672 17673 17674"/></xmi:XMI>